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Secondary metabolites are often restricted in their distribution to different groups of organisms.
For this reason, attempts to study these often useful and interesting products of metabolism require
an ability to work in a diversity of non-model species. Methods for gene discovery with low
investment and high efficiency are needed to effectively identify the biosynthetic genes in these
diverse pathways. During this work, a workflow for efficiently identifying biosynthetic genes was
developed and applied to Amaryllidaceae alkaloid biosynthesis. Genes discovered during this
work include a norbelladine 4’-O-methyltransferase, a cytochrome P450 capable of phenol-phenol
coupling

4’-O-methylnorbelladine

dehydrogenase/reductase

capable

of

to

noroxomaritidine,

forming

norbelladine

and
from

a

tyramine

short-chain
and

3,4-

dihydroxybenzaldehyde. These enzymatic discoveries support the future application of this
workflow to other biosynthetic pathways and organisms.
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Chapter 1: Introduction: The
Amaryllidaceae Alkaloids: Biosynthesis
and Methods for Enzyme Discovery
This chapter is in press as a review in Phytochemistry Reviews as:
The Amaryllidaceae alkaloids: biosynthesis and methods for enzyme discovery
Matthew B. Kilgore1 and Toni M. Kutchan1
1

Donald Danforth Plant Science Center, St. Louis, MO, USA

Amaryllidaceae alkaloids are an example of the vast diversity of secondary metabolites with great
therapeutic promise. The identification of novel compounds in this group with over 300 known
structures continues to be an area of active study. The recent assembly of a transcriptome for
Lycoris aurea highlights the potential for discovery of Amaryllidaceae alkaloid biosynthetic genes
with new technologies. Recent technical advances of interest to studies in non-model species
include those in enzymology, next generation sequencing, nuclear magnetic resonance
spectroscopy (NMR), and mass spectrometry (MS). In this thesis, improvements in sequencing
and co-expression analysis introduced in this chapter are utilized to discover three Amaryllidaceae
alkaloid biosynthetic genes. This is done using the hypothesis that genes involved in the
biosynthesis of particular Amaryllidaceae alkaloids are co-regulated and this leads to correlations
between biosynthetic gene expression and corresponding end product accumulation. At the end of
this introduction, a summary of the individual chapters in the thesis is presented.

1

1.1 Amaryllidaceae Alkaloids
1.1.1 Amaryllidaceae Description with a Narcissus spp. Emphasis
The Amaryllidaceae are a family of bulbous plants with leaves and flowers growing from the top
of a bulb and roots growing from the base of the bulb (Figure 1.1A, B, and C). During this work,
experiments were conducted on members of the Galanthus and Narcissus genera of this family
with the majority of the enzymology on Narcissus sp. aff. pseudonarcissus proteins. Most
Narcissus spp. bloom in the spring followed by leaf, inflorescence, and root senescence. This leads
to a summer of primordia development inside the bulb. During the winter, the roots grow to full
size while leaf and inflorescence tissues grow slowly. The leaf and inflorescence tissues grow
quickly in the spring (Rees, 1969). It can take 3-8 years for a Narcissus sp. plant to reach flowering
age from seed. Starch storage is mediated by bulb scales and old leaf bases that make up the layers
of the bulb. Over the years, bulb depth in the soil is maintained by unbranched contractile roots
(Rees, 1969; Gordon, 2002). The presence of mycorrhizal interactions with Narcissus sp. roots
have been observed (Chilvers and Daft, 1981). Wild Narcissus spp. reproduction is through the
generation of bulblets or seed. Axillary buds inside the bulb develop into bulblets, with
approximately one initiated per year (Rees, 1969). The ability to efficiently reproduce by seed is
limited for many commercial cultivars because they are the result of crosses between species,
which renders them semi-sterile. These cultivars are propagated by bulb mediated bulblet
generation or tissue culture methods for bulblet generation from bulb fragments (Chen and Ziv,
2005).

2

Figure 1.1 Photos of Narcissus sp. aff. pseudonarcissus and Galanthus sp.(A) An herbarium sample of Narcissus sp.
aff. pseudonarcissus collected and pressed by Megan Augustin with major organs labeled. (B) A clump of Narcissus
sp. aff. pseudonarcissus plants in flowering in late-march. (C) Galanthus sp. flowering in early-march.

1.1.2 Amaryllidaceae Alkaloid Introduction
The Amaryllidaceae have a long history as medicines in the cultures throughout their natural range
spanning the Mediterranean, Central America, South America, Europe, Asia, and Africa (Plaitakis
and Duvoisin, 1983; Louw et al., 2002; Cabezas et al., 2003; Howes and Houghton, 2003). The
3

Amaryllidaceae alkaloids are responsible for the medicinal properties of the Amaryllidaceae and
are largely restricted to the family Amaryllidaceae, specifically the subfamily Amaryllidoideae
(Chase et al., 2009). A noteworthy exception is the collection of alkaloids that have been found in
the genus Hosta that is in the order Asparagales along with Amaryllidaceae (Chase et al., 2009; Li
et al., 2012). New Amaryllidaceae alkaloid structures and the biosynthesis of these alkaloids have
recently been reviewed (Kornienko and Evidente, 2008; Bastida et al., 2011; Jin, 2013; Takos and
Rook, 2013). Galanthamine is a prime example of the Amaryllidaceae alkaloids. It is one of the
three primary drugs used for the treatment of Alzheimer’s disease. The Amaryllidaceae alkaloids
and their derivatives have been a source of novel acetylcholine esterase inhibitors, anti-cancer
compounds, anti-viral compounds, and antibacterial compounds with potential clinical
applications. The last 10 years of progress in the identification of these bioactive compounds has
recently been reviewed (He et al., 2015).
The in planta roles of these alkaloids are not as thoroughly examined as their potential
medicinal roles. Some potential in planta roles of these compounds can be postulated based on
their observed biological activities in vivo and in vitro on both mammals and other plant species.
Several Amaryllidaceae alkaloids have been shown to have anti-cancer properties including the
following examples haemanthamine, lycorine, narciclasine, lycoricidine, pancratistatin, β-crinane
distichamine, and narciprimine (Liu et al., 2004; Havelek et al., 2014; He et al., 2015). These
compounds have been highlighted as potential anticancer compounds because of their preferential
cytotoxic action on cancer cell lines over normal cells, but there is usually back-ground toxicity
for normal cells at higher doses. So, these cytotoxic compounds could be poisonous or illness
inducing to an herbivore if consumed in adequate quantities; for this reason, it is possible these
compounds act as herbivore deterrents. Galanthamine, sanguinine, ungiminorine, and 1-O4

acetyllycorine are acetylcholine esterase inhibitors (Irwin and Smith, 1960; He et al., 2015).
Several insecticides including organophosphates and carbamates also act as acetylcholine esterase
inhibitors and cause uncontrolled nerve firing that can lead to death (Casida, 1964). Hence, activity
that makes these alkaloids potential Alzheimer’s treatments my serve in planta as an herbivore
deterrent acting on the nervous system. One of the side effects of galanthamine ingestion in humans
is an upset stomach and diarrhea supporting its role as an herbivore deterrent (Hughes et al., 2004).
Species of Amaryllidaceae frequently have a terrible taste and cause vomiting when ingested. As
a result, poisoning from these species is rare. Oral administration of the Amaryllidaceae species
Boophone disticha ethanol extracts to rats in doses of 240 mg/kg or higher results in death with
symptoms reminiscent of acetylcholinesterase poisoning (tremors, convulsions, paralysis, and
labored breathing) demonstrating the poisonous potential of Amaryllidaceae species (Gadaga et
al., 2011). Some Amaryllidaceae alkaloids could have a similar role in planta as proposed for the
clinic. Several Amaryllidaceae alkaloids are documented to have antiviral (lycorine, pancratistatin,
hippeastrine, and haemanthamine), antibacterial (lycorine, ungeremine), and antiprotozoal
(lycorine) properties which are as pertinent to plants as to humans when exposed to these classes
of parasites (He et al., 2015). In addition to dealing with herbivores and parasites, Amaryllidaceae
may use some of their compounds to modulate the growth of neighboring plants through
allelopathy or perhaps modulate their own growth. The Amaryllidaceae alkaloid narciclasine is a
prime example of a potential allelopathy (inhibitor of surrounding plant growth) agent with well
documented inhibition of Arabidopsis seed germination and seedling growth. The effect is partly
due to inhibition of polar auxin transport in roots and perhaps other tissues (Na et al., 2011).
There are still new alkaloids being discovered in the Amaryllidaceae alkaloids and even
novel carbon skeletons with great potential to contribute to the list of known biologically active
5

compounds. A diversity of carbon skeletons are known for this group of alkaloids including
hostasinine, belladine, galanthamine, crinine, lycorine, galanthindole, homolycorine, galasine,
montanine, cripowellin, cherylline, buflavine, plicamine, tazettine, graciline, augustamine,
pancratistatin, and gracilamine (Jin, 2009). Many of these compounds are of great potential
pharmacological significance and their production through biological means is an area of great
interest.

1.1.3 Prevalent Biosynthetic Gene Superfamilies
To further the biological production of these compounds, an understanding of their biosynthetic
genes is requisite and the majority of the reactions are reaction types that are typically catalyzed
by a collection of characterized enzyme families. The knowledge of these families can help inform
efforts through homology searches to identify candidate genes. When studying secondary
metabolism, in particular Amaryllidaceae alkaloid biosynthesis, several reaction types appear
frequently including methylation, reduction, oxidation, condensation, hydroxylation, phenolphenol’ coupling, and oxide bridge formation. Examples of reductions found in the
Amaryllidaceae include reduction of ketones, aldehydes, carbon-carbon double bonds, and imines.
Two reductase superfamilies noted for their tendency to reduce aldehydes, ketones, carbon-carbon
double

bonds,

and

imines

include

aldo-keto

reductases

(AKRs)

and

short-chain

dehydrogenase/reductases (SDRs) (Jörnvall et al., 1995; Penning, 2015). The SDR superfamily
consists of three families including short-chain dehydrogenase/reductases, medium-chain
dehydrogenase/reductases (MDRs) also known as alcohol dehydrogenases (ADH), and long-chain
dehydrogenases/reductases (LDRs) (Kavanagh et al., 2008; Penning, 2015). The common feature
of the SDR superfamily is a “Rossmann-fold” which is involved in the binding of dinucleotide
cofactors including NADPH or NADH (Kavanagh et al., 2008). In Chapter 4, an SDR is identified
6

with the ability to reduce norcraugsodine, an early intermediate in Amaryllidaceae alkaloid
biosynthesis. Oxidation reactions creating these various double bonds could be catalyzed by AKRs
and SDRs as well because of the potential of these enzyme families to drive oxidations (Porté et
al., 2013). 2-Oxoglutarate dependent dioxygenases and cytochrome P450 enzymes are well known
for their ability to hydroxylate substrates thus making them good candidate gene families for the
various hydroxylases in the biosynthesis of the Amaryllidaceae alkaloids (Lester et al., 1997;
Nelson and Werck-Reichhart, 2011). The formation of an oxide bridge from a methoxy and
hydroxyl group is probably catalyzed by a cytochrome P450 because CYP81Q1, CYP719A1,
CYP719A13, and CYP719A14 are enzymes shown to catalyze this type of reaction (Ikezawa et
al., 2003; Ono et al., 2006; Díaz Chávez et al., 2011). Phenol-phenol’ coupling reactions are also
likely catalyzed by cytochrome P450 enzymes. The cytochromes P450 CYP81Q1, CYP719A1,
CYP719A13, and CYP719A14 have been shown to catalyze phenol-phenol coupling reactions and
are proposed to act by a diradical mechanism (Ikezawa et al., 2003; Ono et al., 2006; Díaz Chávez
et al., 2011). A phenol-phenol coupling cytochrome P450 forms a radical hydroxyl group on each
of the phenol groups to be coupled. Resonance structures of these phenol radicals allow the single
electron to be ortho or para to the initially radicalized hydroxyl. As a result, the electrons from the
two phenol groups from a C-C bond with the possible phenol-phenol coupling possibilities of
ortho-para, para-para, or para-ortho. In the case of the Amaryllidaceae alkaloids, a subsequent
spontaneous nitrogen-ring closure (haemanthamine, crinine, and lycorine type) or oxygen-ring
closure (galanthamine type) prevents the generation of a double phenol end product (Eichhorn et
al., 1998). In other systems, however, with no further reactions or new quaternary carbons, both
phenol groups are regenerated through rearrangement of hydrogens. In Chapter 3, CYP96T1 is
shown to perform the para-para’ phenol-phenol coupling reaction that makes the haemanthamine
7

and crinine carbon skeletons. Other enzyme groups noted for their ability to perform phenolphenol’ coupling reactions are laccases and peroxidases (Schlauer et al., 1998; Constantin et al.,
2012). In the Amaryllidaceae two forms of methylation are common: O-methylation and Nmethylation. O-Methyltransferases are divided into class I and class II methyltransferases (Ibdah
et al., 2003). It is shown in Chapter 2 that the class I O-methyltransferase, N4OMT is responsible
for the methylation of norbelladine to 4’-O-methylnorbelladine in Amaryllidaceae alkaloid
biosynthesis (Kilgore et al., 2014). Other O-methylation reactions in the biosynthesis of these
compounds could be catalyzed by homologues to N4OMT or homologues to other known Omethyltransferases including reticuline 7-O-methyltransferase, (R,S)-norcoclaurine 6-Omethyltransferase, columbamine O-methyltransferase, chavicol O-methyltransferase, and eugenol
O-methyltransferase (Gang et al., 2002; Morishige et al., 2002; Ounaroon et al., 2003). Examples
of N-methyltransferases that could share homology with N-methyltransferases involved in several
Amaryllidaceae alkaloid biosynthetic pathways include coclaurine N-methyltransferase and
caffeine synthase (Kato et al., 2000; Choi et al., 2002). Homologues of O-methyltransferases
would be of potential interest when looking for an N-methyltransferase as well because of the close
homology that exists between the O- and N- methyltransferases (Raman and Rathinasabapathi,
2003).

1.1.4 Core Biosynthetic Pathway
Intermediate Discovery
The core biosynthetic pathway of the Amaryllidaceae alkaloids consists of the reactions required
to produce 3,4-dihydroxybenzaldehyde and tyramine, the condensation and reduction of these
precursors to norbelladine, and the subsequent methylation of norbelladine to 4’-Omethylnorbelladine (Figure 1.2). Phenylalanine and tyrosine were shown to be precursors for
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haemanthamine

by

incorporation

of

[3-14C]phenylalanine

and

[3-14C]tyramine

into

haemanthamine in Nerine bowdenii (Wildman et al., 1962b). Degradation experiments of
haemanthamine generated from radiolabeled tyramine were used to demonstrate the placement of
the labeled carbons on positions C11 and C12 in experiments with [2-14C]tyrosine in Sprekelia
formosissima and [1-14C]tyrosine in Narcissus ‘Twink’ daffodil (Battersby et al., 1961a; Wildman
et al., 1962a). [3-14C]Tyramine has also been documented to incorporate into haemanthamine,
haemanthidine, and 6-hydroxycrinamine in Haemanthus natalensis bulbs (Jeffs, 1962). Lycorine
and norpluviine have been shown to incorporate [2-14C]tyramine and [1-14C]tyramine in Narcissus
“Twink” (Battersby and Binks, 1960; Battersby et al., 1961b). [14C]Phenylalanine and [3H]3,4dihydroxybenzaldehyde were both shown to be precursors to the aromatic half of haemanthamine
and lycorine (Suhadolnik et al., 1962, 1963b). The pathway from phenylalanine to the intermediate
3,4-dihydroxybenzaldehyde was determined by feeding to Narcissus pseudonarcissus [314

C]trans-cinnamic acid, [3-14C]4-hydroxycinnamic acid, [7-14C]benzaldehyde, [7-14C]4-

hydroxybenzaldehyde, [3H]3,4-dihydroxybenzaldehyde and [3H]threo-DL-phenylserine and
monitoring production of haemanthamine. The precursors [3-14C]trans-cinnamic acid, [3-14C]4hydroxycinnamic acid, [3H]3,4-dihydroxybenzaldehyde and [7-14C]4-hydroxybenzaldehyde
showed incorporation into haemanthamine. This led to the conclusion that the pathway for
conversion of phenylalanine to 3,4-dihydroxybenzaldehyde is in the following sequence:
phenylalanine, trans-cinnamic acid, 4-hydroxycinnamic acid, 3,4-dihydroxycinnamic acid or 4hydroxybenzaldehyde, and 3,4-dihydroxybenzaldehyde (Suhadolnik et al., 1963a). 3,4Dihydroxybenzaldehyde has been documented in Hydnophytum formicarum and other plants
outside the Amaryllidaceae (Prachayasittikul et al., 2008). It is possible that the 3,4dihydroxybenzaldehyde pathway is more phylogenetically spread than the latter steps or
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convergent evolution of product formation has occurred. Carbon fourteen labeled norbelladine is
incorporated into the alkaloids lycorine, crinamine, belladine, haemanthamine, and norpluviine
(Battersby et al., 1961b; Battersby et al., 1961a; Wildman et al., 1962c). 4’-O-Methylnorbelladine
is a precursor of all the primary alkaloid skeletons including crinine (crinine), haemanthamine
(vittatine, 11-hydroxyvittatine), galanthamine (galanthamine, N-demethylgalanthamine, and Ndemethylnarwedine), and lycorine (lycorine, norpluviine, and galanthine) (Kirby and Tiwari,
1966; Bruce and Kirby, 1968; Fuganti and Mazza, 1972b, a; Fuganti, 1973; Eichhorn et al., 1998).
4’-O-Methylnorbelladine has long been considered the direct substrate for creation of the parapara’ and ortho-para’ carbon skeletons. 4’-O-Methylnorbelladine has recently been established
as the direct precursor of the para-ortho’ skeleton as well (Eichhorn et al., 1998). This universal
requirement in all phenol-phenol coupling branches for 4’-O-methylnorbelladine makes it the last
common intermediate before a three way split in the Amaryllidaceae biosynthetic pathway. The
three common divisions at 4’-O-methylnorbelladine are the para-para’ coupling that leads to the
crinine and vittatine enantiomeric series, the ortho-para’ phenol coupling that is elaborated into
the classic alkaloid lycorine, and the para-ortho’ coupling that is elaborated into the most widely
used Amaryllidaceae alkaloid galanthamine (Figure 1.3). Most other Amaryllidaceae alkaloid
carbon skeletons are thought to be derivatives of these four skeletons. Examples include the
pancratistatin and tazettine carbon skeletons derived from the haemanthamine skeleton and the
homolycorine skeleton derived from the lycorine skeleton (Figure 1.4 and 1.5). The belladine-type
alkaloids are thought to originate by the simple methylation of norbelladine, though the order of
methylations is not determined. The cherylline skeleton is thought to originate from hydroxylation
at the 11-position of the norbelladine skeleton and subsequent cyclization with the dioxygenated
phenol group (Chan, 1973).
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Figure 1.2. Core biosynthetic pathway for Amaryllidaceae alkaloids. Phenylalanine is converted to trans-cinnamic
acid by phenylalanine ammonia lyase (PAL) and then to 4-hydroxycinnamic acid by CYP73A1. 4-hydroxycinnamic
acid is potentially converted to 3,4-dihydroxycinnamic acid by CYP98A3 or to 4-hydroxybenzaldehyde and then to
3,4-dihydroxybenzaldehyde potentially by a VpVAN paralogue. Tyrosine is converted to tyramine by tyrosine
decarboxylase. 3,4-dihyroxybenzaldehyde and tyramine are condensed to form the Schiff-base, norcraugsodine, and
reduced by an unknown reductase into norbelladine. Norbelladine is methylated by norbelladine 4’-Omethyltransferase (N4OMT) into 4’-O-methylnorbelladine.
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Enzymology
The biosynthesis of 3,4-dihydroxybenzaldehyde from phenylalanine likely involves the early
phenylpropanoid biosynthetic pathway all the way to caffeic acid (3,4-dihydroxycinnamic acid).
Assuming the involvement of the phenylpropanoid pathway, 3,4-dihyroxycinnamic acid is a more
likely intermediate in the biosynthesis than 4-hydroxybenzaldehyde. This is in agreement with the
relatively low incorporation of 4-hydroxybenzaldehyde in radiolabeling experiments (Suhadolnik
et al., 1963a). The deamination of phenylalanine to trans-cinnamic acid is done by phenylalanine
ammonia lyase (PAL) (Tanaka et al., 1989). LrPAL1 and LrPAL2 have been cloned from the
Amaryllidaceae plant Lycoris radiata demonstrating the presence of this enzyme in the
Amaryllidaceae (Jiang et al., 2011; Jiang et al., 2013). The hydroxylation of trans-cinnamic acid
to 4-hydroxycinnamic acid is done by cinnamate 4-hydroxylase (CYP73A1) (Fahrendorf and
Dixon, 1993; Teutsch et al., 1993). CYP98A3 has been documented to hydroxylate the 3-position
of 4-hydroxycinnamic acid (Franke et al., 2002). However, CYP98A3 prefers the shikimic acid or
quinic acid esters over the free 4-hydroxycinnamic acid (Schoch et al., 2001; Franke et al., 2002).
For this reason, it is possible a detour is required through shikimic acid, quinic acid, or acyl-CoA
esters to get hydroxylated 3,4-dihydroxycinnamic acid. The conversion 3,4-dihydroxycinnamic
acid to 3,4-dihydroxybenzaldehyde appears very similar to the conversion of ferulic acid to
vanillin by vanillin synthase (VpVAN), a hydratase/lyase (Gallage et al., 2014). The only
difference is that the 3-hydroxyl is methylated in vanillin biosynthesis. Because of the substrate
and reaction similarity, it is possible this reaction is catalyzed by an enzyme related to VpVAN.
Interestingly, there has been debate regarding the VpVAN’s preference for ferulic acid or 4hydroxycinnamic acid (Havkin-Frenkel et al., 2003). If a similar enzyme in 3,4dihydroxybenzaldehyde biosynthesis shares the ability to perform this reaction on substrates that
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have or have not been hydroxylated at the 3-position, it would explain some of the ambiguity
observed in earlier radiolabeling experiments. The conversion of tyrosine to tyramine is likely
done by a homologue to the enzyme responsible for this reaction in other systems, tyrosine
decarboxylase (Lehmann and Pollmann, 2009). This homologue in Narcissus sp. aff.
pseudonarcissus, KT378599, has been cloned and confirmed to have tyrosine decarboxylase
activity (Appendix A).
Prior to this thesis, the enzymology behind the condensation and subsequent reduction of
3,4-dihydroxybenzaldheyde and tyramine was unknown. The formation of the predicted Schiffbase intermediate, norcraugsodine, from tyramine and 3,4-dihydroxybenzaldehyde was possibly a
spontaneous reaction occurring in solution, an enzymatically catalyzed condensation or both. The
following reduction of the imine double bond to make norbelladine was potentially done by a
reductase belonging to the AKR or SDR superfamilies. An SDR in the ADH family,
tetrahydroalstonine synthase, from Catharanthus roseus can reduce the imine bond on strictosidine
to form tetrahydroalstonine (Stavrinides et al., 2015). An enzyme, norcraugsodine reductase,
capable of reducing norcraugsodine and potentially condensing 3,4-dihydroxybenzaldehyde and
tyramine is discovered and described in Chapter 4. Several more NADPH-dependent imine
reductases have been characterized in bacteria (Wetzl et al., 2015). After this reduction,
norbelladine is shown in Chapter 2 to be methylated by the class I methyltransferase N4OMT in
Narcissus sp. aff. pseudonarcissus (Kilgore et al., 2014). The three common phenol-phenol’
coupling reactions that follow require the same biochemistry to operate and are likely done by
cytochrome P450 enzymes, laccases, or peroxidases (Schlauer et al., 1998; Ikezawa et al., 2003;
Ono et al., 2006; Díaz Chávez et al., 2011; Constantin et al., 2012).

13

Figure 1.3. Primary Amaryllidaceae skeleton biosynthetic pathways with elaboration into the alkaloids
haemanthamine, crinine, lycorine, and galanthamine.
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Figure 1.4. Para-para’ phenol-phenol’ coupling-derived skeletons found in the Amaryllidaceae.
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Figure 1.5. Carbon skeleton rearrangements in narciclasine, tazettine, and plicamine biosynthesis.

1.1.5 Galanthamine-Type Alkaloid Biosynthesis
Galanthamine is the representative alkaloid of the galanthamine type carbon skeleton. It is an
Amaryllidaceae alkaloid used to treat the symptoms of Alzheimer’s disease (Wilcock et al., 2000).
Because of its importance, several studies have been done with radiolabeled isotopes to determine
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its biosynthetic pathway (Barton et al., 1961; Barton and Kirby, 1962; Eichhorn et al., 1998). Initial
studies

by

Barton

et

al.

with

4’-O-methyl-[N-methyl-14C]norbelladine,

[N-methyl-

C]norbelladine, and [4’-O-methyl-14C]norbelladine as precursors of galanthamine showed no
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incorporation of [4’-O-methyl-14C]norbelladine and a significant incorporation of 4’-O-methyl[N-methyl-14C]norbelladine and [N-methyl-14C]norbelladine. This lead to the conclusion that Nmethylation occurs at the norbelladine stage and subsequent O-methylation yields 4’-O-methyl-Nmethylnorbelladine. This 4’-O-methyl-N-methylnorbelladine substrate was a precursor for phenolphenol’ coupling to narwedine that lead to galanthamine through a subsequent reduction (Barton
and Kirby, 1962). This view was revised by subsequent work in Leucojum aestivum where it was
shown that 4’-O-methylnorbelladine could be used as a substrate for phenol-phenol’ coupling
(Figure 1.3). The incorporation of 4’-O-methyl-N-methylnorbelladine was found to be one third
the rate of incorporation of 4’-O-methylnorbelladine with an N-demethylation then occurring prior
to conversion to galanthamine. N-Demethylgalanthamine was shown to be converted into
galanthamine as well (Eichhorn et al., 1998). These two studies are an example of the limitations
of conclusions drawn from negative results in radiolabeling experiments, especially considering
the low incorporation rates observed in the initial study by Barton and Kirby (Barton and Kirby,
1962). The subsequent experiments by Eichhorn et al. revised the pathway establishing 4’-Omethylnorbelladine as the phenol-phenol’ coupling substrate to make N-demethylnarwedine. NDemethylnarwedine is reduced to N-demethylgalanthamine followed by N-methylation to make
galanthamine (Eichhorn et al., 1998).
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1.1.6 Haemanthamine, Pancratistatin, Gracilamine, Cripowellin, Tazettine,
Plicamine, Hostasinine, Graciline, Augustamine, and Montanine-Type
Alkaloid Biosynthesis
Haemanthamine and crinine are Amaryllidaceae alkaloids with well determined biosynthetic
pathways and are the representative alkaloids of their respective skeleton types (Figure 1.3). The
phenol-phenol’ coupling reaction for the biosynthesis these skeletons proceeds with a para-para’
coupling. A transient achiral intermediate is generated. Following the phenol coupling, the
nitrogen attacks one of two carbon double bonds to generate each of the enantiomeric carbon
skeletons. Given the absence of the crinine skeleton in many genera that contain the
haemanthamine skeleton, an enzyme must be guiding this ring closure. In haemanthamine
biosynthesis, (10bR,4aS)-noroxomaritidine results from phenol coupling which is then reduced to
normaritidine. Normaritidine is oxidized to vittatine by the formation of an oxide bridge. The same
enzymatic reactions are required for the conversion of the (10bS,4aR)-noroxomaritidine to crinine
with some ambiguity surrounding the order of reduction and oxide bridge formation. If reduction
is first, macowine is the intermediate, but if oxide bridge formation is first, oxocrinine is the
intermediate (Fuganti and Mazza, 1972b). To make haemanthamine from vittatine requires
hydroxylation and methylation. Hydroxylation to 11-hydroxyvittatine is considered the next step
followed by methylation to haemanthamine as indicated by the incorporation of 11hydroxyvittatine into haemanthidine which is a hydroxylated derivative of haemanthamine (Fales
and Wildman, 1964; Fuganti, 1973). Since 11-hydroxyvittatine is not a catechol, this methylation
is likely catalyzed by a homologue to a class II methyltransferase (Joshi and Chiang, 1998). A 2oxoglutarate dioxygenase is found to hydroxylate vittatine into one of the diastereomeric forms of
11-hydroxyvittatine in Appendix B.
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Radiolabeling studies with [2,4-3H2-4’-O-methyl-14C]norbelladine and [1,4a-3H2-4’-Omethyl-14C]norbelladine as precursors have been used to demonstrate the biosynthesis of
narciclasine, a common pancratistatin-type alkaloid, through the para-para’ phenol-coupling route
(Figure 1.5). In corroboration, feeding of [3H]norpluviine with no significant incorporation
demonstrated the ortho-para’ route to be an unlikely contributor to the biosynthesis of narciclasine
(Fuganti et al., 1971). Narciclasine has been shown to be labeled from the racemic precursors
[1,4a-3H2]noroxomaritidine, [1,3,4a-3H3]normaritidine, and [3-3H]vittatine in Narcissus "Twink"
and Narcissus "Texas" plants (Fuganti and Mazza, 1971). [2,4-3H2]Crinine and [2,4-3H2]vittatine
were made by feeding [2, 4-3H2]4’-O-methylnorbelladine to species known for making these two
enantiomers, Nerine bowdenii and Pancratium maritimum, respectively. When fed to Narcissus
“Twink” and Narcissus “Texas”, [2,4-3H2]crinine was not incorporated into narciclasine and [2,43

H2]vittatine was incorporated. This shows the vittatine enantiomer to be the proper substrate and

established the absolute configuration of narciclasine (Fuganti and Mazza, 1972b). [2,4-3H2]11Hydorxyvittatine has been shown to incorporate into narciclasine and haemanthamine (Fuganti,
1973). 11-Hydroxyvittatine is the last theoretical common intermediate between haemanthamine
and narciclasine. After formation of 11-hydroxyvittatine, the synthesis of narciclasine requires a
series of reactions including a retro-Prins reaction, amine oxidation, 3 hydroxylations, and
oxidation of a hydroxyl to a ketone. The retro-Prins reaction would result in the C2-hydroxyl,
cleavage of the C10b-11 bond, and immigration of the C1-2 double bond to C10b-1. The amine
oxidation to an imine between the nitrogen and C12, in addition to the retro-Prins reaction, would
allow the release of the C11-12 carbon skeleton as glyoxal. The hydroxylations would occur at
positions 4, 6, and 7. The hydroxyl at position 7 would subsequently be oxidized to a ketone. The
Retro-Prins reaction has been implicated as a mechanism for germacradienol/germacrene D
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synthase from Streptomyces coelicolor (Jiang et al., 2006). If the C2 bond is oxidized and then
severed by hydrolysis, SDR and AKR enzymes are prime candidates due to their potential to
perform oxidation reactions.
Gracilamine is an unusual dinitrogenous alkaloid skeleton first discovered in 2005 (Ünver
and Kaya, 2005). It has been proposed to be a derivative of the para-para’ phenol-phenol coupling
reaction and leucine based on biomimetic schemes that have been devised for the total synthesis
gracilamine from the para-para’ skeleton and leucine (Tian et al., 2012).
The cripowellin skeleton was discovered in 1998 in Crinum powellii and resembles a
highly oxidized version of the haemanthamine skeleton that has had the C10b-4a carbon-carbon
bond severed and replaced with a ketone on the C4a position (Velten et al., 1998). If this is the
pathway for generating this alkaloid, it is possible that carbon bond cleavage leading to the
formation of a ketone is catalyzed by a cytochrome P450 similar to secologanin synthase that
converts loganin into secologanin in an analogous manner with a ketone product (Irmler et al.,
2000).
Tazettine biosynthesis proceeds from haemanthidine through a spontaneous ring opening
between C6 and the nitrogen of haemanthidine forming a postulated ketone intermediate (Wildman
and Bailey, 1969) (Figure 1.5). This is followed by the formation of a hemiacetal between the C6
ketone and the C11 hydroxyl and N-methylation (Fales and Wildman, 1964). The resulting
pretazettine can spontaneously convert to tazettine on exposure to basic conditions (Wildman and
Bailey, 1967).
Several other Amaryllidaceae skeletons are likely biosynthesized by a ring opening similar
to the one in tazettine biosynthesis between C6 and the nitrogen, including plicamine, hostasinine,
augustamine, and graciline. Plicamine is a dinitrogenous carbon skeleton thought to be derived
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from a pathway similar to the tazettine skeleton with the addition of nitrogen from tyramine instead
of the oxygen from C11 to the transient ketone intermediate as evidenced by structural similarities
(Ünver et al., 1999) (Figure 1.5). Hostasinine is an alkaloid skeleton documented in Hosta and
listed here because it is potentially derived from the Amaryllidaceae alkaloid haemanthidine. The
proposed mechanism is depicted in Figure 1.6 and involves the spontaneous opening of the six
membered nitrogen containing ring as in tazettine biosynthesis, reduction of the nitrogen C4a
bond, formation of a carbon-carbon bond from C6 to C4, and oxidation of the nitrogen (Wang et
al., 2007; Jin, 2009). Augustamine is potentially formed from the haemanthamine skeleton as
shown by the presence of a direct connection of the five membered ring to carbon-10b as would
be the case if the ether bond in the tazettine skeleton was at the C1 position and not the C11 positon
(Machocho et al., 2004). The graciline skeleton is likely a derivative of the haemanthamine
skeleton with the ether connected to C4a instead of C11 as in tazettine biosynthesis.
The biosynthesis of montanine proceeds through the intermediate vittatine (Feinstein and
Wildman, 1976). One possibility is vittatine is hydroxylated to 11-hydroxyvittatine followed by a
ring expansion triggered by a hydroxylation at C2 with subsequent methylation at C2 (Feinstein,
1967; Feinstein and Wildman, 1976).
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Figure 1.6. Possible mechanism of rearrangement for hostasinine-type alkaloids from haemanthidine. The steps are
written in this order for illustration. There is no evidence regarding the order

1.1.7 Lycorine and Homolycorine-Type Alkaloid Biosynthesis
Lycorine was the first Amaryllidaceae alkaloid for which a structure was determined. The ubiquity
of lycorine in the Amaryllidaceae made it ideal for radiolabeling experiments to elucidate its
biosynthesis. Its early biosynthesis has been determined to be equivalent to that of haemanthamine
and galanthamine (Battersby et al., 1964). At the phenol-phenol’ coupling step, an ortho-para’
reaction leads to the production of noroxopluviine. After the initial phenol-phenol’ coupling, a rearomatization of the phenolic rings or an enolization occurs as indicated by the loss of tritium at
the C10b-position (Kirby and Tiwari, 1966). A stereospecific carbon nitrogen bond is also formed
to create noroxopluviine. If rearomatization or keto-enol tautomerization occurs prior to the carbon
nitrogen bond formation, the bond will form on an achiral or racemic intermediate, respectively.
This indicates an enzyme is involved in the closure of the nitrogen ring. This chirality may be
dictated by the arrangement of the intermediate in the active site of the phenol-phenol’ coupling
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enzyme or of another independent enzyme. Noroxopluviine is reduced to norpluviine (Battersby
et al., 1964). As in haemanthamine biosynthesis, an oxide bridge is formed to make caranine
(Battersby et al., 1964; Fuganti and Mazza, 1972a). This is followed by hydroxylation of the 2position to make lycorine (Battersby et al., 1964; Wildman and Heimer, 1967). Studies in
Zephyranthes candida, Narcissus “Twink” and Narcissus “Deanna Durbin” indicate an inversion
of configuration of the C2 hydrogen at the hydroxylation step, but a study in Clivia miniata
indicates the configuration is retained (Wildman and Heimer, 1967; Bruce and Kirby, 1968;
Fuganti and Mazza, 1972a). Studies in Clivia miniata, Narcissus “Twink”, and Narcissus “Deanna
Durbin” agree that the protonation of C2 following phenol-phenol’ coupling is stereospecific with
addition of hydrogen to the alpha side of the molecule (Bruce and Kirby, 1968; Fuganti and Mazza,
1972a). The disagreement of the data surrounding C2 hydroxylation between these species could
imply a difference in the mechanism of the enzyme conducting hydroxylation between these
species (Figure 1.3).
Homolycorine biosynthesis is thought to start with the hydroxylation of norpluviine at C6
followed by a ring opening at the C6 nitrogen bond. This is followed by the formation of a
hemiacetal connection between the C1 hydroxyl and the C6 ketone and methylations to form the
known alkaloid lycorenine. The oxidation of lycorenine makes the representative alkaloid of the
skeleton homolycorine. The exact order of the hydroxylation, ring breakage/hemiacetal formation
and methylation reactions are poorly determined. The best evidence for order is the presence of
lycorenine and homolycorine as products in feeding experiments for norpluviine. This indicates
the formation of the homolycorine ester may be the last step in the pathway (Harken et al., 1976;
Bastida et al., 2011). This reaction is done by an oxidase that could be an AKR, SDR, or a
cytochrome P450 (Figure 1.7).
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Figure 1.7. Formation of the homolycorine carbon skeleton from norpluviine. The order of reactions between
norpluviine and homolycorine are not determined, but are diagramed in a sequence for illustration of the enzyme types
that may be involved.

1.1.8 Other Amaryllidaceae Alkaloid Biosynthesis: Cherylline, Galanthindole,
Galasine, and Buflavine
Cherylline-type alkaloids have been proposed to have a unique biosynthetic route that makes them
and the belladine alkaloids the only Amaryllidaceae alkaloid skeletons to avoid the phenol-phenol
coupling steps. This biosynthetic route involves a hydroxylation of the 2-position of 4’-Omethylnorbelladine or 4’-O-methyl-N-methylnorbelladine followed by a cyclization reaction by
dehydration (Figure 1.8). An N-methylation is required to make cherylline, but its placement
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before or after the hydroxylation and cyclization is unclear (Chan, 1973). Galanthindole type
alkaloids are indole type alkaloids that were first discovered in 2003 (Unver et al., 2003). The
lycorine or haemanthamine skeletons are potential candidates for their origin, but studies have not
shown a biosynthetic relation to the Amaryllidaceae alkaloids through radiolabeling or other
means (Unver et al., 2003). The galasine alkaloid type is rare and was first isolated in 1995 (Latvala
et al., 1995). The galasine skeleton is perhaps derived from a similar biosynthetic route as
homolycorine except the ether bond is migrated to position 10b. Buflavine-type alkaloids,
including buflavine and apogalanthamine, are potentially of mixed origin. If their hydroxylation
patterns are any indication, they may originate from different phenol-coupling reactions:
haemanthamine/lycorine in the case of buflavine or galanthamine in the case of apogalanthamine,
but having the same end carbon skeleton. There are other Amaryllidaceae alkaloids with diverging
carbon skeletons that do not have their own classification due to their small number.
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Figure 1.8. The pathway for cherylline and the structures of galasine, buflavine, and apogalanthamine. R indicates an
undetermined methyl or hydrogen group.

1.2 Methods of Interest to Pathway Elucidation
1.2.1 Introduction
The themes of miniaturization and increased throughput in methods supporting secondary
metabolism research promise to accelerate discovery of biosynthetic enzymes in these systems.
These trends are particularly relevant because they enable studies in non-model systems with
increased efficiency. How these methods relate to metabolomics has recently been reviewed
(Sumner et al., 2015). In this section, advances in methods and theory of potential use to secondary
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metabolism research in non-model species is examined including gene discovery, next generation
sequencing technologies, NMR and MS.

1.2.2 Gene Clusters and Co-Regulation of Biosynthetic Pathways
Genes involved in the same biosynthetic pathway have recently been found positioned together in
the same chromosome region in plant genomes forming gene clusters. Genes clusters have been
observed in the secondary metabolism of Zea mays, Avena spp., Oryza sativa, Arabidopsis
thaliana, Lotus japonicus, Sorghum bicolor, Manihot esculenta, Papaver somniferum, and
Solanum spp. as reviewed recently (Boycheva et al., 2014; Chae et al., 2014). Current theory for
gene cluster formation postulates that gene clusters form when a particular set of genes, or alleles
of genes, are favored in one environment but disfavored in another and the alleles interact
positively together or negatively apart for plant fitness (Takos and Rook, 2012). In secondary
metabolism, biosynthetic intermediates are often chemically reactive and, thereby, toxic (Takos et
al., 2011). The presence of the entire pathway generates a beneficial compound, but an incomplete
pathway may lead to a loss in fitness. When looking at Amaryllidaceae alkaloid biosynthesis,
several intermediates are catechols. Catechols can form deleterious reactive oxygen species, DNA
adducts, protein adducts, or cause protein-protein cross-linking (Schweigert et al., 2001).
Amaryllidaceae alkaloids are thought to function primarily as herbivore deterrents. Under lownitrogen and/or low-herbivore pressure conditions, the expression of the pathway would have a
fitness cost due to use of nitrogen. Corroborating this perspective, Narcissus rupicola, one of the
only Narcissus spp. without Amaryllidaceae alkaloids, grows on rocky soil where nutrients such
as nitrogen may be limiting (Berkov et al., 2014). Variability in the composition of alkaloids
between Galanthus elwesii populations has been observed; this could indicate environmentspecific benefits for selected alkaloids (Berkov et al., 2004). Considering that Amaryllidaceae
27

alkaloids are favorable in particular environments, but perhaps not in others, and that intermediates
possess reactive functional groups, all criteria are met that favor the generation of gene clusters
(Fisher, 1930; Takos and Rook, 2012). A sequenced genome can be used to discover new genes
surrounding known biosynthetic genes and, assuming a gene cluster organization, these genes
could be tested for involvement in the biosynthetic pathway (Itkin et al., 2013). Members of gene
families with the same theoretical enzymatic mechanism for a proposed reaction are prime
candidates for secondary metabolic pathways because evolutionary changes in substrate
preference are more likely than changes in the underlying chemistry (Furnham et al., 2012).
Gene clustering information could be combined with co-expression analysis to filter and
support candidate gene lists (Itkin et al., 2013). Co-expression is when transcripts express in a
manner similar to each other; if one transcript is high the other will probably also be high and vice
versa. These correlations in expression are frequently scored using correlation statistics including
the Pearson correlation or Spearman’s rank correlation (Kumari et al., 2012). The correlations can
also exist between the transcripts of biosynthetic genes and end products of the biosynthetic
pathway as is observed in proanthocyanidin biosynthesis and anthocyanin biosynthesis (Mellway
et al., 2009; Ravaglia et al., 2013). The chromatin structural protein H2A.Z has been shown to
positively correlate with gene expression in stretches of DNA enriched for this protein, and has
been shown to be important for proper expression of these genes by analysis of gene expression in
H2A.Z mutants in Arabidopsis thaliana. Chromatin modifications such as the content of H2A.Z
are thought to contribute to co-expression of genes in gene clusters (Nützmann and Osbourn,
2015). This could be one of the mechanisms for the co-expression observed for many biosynthetic
genes in secondary metabolic pathways. Another potential mechanism is a shared transcription
factor as noted for the transcription factors OsTGAP1 from momilactone biosynthesis, MYB134
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from poplar in proanthocyanidin biosynthesis, and bHLH3 from Prunus persica in anthocyanin
biosynthesis (Mellway et al., 2009; Okada et al., 2009; Ravaglia et al., 2013). Transcription factors
can act directly by driving the expression of biosynthetic genes or indirectly by driving expression
of other transcription factors. Sharing a transcription factor causes genes to co-express because,
barring additional regulatory factors, the transcription factor will influence the expression of its
downstream genes in the same way under different conditions and developmental time points.
Modification of expression from other transcription factors, transcription factor saturation,
chromatin modifications, or DNA modifications, however, can cause deviations from a perfect
correlation between genes regulated by the same transcription factor (Finnegan et al., 1996;
Kaufmann et al., 2010).
One approach to elucidating biosynthetic pathways is to address correlation between
metabolites or known biosynthetic genes and potential biosynthetic genes with regard to
expression patterns, presence, absence, or pseudo gene status either within a species or between
species. If, for example, genes that co-express with a known biosynthetic gene in multiple species
can be found, it is more likely to be related to the function of this known biosynthetic gene than a
gene co-expressing in only one species. However, when looking for a biosynthetic gene in this
way, the possibility of non-homologous genes doing the same reaction should be considered and
misannotation of the known gene should be guarded against. This is possible when considering
the history of convergent evolution in secondary metabolism (Pichersky and Lewinsohn, 2011;
Takos et al., 2011). This may be the case for the more derivatized Amaryllidaceae alkaloids,
because there is not a clear correlation between phylogeny and the presence or absence of
particular alkaloids (Rønsted et al., 2012). Due to the limitations of detection methods, however,
the absence of these compounds in intervening lineages cannot be determined with certainty.
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Examination of alkaloid composition in species closely related to the species in question may be
helpful. If the biosynthetic pathway seems to be present in most common lineages as indicated by
the presence of the end product, then there is no evidence for convergent evolution and common
origin can be assumed in gene discovery workflows.

1.2.3 Sequencing Technologies
Advances in sequencing technologies show great promise to improve de novo genome and
transcriptome assemblies in non-model systems. These improved datasets will facilitate
identification of gene clusters, co-expression analysis, and cloning of candidate genes. Second
generation sequencing has improved the efficiency with which genomic and transcriptomic
sequence information can be obtained. It is of particular value when studying systems without
previous sequencing information as is discussed in Chapter 2 (Kilgore et al., 2014). Early platforms
for high-throughput sequencing are Roche 454 sequencing by Life sciences corporation; second
generation MiSeq, NextSeq, HiSeq, and HiSeq X Illumina platforms; and SOLiD from life
technologies. De novo genome assemblies can be made with second generation sequencing data
using programs such as ALLPATHS, Velvet, ABySS, and SOAPdenovo (Zerbino and Birney,
2008; Simpson et al., 2009; Li et al., 2010; Gnerre et al., 2011). These genomes can provide
information for the majority of the genome including genes, intergenic space, promoters, and
introns. If the actual transcripts or the proteins they encode are the primary interest of the study,
then de novo transcriptome assemblies will be more practical because of the reduced level of
information required for sequence coverage and ability to focus only on transcripts that are being
transcribed in samples of interest. De novo transcriptome assembly can provide a combination of
sequence information, alternative splicing, and expression information in one experiment (Wang
et al., 2009; Liu et al., 2014). Several prominent de novo transcriptome assemblers include Trinity,
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Oases, and Trans-ABySS (Robertson et al., 2010; Schulz et al., 2012; Haas et al., 2013). Programs
commonly used to align reads back to the transcriptomes and obtain expression estimates in the
form of read counts include Bowtie and BWA (Li and Durbin, 2009; Langmead, 2010). This
combination of information allows workflows for candidate gene selection based on homology
and co-expression to be carried out with a very manageable initial investment and no prior
sequence information (Giddings et al., 2011; Yeo et al., 2013; Kilgore et al., 2014). Workflows of
this nature are used to identify biosynthetic genes in Chapters 2, 3, and 4. Many transcriptomes
have been assembled using second generation sequencing, thereby providing information on a
genetic level to previously uncharacterized systems such as Camptotheca acuminata,
Catharanthus roseus, Rauvolfia serpentine, Valeriana officinalis, and Veratrum californicum,
(Góngora-Castillo et al., 2012; Yeo et al., 2013; Augustin et al., 2015). As more organisms are
sequenced, homology-based comparisons become more meaningful because these sequences can
be used to prepare phylogenies. When these phylogenies are combined with biochemical validation
data for proteins contained in the phylogenies, annotations can be made more accurate through
programs like SIFTER (Engelhardt et al., 2009).
Second generation sequencing generates short reads that create fragmented genomes in
non-model and model systems alike. The inability to differentiate reads from highly similar
transcripts can make de novo transcriptome and genome assemblies prone to collapsing these
similar sequences into one contig. Sophisticated analysis workflows have been developed to
resolve this problem in second generation sequencing (Spannagl et al., 2013). In addition, third
and fourth generation sequencing technologies that provide longer sequencing reads are a
promising new tool. PacBio from pacific biosciences is an instrument that monitors the
incorporation of fluorescently labeled bases into a DNA strand by a polymerase tethered to a pore
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on a sequencing cell. The system is able to routinely generate sequences ~5 kb long with up to 50
kb possible. The down side is a ~80% error rate (Lee et al., 2014). Using circular libraries, the
polymerase used for sequencing can read the same sequence multiple times and this data can be
processed for error reduction. This results in a tradeoff between read length and accuracy
determined by the number of times the polymerase can make a cycle around a loop. This system
has been used for the sequencing and distinguishing of members of the highly similar vomeronasal
receptor class 1 gene family in the non-model lemur Microcebus murinus (Larsen et al., 2014).
One advantage of this system is its ability to simultaneously detect DNA modifications including
the modified bases N6-methyladenosine, 5-methylcytosine, and 5-hydroxymethylcytosine. This
information could be of value when using genomic DNA as a template and searching for regulatory
modifications (Flusberg et al., 2010). A fourth generation system for DNA sequencing that
commercializes nanopore technology is the MinION system that measures changes in electrical
conductance as a DNA strand passes through a protein pore. This instrument is produced by Oxford
Nanopore Technologies. One of the advantages of this technology is its size, measuring only 4
inches long and the ability to be powered by a standard USB 3.0 port making it the first highly
portable sequencer. It has been shown to have an average read size of ~5 kb with reads reaching
10 kb. The low accuracy of MinION has improved from ~65% to ~85% since its first appearance,
but still makes the technology impractical when used alone (Mikheyev and Tin, 2014; Loman and
Watson, 2015). A combination of Illumina sequencing and MinION to make accurate Nanopore
Synthetic-long reads prior to assembly has been used, however, to generate an Acinetobacter
baylyi assembly with 99.99% accuracy (Madoui et al., 2015). A third approach to the generation
of long reads is Illumina TruSeq which is a variant of second generation sequencing. This
technique shears genomes into 10 kb sections and then performs short read sequencing and
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assembly workflow on these 10 kb sections. This has been shown to be effective in the placement
of the highly related transposable elements within the Drosophila melanogaster genome (McCoy
et al., 2014). The longer sequence reads from PacBio, MinION, and Illumina TruSeq will help
improve genome assemblies and connect contigs separated by highly repetitive regions. PacBio
and MinION should also be able to provide start to end sequencing information of transcripts
enabling splice variant analysis. The current downside to PacBio and MinION technologies is the
high error rate associated with the raw read data. The Illumina TruSeq technology has low error
rates ~0.03% because its reads are built with short reads. As for MinION, the high error rate can
be corrected in PacBio with very high coverages with circular libraries or by combining the second
generation short reads with third generation long reads as the programs LSC, proovread, and
LoRDEC are designed to do (Au et al., 2012; Hackl et al., 2014; Salmela and Rivals, 2014).

1.2.4 Nuclear Magnetic Resonance Spectroscopy
NMR techniques have become more practical for the identification of the small quantities of
compound observed in metabolomics surveys and generated during many enzyme assays. This
will allow more complete catalogs of compounds in plant species to determine the presence or
absence of compounds and their associated metabolic pathways. It will also facilitate identification
of unknown products observed in enzyme assays. The usage of solid phase extraction (SPE) to
concentrate metabolite fractions coming out of a separation technique like HPLC and the release
of metabolite for NMR analysis has been of great utility. This workflow enables the structural
elucidation of compounds from complex mixtures. When used in parallel with 2D NMR
techniques for deconvolution of co-eluting compounds chromatography issues can be avoided
(Mahrous and Farag, 2015). Another improvement of NMR technique is the invention of
microprobes and miniaturized coils with current volumes of 10 µl and the potential of nanoliter
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sample sizes (Fratila and Velders, 2011). The low volumes required allow for the elucidation of
structures with microgram quantities of compound (Aramini et al., 2007). Without these
innovations for deconvolution and miniaturization of NMR experiments, the workflows that utilize
NMR in high-throughput systems with LC-MS outlined in the following section would not be
practical.

1.2.5 Mass Spectrometry
MS has improved in mass accuracy with the development of fourier transform mass spectrometers
(FTMS). The increased mass accuracy of FTMS like the Orbitrap can be of immense value in
metabolomics by providing the accuracy needed to infer the molecular formula of compounds
(Krauss et al., 2010). Combined with MS/MS data the compounds can be searched against
databases for the inference of structure. This is of great value in metabolomics studies and in
enzyme product identification when the product is a characterized structure for which standard is
lacking. Several workflows apply MSn and HPLC with SPE and NMR for the systematic structure
elucidation of components in complex mixtures of metabolites (Castro et al., 2010; Sumner et al.,
2015). To obtain quantification of compounds, evaporative light scattering detection (ELSD) can
be used in combination with LC-MS (LC-ELSD-MS) (Cremin and Zeng, 2002). Another example
of a combination workflow utilizes LC-ELSD-MS detection for initial characterization of complex
plant extracts, followed by structural elucidation of select compounds by NMR. A significant
effect in a high-throughput screen for a biological activity of interest, such as a greater than 32%
reduction in the cancer cell lines MCF7, NCI-H460, or SF-26, is used to prioritize compounds for
structural elucidation with NMR (Eldridge et al., 2002). These systematic catalogs of structures
are very useful to secondary metabolism research because the associated MS n and NMR data
become available in databases for future analysis of enzyme products or identification of
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metabolites from other complex mixtures in workflows lacking MSn or NMR components. In GCMS data analysis, the use of libraries such as just described is relatively simple because of the
standard ionization settings and resulting reproducibility of spectra. In LC-MSn the fragmentation
of compounds can vary greatly depending on the instrument setup and settings (Hopley et al.,
2008). To use existing LC-MSn libraries the setup and setting used for the library construction
should be used and this can be difficult if the instruments used in library construction and available
to the researchers are not the same. To deal with this problem there are prediction algorithms that
utilize LC-MSn data with fragmentation rules for ion trees and algorithms for relating MSn data to
databases with different instrument setup and settings including the Mass Frontier software from
Thermo Scientific.

1.2.6 Substrate Considerations
Advances in MS, and NMR promise to lower the quantity of product required in enzyme assays.
This also lowers the quantity of substrate required which can also be a limiting factor when
performing enzyme assays. When trying to acquire substrates for enzyme assays the substrates can
be bought, synthesized, or isolated from the source. Purchasing the substrate is frequently not an
option in highly specialized pathway intermediates, so the latter two lines of inquiry become
necessary. In the case of Amaryllidaceae alkaloids, there is a large diversity of specialized
synthesis methods that have regularly been reviewed by Zhong Jin and can be used for production
of various pathway intermediates (Jin, 2013). As biosynthetic genes are discovered expression of
these genes in a heterologous system for the production of pathway intermediates that can be used
in enzyme assays becomes possible (Augustin et al., 2015). Methods for source isolation are
provided in the publication of a compound’s discovery but the availability of plant material can be
a major constraint particularly for endangered species.
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1.3 Conclusion
In conclusion, the Amaryllidaceae alkaloids are a diverse group of alkaloids with many
undiscovered biosynthetic enzymes. Advances in sequencing will facilitate genomic and
transcriptomic analyses of these plants to identify candidate biosynthetic genes. In this thesis
transcriptomes for Narcissus sp. aff. pseudonarcissus, Galanthus sp., and Galanthus elwesii are
generated and described in Chapters 2 and 3. Previous work has generated a transcriptome for
Lycoris aurea (Wang et al., 2013). The combination of sequencing with other methods such as
proteomics can be a powerful approach for the identification of candidate genes. This combination
was implemented during the discovery of VpVAN in Vanilla planifolia by selectively looking for
transcripts and proteins highly present in the biosynthetic tissue for vanillin, inner bean pod
(Gallage et al., 2014). Transcriptomic and genomic sequencing can also provide complementary
information during candidate gene selection by allowing the combination of co-expression analysis
and gene cluster searches. This combination of transcriptomic and genomic resources have become
available in Catharanthus roseus through next generation sequencing (Kellner et al., 2015).
Testing the candidate enzymes that will be identified through combinations of omics approaches
including transcriptomics, proteomics, and genomics will be facilitated through more sensitive
detection and structural elucidation of substrates and products by MS and NMR techniques either
through plant-to-plant comparisons or direct assay of the candidate enzymes. The discovery of
N4OMT in Chapter 2 is an example. A de novo transcriptome assembly of Narcissus sp. aff.
pseudonarcissus provided both the sequence and expression information needed to identify a
candidate methyltransferase. Once the methyltransferase is shown to make a methylated product
from norbelladine with MS/MS, small volume NMR technologies are utilized to identify the
product, 4’-O-methylnorbelladine (Kilgore et al., 2014). Another example of combining
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transcriptomics with sensitive techniques such as small volume NMR is the discovery of the first
6 steps of cyclopamine biosynthesis from cholesterol up to the intermediate verazine. In this study
a de novo transcriptome assembly of Veratrum californicum is used to find candidates through coexpression analysis. The candidates are expressed in insect cells and the various products are
identified by a combination of MS/MS and NMR (Augustin et al., 2015). These examples of
enzyme discovery in different species with different compound classes show these improvements
are generally applicable to secondary metabolism in non-model systems when looking for novel
enzymes.

1.4 Chapter Summary
1.4.1 Chapter 2
In this thesis, the Amaryllidaceae alkaloid biosynthetic genes are shown to co-express in leaf, bulb
and inflorescence tissues with the accumulation of the Amaryllidaceae alkaloid galanthamine, and
with each other. In Chapter 2, I show that N4OMT transcript co-accumulates with galanthamine in
Narcissus sp. aff pseudonarcissus. This is done using a de novo assembled Narcissus sp. aff
pseudonarcissus transcriptome with associated leaf, bulb, and inflorescence expression estimates
to find methyltransferase gene transcripts that co-accumulate with galanthamine, and then testing
these recombinant methyltransferases for enzyme activity with putative intermediates of
galanthamine biosynthesis. N4OMT was shown to have the ability to methylate norbelladine to
4’-O-methylnorbelladine. The discovery of this enzyme/gene co-accumulating with galanthamine
supports the starting hypothesis that Amaryllidaceae biosynthetic genes will co-express in a tissue–
specific pattern that reflects galanthamine accumulation in the plant. This work was done in
collaboration with Megan M. Augustin, Courtney M. Starks, Mark O’Neil-Johnson, Gregory D.
May, John A. Crow, and Toni M. Kutchan.
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Previously published in PLoS One 9(7):e103223
Cloning and characterization of a norbelladine 4’-O-methyltransferase involved in the
biosynthesis of the Alzheimer’s drug galanthamine in Narcissus sp. aff. pseudonarcissus

1.4.2 Chapter 3
Chapter 3 demonstrates that co-expression is observed between Amaryllidaceae alkaloid
biosynthetic genes and between species through the discovery of CYP96T1. CYP96T1 is a parapara’ phenol-phenol coupling cytochrome P450 capable of forming noroxomaritidine. The gene
was discovered by looking for cytochrome P450 transcripts that co-expressed with the N4OMT
(discovered in Chapter 2) in Narcissus sp. aff pseudonarcissus, Galanthus sp., and Galanthus
elwesii. When characterizing the recombinant enzyme, it was found to catalyze the formation of
both enantiomers of noroxomaritidine. This indicates that CYP96T1 is involved in the initial parapara’ phenol-phenol coupling to form an achiral intermediate and then releases this intermediate
prior to a spontaneous nitrogen ring closure, thereby generating both enantiomers. This work was
done in collaboration with Megan M. Augustin, Gregory D. May, John A. Crow, and Toni M.
Kutchan.

1.4.3 Chapter 4
Chapter 4 demonstrates that the co-expression observed for N4OMT and CYP96T1 is shared with
all of the core Amaryllidaceae alkaloid biosynthetic genes by identifying a norcraugsodine
reductase. The discovery of this enzyme was through a similar work-flow as used in Chapter 3,
but interrogating for oxidoreductases instead of cytochromes P450. The discovery of
norcraugsodine reductase through co-expression analysis provides all the Amaryllidaceae alkaloid
specific biosynthetic genes prior to the phenol-phenol coupling branch point. This enzyme was
shown to have norcraugsodine reductase activity, and potentially facilitates the condensation of
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tyramine and 3,4-dihydroxybenzaldehyde to form norcraugsodine. Cynthia K. Holland, Joseph
M. Jez, and Toni M. Kutchan were key collaborators in this work.

1.4.4 Chapter 5
In Chapter 5, I present the major conclusions of this thesis. I address how this thesis will assist
future research on Amaryllidaceae alkaloid biosynthesis, and on non-model species in general.
Potential applications of the transcriptomic resources generated during my thesis research, and the
enzymes discovered, are also discussed. The discovery of these three biosynthetic genes will
facilitate the research on how variation in these genes and their expression leads to the observed
variability in Amaryllidaceae alkaloid content across tissues, populations, and species. It will also
facilitate discovery of additional biosynthetic genes for Amaryllidaceae alkaloids and regulatory
elements, including transcription factors. These discoveries have the potential to be used for
improved production of valuable Amaryllidaceae alkaloids and to provide experimental systems
for clear examination of the roles these compounds play in planta and in the surrounding
environment.

39

Chapter 2: Cloning and Characterization of
a Norbelladine 4’-O-Methyltransferase
Involved in the Biosynthesis of the
Alzheimer’s Drug Galanthamine in
Narcissus sp. aff. pseudonarcissus
This chapter was previously published in PLoS One 9(7):e103223
Cloning and characterization of a norbelladine 4’-O-methyltransferase involved in the
biosynthesis of the Alzheimer’s drug galanthamine in Narcissus sp. aff. pseudonarcissus
Matthew B. Kilgore1, Megan M. Augustin1, Courtney M. Starks2, Mark O’Neil-Johnson2, Gregory D. May3,
John A. Crow3, Toni M. Kutchan1†
1Donald

Danforth Plant Science Center, St. Louis, MO, USA

2Sequoia

Sciences, St. Louis, MO, USA

3National

Center for Genome Resources, Santa Fe, NM, USA

Galanthamine is an Amaryllidaceae alkaloid used to treat the symptoms of Alzheimer’s disease.
This compound is primarily isolated from daffodil (Narcissus spp.), snowdrop (Galanthus spp.),
and summer snowflake (Leucojum aestivum). Despite its importance as a medicine, no genes
involved in the biosynthetic pathway of galanthamine have been identified. This absence of genetic
information on biosynthetic pathways is a limiting factor in the development of synthetic biology
platforms for many important botanical medicines. The paucity of information is largely due to
the limitations of traditional methods for finding biochemical pathway enzymes and genes in nonmodel organisms. A new bioinformatic approach using several recent technological improvements
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was applied to search for genes in the proposed galanthamine biosynthetic pathway, first targeting
methyltransferases due to strong signature amino acid sequences in the proteins. Using Illumina
sequencing, a de novo transcriptome assembly was constructed for Narcissus sp. aff.
pseudonarcissus. BLAST was used to identify sequences that contain signatures for plant Omethyltransferases in this transcriptome. The program HAYSTACK was then used to identify
methyltransferases that fit a model for galanthamine biosynthesis in leaf, bulb, and inflorescence
tissues. One candidate gene for the methylation of norbelladine to 4’-O-methylnorbelladine in the
proposed galanthamine biosynthetic pathway was identified. This methyltransferase cDNA was
expressed in E. coli and the protein purified by affinity chromatography. The resulting protein was
found to be a norbelladine 4’-O-methyltransferase (NpN4OMT) of the proposed galanthamine
biosynthetic pathway.

2.1 Introduction
Amaryllidaceae alkaloids are a group of alkaloids with many documented biological activities.
This makes them valuable potential medicines several examples are the anti-cancer compounds
haemanthamine and lycorine and the anti-viral compound pancratistatin (Gabrielsen et al., 1992;
Liu et al., 2004; Havelek et al., 2014). One example of an Amaryllidaceae alkaloid already used
medically to treat Alzheimer’s disease is galanthamine. Galanthamine is an alkaloid discovered in
1953 that is produced by members of the Amaryllidaceae family (Uyeo and Kobayashi, 1953). It
reduces the symptoms of Alzheimer’s disease through acetylcholine esterase inhibition and
nicotinic receptor binding. These activities are thought to compensate for reduced acetylcholine
sensitivity in Alzheimer’s disease by increasing acetylcholine levels and perhaps increasing
acetylcholine sensitivity (Irwin and Smith, 1960; Barik et al., 2005). Until now, no committed
biosynthetic genes have been identified (Wilcock et al., 2000; Wilcock et al., 2003). Limited
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enzyme kinetic characterization has been done on plant protein extracts enriched for the
norbelladine 4’-O-methyltransferase (N4OMT) of Nerine bowdenii, but the underlying gene was
never identified (Mann, 1963).
The putative galanthamine biosynthetic pathway has been studied in detail and
intermediates in the pathway have been determined. This knowledge is based on radiolabeling
experiments. Work on other Amaryllidaceae alkaloids including lycorine and haemanthamine
studying steps prior to 4’-O-methylnorbelladine can be applied to galanthamine biosynthesis
because 4’-O-methylnorbelladine is a universal substrate for these alkaloids (Eichhorn et al.,
1998). The proposed pathway starts with the amino acids phenylalanine and tyrosine (Barton et
al., 1963). In Narcissus incomparabilis phenylalanine was established as a precursor that
contributes the catechol portion of norbelladine. This was done using radiolabeling experiments to
trace incorporation of [3-14C]phenylalanine into lycorine and degradation experiments on the
resulting lycorine to determine the location of the

14

C label (Suhadolnik et al., 1962). Similar

experiments with phenylalanine were performed in Nerine browdenii monitoring haemanthamine
incorporation (Wildman et al., 1962b). As a follow up radiolabeling experiments were used to
determine that phenylalanine probably proceeds sequentially through the intermediates transcinnamic

acid,

p-hydroxycinnamic

acid

and

3,4-dihydroxycinnamic

acid

or

p-

hydroxybenzaldehyde before conversion into 3,4-dihydroxybenzaldehyde (Suhadolnik et al.,
1963a). Tyrosine has been established as a precursor of galanthamine that in contrast to
phenylalanine contributes only to the non-catechol half of the norbelladine intermediate. This was
done by observing [2-14C]tyrosine incorporation into galanthamine and degradation experiments
of galanthamine (Barton et al., 1963). Tyrosine decarboxylase converts tyrosine into tyramine and
is well characterized in other plant families (Lehmann and Pollmann, 2009). 3,442

Dihydroxybenzaldehyde and tyramine condense into a Schiff-base and are reduced to form the
first alkaloid in the proposed pathway, norbelladine. Norbelladine has been documented to
incorporate into galanthamine and all major Amaryllidaceae alkaloid types in

14

C radiolabeling

studies (Barton et al., 1961; Battersby et al., 1961b; Battersby et al., 1961a; Barton et al., 1963).
4’-O-Methylnorbelladine is then formed by O-methylation of norbelladine (Barton et al., 1963).
A phenol-coupling reaction, followed by spontaneous oxide bridge formation, creates Ndemethylnarwedine, which is then reduced and N-methylated to yield galanthamine (Figure 2.1)
(Eichhorn et al., 1998). In one study, Barton et al. fed O-methyl[1-14C]norbelladine to flower stalks
of King Alfred daffodils, but it was not incorporated into galanthamine. The authors concluded
that the intermediate in the pathway must be 4’-O-methyl-N-methylnorbelladine despite low
incorporation of this compound when the equivalent experiment was conducted with 4’-O-methyl[N-methyl-14C]norbelladine (Barton et al., 1963). A recent revision of the proposed pathway by
Eichhorn et al. contradicted this conclusion and placed the N-methylation step at the end of the
proposed pathway instead of before the phenol-coupling reaction. In that study, [OC3H3]4’-Omethylnorbelladine was applied to ovary walls of Leucojum aestivum. Incorporation into products
indicated that the pathway produced N-demethylated intermediates up until the penultimate step
to galanthamine. N-methylation was proposed as the final step of biosynthesis (Eichhorn et al.,
1998).
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Figure 2.1. Proposed biosynthetic pathway for galanthamine. 3,4-Dihydroxybenzaldehyde derived from phenylalanine
and tyramine derived from tyrosine are condensed to form norbelladine. Norbelladine is methylated by NpN4OMT to
4’-O-methylnorbelladine. 4’-O-Methylnorbelladine is oxidized to N-demethylnarwedine. N-demethylnarwedine is
then reduced to N-demethylgalanthamine. In the last step, N-demethylgalanthamine is methylated to galanthamine.

The discovery of genes involved in metabolism is essential to metabolic engineering and
synthetic biology. The elucidation of plant biochemical pathways can take decades. In fact, the
biosynthesis of morphine, an important opiate analgesic, is still not completely elucidated at the
gene level, even though the first enzyme specific to morphine biosynthesis was discovered more
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than 20 years ago in 1993 (Gerardy and Zenk, 1993). Reports on the enzymatic activities of poppy
extracts to describe the morphine biosynthetic pathway go even farther back to 1971 (Roberts,
1971). After more than 40 years of enzymology and reverse genetics, the morphine biosynthetic
pathway is still incomplete at the gene level. Traditionally, plant biochemical pathway enzymes
have been identified either directly by purification from plant extracts or indirectly by examining
enriched cDNA libraries and functionally expressing clones (Mann, 1963; Takeshita et al., 1995;
Frick and Kutchan, 1999; Morishige et al., 2002; Ounaroon et al., 2003; Raman and
Rathinasabapathi, 2003; Nomura and Kutchan, 2010; Widiez et al., 2011). To reduce pathway
discovery from a 20+ year process to a more reasonable time frame, new methods must be
developed and embraced. The previous work on galanthamine biosynthesis makes the prediction
of enzyme classes involved in the proposed pathway possible, thereby rendering the galanthamine
pathway a suitable system for development of an omic methodology for biochemical pathway
discovery.
In this study, using galanthamine biosynthesis as proof-of-concept, a novel workflow is
presented to streamline the identification of biosynthetic pathway genes. A de novo transcriptome
is created for Narcissus sp. aff. pseudonarcissus using illumina sequencing. HAYSTACK, a
program that utilizes the Pearson correlation, is used to find genes that co-express with
galanthamine accumulation in this transcriptome. This set of candidates is interrogated for
homologs to methyltransferases. An OMT that converts norbelladine to 4’-O-methylnorbelladine
(NpN4OMT) in the proposed biosynthesis of galanthamine is identified in this manner and
characterized.
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2.2 Materials and Methods
2.2.1 Plant Tissue and Chemicals
N. sp. aff. pseudonarcissus plants were collected from an outdoor plot in St. Louis, MO, with the
GPS coordinates (38.659305, -90.410203), during peak flowering and separated into leaf, bulb,
and inflorescence tissues. Inflorescence is considered all tissues above the spathe. The plants were
collected with the permission of the corresponding author who is the owner of the private property.
No endangered species were involved in this collection.
Formic

acid,

potassium

tris(hydroxymethyl)aminomethane,

phosphate
glycerol,

monobasic,
sodium

potassium

phosphate

acetate,

sodium

dibasic,
chloride,

tetramethylethylenediamine, calcium chloride, magnesium chloride, and β-mercaptoethanol were
obtained from Acros Organics. Glycine, papaverine hydrochloride, S-adenosyl methionine
(AdoMet), cobalt chloride, zinc chloride, and manganese chloride were obtained from Fisher
Scientific. Other chemicals include acetonitrile, JT Baker; InstaPAGE, IBI Scientific; ethanol 200
proof, KOPTEC; Bradford reagent, Bio-Rad; S-adenosyl-L-homocysteine, Sigma-Aldrich;
deoxynucleotide triphosphates (dNTPs), New England BioLabs, Inc. (NEB); and isopropyl β-D1-thiogalactopyranoside (IPTG), Gold Biotechnology. The norbelladine N-methylnorbelladine, 4’O-methyl-N-methylnorbelladine, and 4’-O-methylnorbelladine were synthesized previously
(Eichhorn et al., 1998). NotI, NdeI, T4 DNA ligase, Taq DNA Polymerase, and Phusion HighFidelity DNA Polymerase enzymes were from NEB. M-MLV reverse transcriptase and
RNaseOUT were obtained from Invitrogen.

2.2.2 Alkaloid Extraction and Quantification
N. sp. aff. pseudonarcissus leaf, bulb, and inflorescence tissues were extracted by grinding tissue
with a mortar and pestle cooled with liquid nitrogen. Each ground sample was split into three
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technical replicates. Two volumes of 70 % ethanol were added followed by vortexing 5 min and
centrifuging at 14,000 xg for 10 min. The supernatant was filtered through a 0.2 µm low protein
binding hydrophilic LCR (PTFE, millex-LG) membrane. For galanthamine quantitation, samples
were diluted 1000 fold. Liquid chromatography samples were injected (10 µl) onto an LC-20AD
(Shimadzu) with a Waters Nova Pak C-18 (300 X 3.9 mm 4 µm) column coupled to a 4000 QTRAP
(AB Sciex Instruments) for MS/MS analysis. The gradient program had a flow rate of 0.8 ml/min;
solvent A was 0.1 % formic acid in H2O and solvent B was 0.1 % formic acid in acetonitrile. At
the beginning of the program, solvent B was held at 15 % for 2 min, followed by a linear gradient
to 43 % B at 15 min, 90 % B at 15.1 min, 90 % B at 20 min, 15 % B at 21 min, and 15 % B at 26
min. A Turbo Ion Spray ionization source temperature of 500 °C was used with low resolution for
Q1 and Q3. All multiple reaction monitoring (MRM) scans were performed in positive ion mode.
The ion fragment used for quantitation of galanthamine was 288.00 [M+H]+/213.00 [M-OHC3H7N]+● m/z. Galanthamine was identified by comparison of retention time and fragmentation
pattern to authentic galanthamine standard. The Analyst 1.5 software was used to quantitate
galanthamine using a comparison of peak area of the unknown to authentic galanthamine.

2.2.3 Illumina Sequencing and Transcriptome Assembly
The transcriptome was generated via data cleaning, short read assembly, final assembly, and post
processing steps. A modified TRIzol RNA isolation method found as protocol number 13 in
Johnson et al. was used to obtain RNA for cDNA library preparation (Johnson et al., 2012).
Illumina RNA-Seq was used to generate 100 base pair paired-end reads from the cDNA library.
The resulting data was monitored for overrepresented reads. Having found no such reads, adaptor
sequences and sections of the standard phi X genome were identified and removed. Reads were
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then trimmed for quality using the FASTX toolkit version 0.0.8 with a Q value cutoff of 10 as is
default for PHRAP.
Reads were assembled in the following manner. ABySS was used to run multiple
assemblies of the reads with a range of kmers 24≤k≤54. The resulting assemblies were assembled
into scaffolds using ABySS scaffolder (Birol et al., 2009). Gaps in the sequences were resolved
using GapCloser from the SOAPdenovo suit (Luo et al., 2012). A final assembly was conducted
on the resulting synthetic ESTs using Mira in EST assembly mode (Chevreux et al., 2004). All
sequences with over 98 % identity were considered redundant and removed using CD-Hit (Li and
Godzik, 2006). The resulting contigs >100 base pairs long were included in the final assembly.
Protein products for these contigs were predicted using ESTScan (Iseli et al., 1999; Lottaz et al.,
2003); all peptides over 30 amino acids were reported. Burrows-Wheeler Aligner was used to align
the original reads to the assembled transcriptome to generate relative expression data for the
contigs in leaf, bulb and inflorescence tissues (Li and Durbin, 2009). The N. sp. aff.
pseudonarcissus assembly and the raw read data can be found at the MedPlant RNA Seq Database,
http://www.medplantrnaseq.org. Anomalies in the number of reads per contig and abnormally long
or short contigs were manually curated. To normalize for read depth, each expression value for
each contig was divided by the total reads for the respective tissue and multiplied by 1 million.

2.2.4 Candidate Gene Identification
Relative expression data was compared to the levels of galanthamine in N. sp. aff. pseudonarcissus
tissues using HAYSTACK with a background cutoff of 1, correlation cutoff 0.8, fold cutoff 4, and
p-value 0.05 (Mockler et al., 2007). Using BLASTP, a list of known methyltransferases were
queried against the N. sp. aff. pseudonarcissus transcriptome peptide list with an E-value of e-9 to
identify methyltransferase homologs (Altschul et al., 1997). Accession numbers from NCBI for
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these methyltransferases are presented in Table C.1. Overlap between the methyltransferase
homologs and contigs that pass the HAYSTACK criteria were considered candidate genes. The
candidate

N.

sp.

aff.

pseudonarcissus

norbelladine

4’-OMT

has

the

designation

medp_9narc_20101112|62361 in the contigs.fa file in the Narcissus_spp.tar file on
http://www.medplantrnaseq.org.

2.2.5 Phylogenetic Tree
Sequences found in Table C.2 were aligned using MUSCLE in the MEGA 5.2 software with
default parameters (Tamura et al., 2011). For the phylogeny, this alignment was provided as input
into the Maximum-Likelihood algorithm also found in MEGA 5.2. Default parameters were used
except the Gaps/Missing Data treatment was set to partial deletion.

2.2.6 PCR and Cloning
The 5’ and 3’ ends of the NpN4OMT sequence were completed using Rapid Amplification of
cDNA Ends (RACE) with the Invitrogen RACE kit. For gene specific primers (GSP) see Table
C.3. The same PCR program was used for both 5’ and 3’RACE. This applies to both cycles of
nested PCR as well. The PCR program parameters were 30 s 98 ⁰C 1 cycle; 10 s 98 ⁰C, 30 s 60
⁰C, 1 min 72 ⁰C 30 cycles; 5 min 72 ⁰C 1 cycle. The outer-primer PCR was a mixture of 4.6 ng/µl
RACE ready bulb cDNA, 0.3 mM dNTPs, 0.3 µM GSP primer, 0.9 µM kit provided RACE primer,
1 U NEB Phusion High-Fidelity DNA Polymerase, and Invitrogen recommended quantity of
buffer in a 50 µl reaction. The inner-primer PCR used the product of the outer-primer PCR as
template with 0.2 µM of the inner RACE GSP and Invitrogen primers and 0.2 mM dNTPs.
Amplification of the NpN4OMT open reading frame was performed with 5.1 ng/µl N. sp.
aff. pseudonarcissus bulb oligo(dT) primed cDNA, 0.4 mM dNTPs, 0.4 µM each forward and
reverse outer-primer, 1 UNEB Phusion High-Fidelity DNA Polymerase, and recommended buffer
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in a 50 µl reaction. With the following PCR program parameters: 30 s 98 ⁰C 1 cycle; 10 s 98 ⁰C,
30 s 52 ⁰C, 1 min 72 ⁰C for 30 cycles; 5 min 72 ⁰C 1 cycle. The inner-primer PCR used 1 µl of
the outer-primer PCR product and used the inner-primers in Table C.3. The same PCR time
program was used except the annealing temperature was increased to 53⁰C.
NpN4OMT was cloned into the pET28a vector with the NotI and NdeI restriction sites that
were added to the 5’ and 3’ ends of the open reading frame using the inner PCR primers. PCR
product and pET28a were digested with NotI and NdeI enzymes, followed by gel purification and
ligation with the T4 DNA ligase. The resulting construct was transformed into E. coli DH5α cells
and screened on Luria-Bertani agar plates with 50 µg/ml kanamycin. Resulting colonies were
screened by colony PCR with T7 sequencing and T7 terminator primers and Taq DNA Polymerase.
The following cycle program was used: 3 min 94 ⁰C 1 cycle; 30 s 94 ⁰C, 30 s 52 ⁰C, 2 min 72 ⁰C
30 cycles; 7 min 72 ⁰C 1 cycle. Plasmid minipreps were obtained using the QIAGEN QIAprep
Spin Miniprep Kit. After Sanger sequencing of constructs (Genewiz), the desired plasmids were
transformed into E. coli BL21(DE3) Codon Plus RIL competent cells. The sequences of the
resulting five variants have the following accession numbers KJ584561(NpN4OMT1),
KJ584562(NpN4OMT2),

KJ584563(NpN4OMT3),

KJ584564(NpN4OMT4),

and

KJ584565(NpN4OMT5).

2.2.7 Protein Purification
Recombinant protein production in 1 L of E. coli and purification with TALON resin followed the
protocol found in (Higashi et al., 2010). No proteases were added to the protein extract, and
desalting was performed with PD-10 columns from GE Healthcare. Protein quantity was
determined according to Bradford; purity was monitored by SDS-PAGE. The E. coli cell line
containing the hexahistidine-tagged methylthioadenosine/S-adenosylhomocysteine nucleosidase
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(Pfs) construct from Choi-Rhee and Cronan’s work was used to purify Pfs protein (Choi-Rhee and
Cronan, 2005).

2.2.8 Screening Enzyme Assays
Enzyme assays for initial testing of NpN4OMT1 contained 10 µg of pure protein with 200 µM
AdoMet, 100 µM norbelladine, and 30 mM potassium phosphate buffer pH 8.0 in 100 µl. The
assays were incubated for 2 hr at 30⁰C. The vector control was an E. coli extract purified with
TALON in the same way as the methyltransferase protein. For the vector control assay, an equal
volume of the pure vector control extract was substituted for the NpN4OMT1 protein in the
enzyme assay. These assays were quenched by adjusting the pH to 9.5 with two volumes of sodium
bicarbonate and extracted with two volumes ethyl acetate two times. After drying, the extracts
were re-suspended in the initial mobile phase of the HPLC program. The HPLC separation of the
assays was performed using a phenomenex Luna C8(2) 5 µm 250 x 4.6 mm column with solvent
A (0.1 % formic acid in H2O) and solvent B (acetonitrile). The program started with 10 % solvent
B and a flow rate of 0.8 ml/min, a linear gradient began at 2 min to 30 % at 15 min, 90 % at 15.1
min, 90 % at 20 min, 10 % at 21 min, and 10 % at 28 min. Injection volume was 20 µl using a
Waters Autosampler. Waters UV detector was set to 277 nm.

2.2.9 Kinetic Characterization
After optimization of the assay, the buffer was changed to 100 µM glycine at pH 8.8, with 5 mM
of MgCl2 added and the temperature was increased to 37 ⁰C in 100 µl total reaction volume. When
performing kinetic assays, the E. coli enzyme Pfs was added to break down SAH and prevent
product inhibition. Product formation in kinetic experiments was quantified by comparing product
peak area to a standard curve of the expected product or equivalent. Papaverine was used as an
internal standard.
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With the same solvent system as for screening enzyme assays, the HPLC program started
with 20 % B and a flow rate of 0.8 ml/min, a linear gradient began at 2 min to 25.4 % B at 7 min,
90 % at 7.2 min, 90 % at 9 min, 20 % at 9.1 min, and 20 % at 14 min. A 4000 QTRAP mass
spectrometer coupled to the same LC column and time program as used in HPLC was used to
collect all compound mass and fragmentation data. For program setting details see Table C.4. For
norbelladine kinetics an MRM program in positive ion mode was used to monitor the following
fragments 260.0 [M+H]+/138.0 [M-C8H9O]+● m/z, 260.0 [M+H]+/121.0 [M-C7H8NO2]+● m/z,
274.0 [M+H]+/137.0 [M+H-C8H9O2]+ m/z, 274.0 [M+H]+/122.0 [M+H-C8H10NO2]+ m/z. The
fragments with 260.0 [M+H]+ m/z and 274.0 [M+H]+ m/z molecular ions were replaced when
looking at N-methylnorbelladine for 274.0 [M+H]+/152.1 [M-C8H9O]+● m/z, 274.0 [M+H]+/121.0
[M-C9H12NO2]+● m/z, 288.0 [M+H]+/150.1 [M-C8H9O2]+● m/z, and 288.2 [M+H]+/137.0 [MC9H12NO]+● m/z. Papaverine internal standard was monitored with the following fragments 340.4
[M+H]+/324.2 [M-CH3]+● m/z and 340.4 [M+H]+/202.1 [M-C8H9O2]+● m/z. When conducting
dopamine kinetics, galanthamine was used as the internal standard and samples were not ethyl
acetate extracted prior to LC/MS/MS analysis. To remove protein, two volumes of acetonitrile
were added followed by 1 hr at -20 ⁰C and 10 min centrifugation at 16,100 xg, 4 ⁰C. The
supernatant was dried under vacuum and re-suspended in the starting mobile phase before analysis.
The HPLC time program was changed to start at 5 % solvent B with solution going to waste until
3.9 min, at 5 min start linear gradient to 25 % B at 25 min, 90 % B at 9.5 min, 90 % B at 11 min,
5 % B at 11.1 min, and 5 % B at 16 min. Ions monitored in the MRM were 168.0 [M+H]+/151.0
[M+H-OH]+ m/z and 168.0 [M+H]+/119.0 [M-OH-OCH3]+● m/z. AdoMet steady state kinetic
parameters were determined with norbelladine as the saturated substrate. Product was quantitated
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using HPLC with the 28 min program used for screening enzyme assays. Product for assays on the
additional NpN4OMT variants was detected with this same 28 min program on HPLC.
When conducting kinetic experiments the Km was at least five fold higher than the
minimum concentration of substrate and fivefold lower than the maximum concentration of
substrate tested. Km and kcat were calculated by nonlinear regression to the Michaelis-Menten
kinetics equation with the GraphPad PRISM 5.0 software.

2.2.10 NMR
NMR spectra were acquired for 4’-O-methylnorbelladine in CD3OD at 600 MHz on a
BrukerAvance 600 MHz spectrometer equipped with a BrukerBioSpin TCI 1.7 mm
MicroCryoProbe. Proton, gCOSY, ROESY, gHSQC, and gHMBC spectra were acquired;

13

C

chemical shifts were obtained from the HSQC and HMBC spectra. Chemical shifts are reported
with respect to the residual non-deuterated MeOD signal (H 3.31) (Figure C.1, C.2, C.3, C.4, and
C.5).

2.2.11 Quantitative Real Time-PCR (qRT-PCR)
cDNA for leaf, bulb, and inflorescence tissues of N. sp. aff. pseudonarcissus were created using 1
µg RNA from the respective tissues, random primers, and M-MLV reverse transcriptase according
to the Invitrogen protocol. qRT-PCR was conducted with a TaqMan designed gene expression
assay for the methyltransferase with ribosomal RNA as a reference according to manufacture
protocol. Reactions (5 µl) were performed in quadruplicate with outlier exclusion using Applied
Biosystems StepOnePlus Real-Time PCR system. Methyltransferase relative expression values
were determined by calculating ∆∆CT values relative to standard ribosomal RNA and leaf tissue
(Livak and Schmittgen, 2001).
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2.3 Results
The Illumina sequencing of N. sp. aff. pseudonarcissus leaf, bulb, and inflorescence tissues
resulted in 65 million paired-end reads that were used to make the N. sp. aff. pseudonarcissus
transcriptome assembly. The transcriptome assembly consisted of 106,450 sequences (Figure
2.2A) with a mean length of 551 base pairs and a maximum length of 13,381 base pairs. A similar
number of >100 base pair sequences were found in the transcriptome of Chlorophytum
borivilianum (Kalra et al., 2013). This mean length indicates a high number of the sequences are
long enough for homology searches and cloning work. Of these sequences, 79,980 were predicted
to have open reading frames and were translated into peptides. After determining the reads coming
from the three tissues, several homologs of genes with predictable expression patterns were used
to evaluate the quality of the expression estimations. The RuBisCO large and small subunits have
high amounts of expression in the photosynthetic leaf and inflorescence tissues compared to the
non-photosynthetic bulb tissue. A homolog to the MADS62 floral development transcription factor
is exclusively expressed in the inflorescence tissue as would be expected (Kwantes et al., 2012).
The read counts were thus determined to produce expected expression patterns.
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Figure 2.2. Identification of NpN4OMT in the N. sp. aff. pseudonarcissus transcriptome. (A) Venn diagram of all
sequences, all OMTs, and all galanthamine correlating sequences according to HAYSTACK. (B) Accumulation level
of galanthamine in N. sp. aff. pseudonarcissus (C) Candidate NpN4OMT expression profile in leaf, bulb, and
inflorescence with the relative initial read estimate and qRT-PCR ∆∆Ct on the y-axis with leaf tissue set to 1.
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The LC/MS/MS data for leaf, bulb, and inflorescence tissues resulted in a pronounced
accumulation pattern of galanthamine. The largest concentration was found in bulb tissue, with a
lower level found in leaf and the lowest level in inflorescence (Figure 2.2B).
Using BLAST to seek homologs to the methyltransferases found in Table C.1 yielded 298
methyltransferase candidate genes (Raman and Rathinasabapathi, 2003). Separately, HAYSTACK
identified 9,505 contigs that co-express with galanthamine accumulation. A comparison of the two
resulting lists revealed one methyltransferase NpN4OMT that fits the HAYSTACK model (Figure
2.2A). This methyltransferase was chosen for functional analysis. After RACE, NpN4OMT was
found to be a 239 amino acid protein with a predicted molecular weight (MW) of 27 kDa. When
expressed using the pET28a vector, the added N-terminal Histidine tag increased the MW to 29
kDa (Figure 2.3A). In the course of cloning, five unique clones were obtained with >96 % identity
to each other. Due to the two-toned yellow flower color, single flower, and size, the N. sp. aff.
pseudonarcissus variety used in this study is likely Carlton. Based on genome size estimates,
Carlton is thought to be a domesticated form of Narcissus pseudonarcissus with a genome
duplication event that resulted in a tetraploid (Zonneveld, 2010). A high number of paralogs is,
therefore, expected. In addition, these bulbs have been propagated vegetatively. For these reasons,
the existence of multiple similar sequences is not surprising.
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Figure 2.3. Recombinant NpN4OMT1 purification, enzyme assay, and NMR structure elucidation of the 4’-Omethylnorbelladine product. (A) SDS-PAGE gel 10 % including fractions from crude extract and the desalted protein
prep. This is shown for vector only, NpN4OMT1, and Pfs preparations. (B) Enzyme assays (top to bottom):
Norbelladine standard; 4’-O-Methylnorbelladine standard; Assay with E. coli vector-only crude extract added; Assay
without AdoMet added; Complete methyltransferase assay. (C) NMR structure elucidation: proton chemical shifts are
black, carbon chemical shifts are blue, key HMBC correlations are black arrows, and key ROESY correlations are red
arrows.
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Due to the high similarity of the clones, the first to be cloned was selected for thorough
characterization. The clone selected for characterization is 92.5 % identical on the amino acid level
to the original sequence in the transcriptome assembly (Figure 2.4). The recombinant protein was
purified with a yield of 16.7 mg protein/L E. coli culture. SDS-PAGE analysis revealed the protein
to be of apparent homogeneity (Figure 2.3A). Initial enzyme assays with NpN4OMT1 yielded,
upon HPLC analysis, a peak with the retention time of 4’-O-methylnorbelladine. The vector only
control lacks NpN4OMT1 but has all other assay components. Therefor the absence of product in
the vector control assay excludes the possibility of a background reaction. The absence of product
in the assay lacking AdoMet shows that the methyltransferase uses AdoMet as a co-substrate and
cannot form product without AdoMet (Figure 2.3B). The pH optimum was found to be 8.8 and the
temperature optimum 45 ⁰C (Figure C.6B-C). The Pfs protein, shown purified in Figure 2.3A, was
added to prevent SAH inhibition in kinetic enzyme assays, through the Pfs catalyzed hydrolysis of
SAH to adenine and S-ribosyl-homocysteine (Choi-Rhee and Cronan, 2005).
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Figure 2.4. Protein sequence alignment of NpN4OMT variants. Five unique variants of the NpN4OMT sequence are
aligned against the original sequence predicted by the de novo assembled transcriptome using CLC software. Dots are
identical residues.

An alternative methylation product, 3’-O-methylnorbelladine, has the same retention time
on HPLC, the same UV profile, and MS/MS fragmentation pattern as 4’-O-methylnorbelladine.
Thus, NMR analysis was performed to determine the regiospecificity of O-methylation. HMBC
correlations from both the methoxyl protons (H 3.88) and H-6’ (H 6.90) to the same carbon (C
149.9) placed the methoxyl group at C-4’. Its location was further supported by a ROESY
correlation from the methoxyl protons to H-5’ (H 6.98). The NMR data thus confirmed that 4’-Omethylnorbelladine is the product of the enzyme reaction (Figure 2.3C).
To determine the substrate specificity of this methyltransferase, several similar substrates
were tested. Activity comparable to that found with norbelladine was observed using Nmethylnorbelladine as the substrate. Dopamine also served as a substrate. Under the assay
conditions used, product was not detected with caffeic acid, vanillin, 3,4-dihydroxybenzaldehyde,
and tyramine as substrates (Table 2.1). To determine if the other 4 variants show similar activity,
they were purified, and enzymatic activity was confirmed for all variants using norbelladine as the
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substrate. When monitoring NpN4OMT1 norbelladine assays allowed to proceed to completion,
no sign of double methylation products were observed as expected.
Table 2.1. Substrate specificity of NpN4OMT1

Substrate

Km (µM)

kcat (1/min)

kcat/Km
(1/µM*min)

Norbelladine
AdoMet
N-Methylnorbelladine
Dopamine
Caffeic acid
Vanillin
3,4Dihydroxybenzaldehyde
Tyramine

1.6±0.3
28.5±1.6
1.9±0.4
7.3±2.7
ND
ND
ND

1.3±0.06
4.5±0.01
2.6±0.15
3.6±0.15
ND
ND
ND

0.8
0.16
1.3
0.5
ND
ND
ND

ND

ND

ND

ND, Not detected
±, Standard error
Phylogenetic analysis of the NpN4OMT1 placed it in the class I OMT group (Figure 2.5).
NpN4OMT1 has a length consistent with the 231-248 amino acid range found in class I OMTs.
This is in contrast to other known plant catechol 4-OMTs which all group in the class II OMTs as
their length and cofactor requirements reported in previous work would predict. All these
methyltransferases are significantly longer than the standard class I OMTs and none are reported
to have the characteristic divalent cation dependence of class I OMTs (Joshi and Chiang, 1998;
Gang et al., 2002; Akashi et al., 2003; Schröder et al., 2004; Kim et al., 2005). When testing
NpN4OMT1 for cation dependence, enzymatic activity improved upon the addition of cobalt.
Enzymatic activity increased four-fold more with the addition of magnesium instead of cobalt
(Figure C.6A). This preference for magnesium over other divalent cations is also to be expected
from a class I OMT (Joshi and Chiang, 1998). It is, furthermore, consistent with previous work on
enzyme extracts enriched for this OMT (Mann, 1963).
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Figure 2.5. Phylogenetic analysis of NpN4OMT1. A maximum-likelihood phylogenetic tree of characterized
methyltransferases listed in Table C.2. Alignment constructed using MUSCLE.

To validate the expression profiles predicted based on read counts; qRT-PCR was
conducted with the same RNA preparation used to prepare the cDNA libraries for Illumina
sequencing. The resulting expression profile is slightly different from that obtained from Illumina
sequencing. The qRT-PCR expression profile has a higher quantity of inflorescence transcript
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relative to bulb transcript (Figure 2.2C). This minor difference is potentially due to cross
amplification, during qRT-PCR, with other close homologs in the plant.

2.4 Discussion
The expression pattern, product formation, and low Km for norbelladine all indicate NpN4OMT
methylates norbelladine in the proposed galanthamine biosynthetic pathway. Two differing orders
of methylation have been proposed for galanthamine biosynthesis (Eichhorn et al., 1998). The
methylation of N-methylnorbelladine was tested to determine if a preference for the N-methylation
state could be observed at O-methylation. Similar Km and kcat values for N-methylnorbelladine and
norbelladine indicate that a preference for the N-methylation state does not occur at O-methylation.
The results presented here support both proposed galanthamine biosynthetic pathways. Future
work on additional enzymes in the pathway will be needed to enzymatically validate one pathway
or the other. The lack of enzymatic activity when testing 3,4-dihydroxybenzaldehyde suggests that
methylation does not occur prior to formation of norbelladine. The methylation of dopamine is
expected considering structural similarity to the methylated moiety of norbelladine. Tyramine was
not methylated; this is as expected for a class I OMT (Table 2.1).
Several aspects of the candidate gene selection approach proved important for this
successful identification. One is the selection of a variety of methyltransferases for the homology
search. If only the known 4-OMTs had been used in the homology search, the gene would have
been missed due to the large difference in sequence between known 4-OMTs and NpN4OMT. It
has been shown that catechol 4’-OMT and catechol 3’-OMT can differ by as little as one amino
acid (Wils et al., 2013). Because of this potential for a conversion form catechol 3’-O-methylation
to 4’-O-methylation though evolution, OMTs of both positions were used in the homology search.
Also, both class I and class II OMTs were used in the search because both classes are known to
62

methylate catechols. Considering the multiple branches of the N-methyltransferases in the OMT
phylogeny, it is worth investigating enzymes that annotate as N-methyltransferases (Raman and
Rathinasabapathi, 2003). For these reasons, the sequences used in the initial BLAST search
consisted of representatives of known O- and N-methyltransferases of small metabolites. The
NpN4OMT turned out to be a member of the class I OMTs. Class I OMTs show closer homology
to human catechol OMT than to all known plant catechol 4-OMTs in class II, as demonstrated in
Figure 2.5 (Ibdah et al., 2003). The closest known catechol 4-OMT to NpN4OMT is bacterial, has
34 % identity to NpN4OMT, and is a class I OMT from Cyanobacterium Synechocystis sp. Strain
PCC 6803 (SynOMT) (Kopycki et al., 2008). Many 3-OMTs show even higher homology to
NpN4OMT than SynOMT. It is probable that the 4-OMT activity of NpN4OMT was acquired
independently of SynOMT (Figure 2.5).
The second selection criterion, co-expression with galanthamine accumulation, was also of
great value. It reduced the number of candidate OMTs from hundreds to one. There are a variety
of methods for the prioritization of candidate genes (Moreau and Tranchevent, 2012). Many of
these methods are oriented towards species and systems for which there are extensive databases or
prior knowledge regarding a gene involved in the pathway or process. In one study, a collection of
~500 microarrays was used to demonstrate the co-expression of genes in the same pathway in
Arabidopsis (Wei et al., 2006; Saito et al., 2008). However, extensive gene expression data are
typically not available for non-model systems. There have been several studies that use coexpression analysis to find genes in a pathway and produce promising candidate gene lists. These
studies often lack biochemical validation of the in silico candidates (Sun et al., 2011). If a novel
function is proposed, this type of analysis is incomplete without biochemical validation of enzyme
activity. Enzymes that are homologous to functionally equivalent enzymes in a different species
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can be corroborated by co-expression analysis (Sun et al., 2011). There are several studies that use
a simple differential expression model and microarrays to find biosynthetic genes by comparing
biosynthetically active and inactive accessions in rose and strawberry (Aharoni et al., 2000;
Guterman et al., 2002). Differential expression analysis lacks algorithms to use data with differing
levels of metabolism occurring in more than two samples. The Pearson correlation can compare
data from multiple samples. Mercke et al. have used a Pearson correlation-based method to identify
gene expression with microarrays that correlate with levels of specific terpenes in cucumber
(Mercke et al., 2004). Illumina-based transcriptomes are, however, more sensitive to minor
variants in the sequences and to splice variants. Illumina-based gene expression data also have a
far greater dynamic range, limited only by sequence depth, than microarrays (Wang et al., 2009).
Subtleties in the sequences that could be missed with microarrays can now be detected with
Illumina sequencing.
The use of HAYSTACK as a platform to use the Pearson correlation is ideal because it is
designed to receive a hypothesis for gene expression and look for gene expression that correlates
with that hypothesis. This is in contrast to an approach in which gene expression patterns are
clustered based on similarity to each other. The search for a defined pattern in the data allows the
number of required expression data points to be reduced compared to an approach that needs to
define clusters of gene expression patterns based on similarity. In HAYSTACK, the shared
expression pattern is already defined. HAYSTACK applies additional screening criteria including
a p-value test for significance, a fold cutoff, and background cutoff. The approach chosen in our
study used knowledge of known chemical intermediates, a transcriptome with expression profiles
for three tissues, and metabolite levels to identify a candidate gene product to validate with in vitro
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enzyme activity. Little prior knowledge of a pathway is required to use this approach, making this
workflow ideal for the identification of genes in unknown biochemical pathways.
There are several modifications to this approach that could be used to improve its power.
It could be applied to more tissues, environmental conditions or time points to provide even greater
statistical power to correlate co-expression of biosynthetic genes with the biosynthesis of their
products. The method could also be modified to include analysis of multiple end products. If the
pathway in which the enzyme participates branches, several end products could be equally
important to co-expression analysis. This combined consideration of multiple end products could
lead to more informative models (Yamazaki et al., 2013). Another potential source of information
on the metabolite level could be the concentrations of intermediates made during synthesis.
Correlations between biosynthetic gene expression, and perhaps the accumulation of metabolites
as well, tend to decrease as distance in a pathway increases (Wei et al., 2006). Experiments that
quantitate metabolic intermediates could be useful for finding biosynthetic genes if the flux
through the pathway is not so high that intermediates do not accumulate. The latter would be the
case in a pathway assembled into a metabolon.
The discovery of this enzyme enables the future elucidation of other enzymes in the
proposed galanthamine biosynthetic pathway and other novel pathways. Genes that co-express
with NpN4OMT can be identified and used as candidate genes for other steps in the proposed
galanthamine biosynthetic pathway. This will potentially be useful for earlier steps in the pathway,
considering the tendency of expression correlations to decrease as distance in metabolic pathways
increase (Wei et al., 2006). This enzyme discovery also validates the utility of this workflow to
characterize metabolic pathways and provides a valuable method for pathway discovery in orphan
species.
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Chapter 3: CYP96T1 of Narcissus sp. aff.
pseudonarcissus Catalyzes Formation of
the Para-Para’ C-C Phenol Couple in the
Amaryllidaceae Alkaloids
This chapter has been submitted for publication as:
CYP96T1 of Narcissus sp. aff. pseudonarcissus Catalyzes Formation of the Para-Para’ C-C
Phenol Couple in the Amaryllidaceae Alkaloids
Matthew B. Kilgore1, Megan M. Augustin 1, Gregory D. May2, John A. Crow2, Toni M. Kutchan1
1

Donald Danforth Plant Science Center, St. Louis, MO, USA

2

National Center for Genome Resources, Santa Fe, NM, USA

The Amaryllidaceae alkaloids are a family of amino acid derived alkaloids with many biological
activities; examples include haemanthamine, haemanthidine, galanthamine, lycorine, and
maritidine. Central to the biosynthesis of the majority of these alkaloids is a C-C phenol-coupling
reaction that can have para-para’, para-ortho’, or ortho-para’ regiospecificity. Through
comparative transcriptomics of Narcissus sp. aff. pseudonarcissus, Galanthus sp., and Galanthus
elwesii we have identified a para-para’ C-C phenol coupling cytochrome P450, CYP96T1,
capable of forming the products (10bR,4aS)-noroxomaritidine and (10bS,4aR)-noroxomaritidine
from 4’-O-methylnorbelladine. CYP96T1 was also shown to catalyzed formation of the paraortho’ phenol coupled product, N-demethylnarwedine, as less than 1 % of the total product.
CYP96T1 co-expresses with the previously characterized norbelladine 4’-O-methyltransferase.
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The discovery of CYP96T1 is of special interest because it catalyzes the first major branch in
Amaryllidaceae alkaloid biosynthesis. CYP96T1 is also the first phenol-coupling enzyme
characterized from a monocot.

3.1 Introduction
The Amaryllidaceae alkaloids are produced by species of Amaryllidaceae including Narcissus spp.
(daffodil) and Galanthus spp. (snowdrop). Alkaloids from all major structural classes of
Amaryllidaceae alkaloids have biological activities. Some of these alkaloids have potential
pharmaceutical applications or are already established medicines. The alkaloid skeleton types,
haemanthamine, narciclasine, tazettine, and montanine are derived from the para-para’ C-C
phenol coupled, (10bR,4aS)-noroxomaritidine, biosynthetic precursor (Wildman and Bailey, 1969;
Fuganti et al., 1971; Feinstein and Wildman, 1976) (see Figure 3.1 and Figure 3.2 for
representative structures). Specific examples of alkaloids derived from (10bR,4aS)noroxomaritidine include haemanthamine, maritidine, vittatine, and pretazettine. Haemanthamine
has been shown to have antiproliferative and apoptotic effects on cancer cell lines and antioxidant
activity in a 2,2-diphenyl-1-picrylhydrazyl scavenging assay (Oloyede et al., 2010; Van
Goietsenoven et al., 2010; Havelek et al., 2014). Crinine and its derivatives are also derived from
a para-para’ C-C phenol coupling, however, the phenol-coupled product is the enantiomer,
(10bS,4aR)-noroxomaritidine. Antibacterial activities have been noted for the derivatives of the
(10bS,4aR)-noroxomaritidine skeleton including buphanidrine and distichamine (Cheesman et al.,
2012). An example of an ortho-para’ C-C phenol-coupling product is lycorine, derived from
noroxopluvine. Lycorine has been documented to cause apoptosis in leukemia and multiple
myeloma cancer cell lines (Liu et al., 2004; Li et al., 2007; Liu et al., 2009). Galanthamine is a
representative derivative of the para-ortho’ C-C phenol-coupled product N-demethylnarwedine
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and is used as an Alzheimer’s treatment drug (Wilcock et al., 2003). It acts through acetylcholine
esterase inhibition and nicotinic receptor binding (Irwin and Smith, 1960; Barik et al., 2005). The
limited supply of some Amaryllidaceae alkaloids and diversity of biological activities make the
biosynthesis of Amaryllidaceae alkaloids a topic of interest for biotechnology.

Figure 3.1. Proposed biosynthetic pathways for representative Amaryllidaceae alkaloids directly derived from C-C
phenol coupling. The previously discovered NpN4OMT, the CYP96T1 discovered in this study, and potential enzyme
classes involved in each step of the pathways are in blue.
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Figure 3.2. Structures of relevant compounds.

Haemanthamine is derived from the amino acids phenylalanine and tyrosine.
Phenylalanine was established as a precursor by incorporation of [3-14C]phenylalanine into
haemanthamine in Nerine bowdenii (Wildman et al., 1962b). The conversion of phenylalanine to
3,4-dihydroxybenzaldehyde in haemanthamine biosynthesis was clarified by feeding [3-14C]transcinnamic

acid,

[3-14C]para-hydroxycinnamic

acid,

[7-14C]benzaldehyde,

[7-14C]para-

hydroxybenzaldehyde, [3H]3,4-dihydroxybenzaldehyde, and [3H]threo-DL-phenylserine to
Narcissus pseudonarcissus. Incorporation into haemanthamine from the precursors [3-14C]trans70

cinnamic acid, [3-14C]para-hydroxycinnamic acid, [3H]3,4-dihydroxybenzaldehyde, and trace
incorporation of [7-14C]para-hydroxybenzaldehyde, but not other administered compounds, lead
to the conclusion that the pathway proceeds as follows: phenylalanine is converted to transcinnamic acid, then to para-hydroxycinnamic acid, then to 3,4-dihydroxycinnamic acid or parahydroxybenzaldehyde followed by conversion to 3,4-dihydroxybenzaldehyde (Suhadolnik et al.,
1963a). Observation of radiolabeled [3-14C]tyrosine incorporation into haemanthamine established
tyrosine as a precursor (Jeffs, 1962). Tyrosine was demonstrated to contribute to C11 and C12 of
haemanthamine by feeding [β-14C]tyrosine to Sprekelia formosissima and [α-14C]tyrosine to
Narcissus ‘Twink’ daffodil followed by haemanthamine degradation experiments (Battersby et al.,
1961a; Wildman et al., 1962a) (Figure 3.1). These results indicate tyrosine also contributes C1-4,
C4a, and C10b because of their ring shape and proximity to the C11 and C12 of haemanthamine.
Equivalent sections of the galanthamine and lycorine carbon skeleton also originate from tyrosine
(Battersby and Binks, 1960; Barton et al., 1963). Tyrosine is converted into tyramine by tyrosine
decarboxylase, a well characterized enzyme in other secondary metabolite pathways (Lehmann
and Pollmann, 2009).
3,4-Dihydroxybenzaldehyde and tyramine are condensed to a Schiff-base and reduced to
norbelladine. The central role of norbelladine in Amaryllidaceae alkaloid biosynthesis was
demonstrated by incorporation of [1-14C]norbelladine into haemanthamine, lycorine, and
galanthamine (Barton et al., 1961; Battersby et al., 1961b; Battersby et al., 1961a). Next,
norbelladine is methylated to 4’-O-methylnorbelladine. In 1963, crude enzyme extracts of N.
bowdenii were used to perform a preliminary characterization of the 4’-O-methyltransferase
conducting this methylation (Mann, 1963). This cation-dependent norbelladine 4’-Omethyltransferase (N4OMT) was identified in Narcissus sp. aff. pseudonarcissus, and
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enzymatically characterized by heterologous expression in E. coli in Chapter 2 (Kilgore et al.,
2014). (10bR,4aS)-Noroxomaritidine is formed from the para-para’ C-C phenol coupling of 4’O-methylnorbelladine. The biosynthesis of haemanthamine deviates from alkaloids with orthopara’ and para-ortho’ carbon skeletons at this branch point. The next step is thought to be a
reduction of the ketone group to synthesize 8-O-demethylmaritidine followed by an oxide bridge
formation to form vittatine. Conversion of vittatine to haemanthamine is thought to occur through
hydroxylation followed by methylation (Figure 3.1). The conversion of vittatine to haemanthamine
has been demonstrated by radiolabeling studies. The order of hydroxylation and methylation in
this conversion is inferred from the presence of the hydroxylated 11-hydroxyvittatine in the N.
bowdenii plants under investigation and the absence of the methylated (10bR,4aS)-buphanisine
(Feinstein and Wildman, 1976). Haemanthamine accumulates in planta and is modified further to
compounds such as haemanthidine and pretazettine in some Amaryllidaceae. The proposed
biosynthesis of galanthamine from the ortho-para’ product N-demethylnarwedine through the
reduced intermediate N-demethylgalanthamine has been reviewed in Chapter 1 and discussed in
Chapter 2 (Eichhorn et al., 1998; Kilgore et al., 2014).
Cytochrome P450 enzymes are a diverse enzyme family with numerous functions.
Reactions catalyzed include hydroxylation, C-C and C-O phenol coupling, oxide bridge formation,
carbon-carbon bond cleavage, demethylation, and rearrangements of carbon skeletons (Mizutani
and Sato, 2011). Previously documented C-C phenol coupling by cytochrome P450 enzymes that
synthesize salutaridine (CYP719A1), (S)-corytuberine (CYP80G2), and cyclodipeptide cyclo(lTyr-l-Tyr) (CYP121), suggest the C-C phenol coupling reactions found in Amaryllidaceae alkaloid
biosynthesis are cytochrome P450 dependent (Ikezawa et al., 2008; Belin et al., 2009; Gesell et
al., 2009). C-C phenol coupling reactions have also been documented in the human cytochromes
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P450 CYP2D6 and CYP3A4 with the substrate (R)-reticuline (Grobe et al., 2009). In addition to
cytochromes P450 peroxidases and laccases are documented phenol-coupling enzymes (Schlauer
et al., 1998; Davin et al., 2008; Constantin et al., 2012)
Orphan plant species are frequently of interest due to their unique metabolism. Study of
this metabolism is problematic due to scarcity of genetic information, limited mutant libraries, and
lack of efficient transformation methods. In addition, secondary metabolites can be
phylogenetically restricted. Method development for efficient metabolic pathway elucidation in
orphan species is therefore desirable. An efficient work-flow for the identification of biosynthetic
genes has been previously developed and applied to Amaryllidaceae alkaloid biosynthesis.
Methyltransferase transcripts correlating with galanthamine accumulation in N. sp. aff.
pseudonarcissus were targeted and tested for norbelladine 4’-O-methyltransferase activity, leading
to the discovery of the biosynthetic gene N4OMT in Chapter 2 (Kilgore et al., 2014). In this study,
a similar work-flow is applied utilizing transcriptomic data from multiple species to identify
cytochrome P450 genes that co-express with N4OMT. This led to the isolation and characterization
of CYP96T1, which catalyzes formation of the para-para’ and a small quantity of the para-ortho’
C-C phenol couple with 4’-O-methylnorbelladine.

3.2 Materials and Methods
3.2.1 Plant Tissue and Chemicals
Leaf, bulb, and inflorescence tissues were collected from adult blooming N. sp. aff.
pseudonarcissus and Galanthus sp. plants in St. Louis, MO and Galanthus elwesii in Pullman,
WA. Chemicals acquired from Sigma Aldrich include ammonium acetate 97 % A.C.S. reagent,
HPLC grade ethanol, and tyramine 99 %. Other chemicals purchased include ammonium acetate
extra pure 25 % solution in water from Acros Organics, ampicillin from GoldBio, and vanillin
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from Merck. Several compounds were obtained previously by synthesis including: veratraldehyde,
(R)-coclaurine, and (S)-coclaurine. Haemanthamine was previously isolated from Narcissus
pseudonarcissus. Additional materials are as described previously in Chapter 2 and (Gesell et al.,
2009).

3.2.2 Transcriptome Assembly and Transcript Abundance Estimation
The transcriptomes assembled using ABySS and MIRA for Galanthus sp. and G. elwesii were
assembled in the same manner as in Chapter 2 for the previously described ABySS and MIRA N.
sp. aff. pseudonarcissus transcriptome (Kilgore et al., 2014), but with 50 base paired-end reads
with leaf, bulb, and inflorescence tissues. Alternative transcriptomes were made using Trinity. For
these transcriptomes the same raw reads were assessed using FastQC followed by trimming with
the FASTX tool kit. The fastx_trimmer was used to remove the first 13 bases and
fastq_quality_trimmer was used to remove all bases on the 3’ end with a Phred quality score lower
than 28. Sequences below 30 bases or without a corresponding paired-end read were removed from
the trimmed data set. Cleaned reads were input into the Trinity pipeline with default parameters
for each data set (Haas et al., 2013). The unprocessed reads and Trinity assemblies were used with
the Trinity tool RNA-Seq by Expectation-Maximization (RSEM) to obtain the transcripts per
million mapped reads (TPM) for all transcripts in each tissue (leaf, bulb, and inflorescence) for
each Trinity assembly. To assess quality, the following parameters were considered: the size of
the resulting assembly and identification of homologues to the conserved genes Zea mays MADS6
(NP_001105153.1), Arabidopsis thaliana ribulose bisphosphate carboxylase small chain 1A
(NP_176880.1), and the Oryza sativa ribulose-1,5-bisphosphate carboxylase/oxygenase large
subunit (AAB02583.1). Assemblies and transcript expression data are deposited in the MedPlant
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RNA Seq Database, http://www.medplantrnaseq.org. ESTScan trained against A. thaliana open
reading frames was used to predict peptides encoded in all Trinity assemblies (Iseli et al., 1999).

3.2.3 Candidate Gene Identification
BLASTP with an e-value cut off of 1 x 10-4 was used to find homologs to known cytochrome P450
enzymes in all transcriptomes. A list of 472 unique, curated plant cytochrome P450 sequences
from Dr. David Nelson, University of Tennessee, was used as a query against the ESTScan
predicted peptides for each assembly (supplemental File 1). HAYSTACK was used to find
correlations between the appropriate N4OMT expression model for each assembly (Table 3.1) and
the transcripts in each assembly. All Galanthus models were based on the expression estimates for
the closest NpN4OMT1 homologue in the assembly being used. The N. sp. aff. pseudonarcissus
model was based on the RT-PCR data for NpN4OMT1 expression obtained in Chapter 2 (Kilgore
et al., 2014). HAYSTACK parameters are as follows: correlation cutoff ≥ 0.8, background cutoff
≥ 1, fold cutoff ≥ 4, and p-value cutoff ≤ 0.05 (Mockler et al., 2007). Homologues to annotated
cytochrome P450 enzymes that were correlating with the N4OMT models were identified using
BLASTN with an e-value cut off of 1 x 10-50 queried against the N4OMT co-expressing candidates
in every other assembly. For each cytochrome P450 candidate, the total number of assemblies with
an N4OMT co-expressing BLASTN hit were determined. Candidates present in five of the five
comparable lists were considered top priority candidate genes and were cloned (Figure 3.3).
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Table 3.1. Models used in HAYSTACK analysis

Model name

Leaf Inflorescence Bulb

N

1
0.01
2.24
NA
2.42
15.95

N. sp. aff. pseudonarcissus N4OMT (relative units)
Galanthus sp. N4OMT (RPM)
N
Galanthus elwesii N4OMT (RPM)
TC
N. sp. aff. pseudonarcissus N4OMT (TPM)
T
Galanthus sp. N4OMT (TPM)
T
Galanthus elwesii N4OMT (TPM)
N

30
33.34
22.59
NA
29.02
49.32

45
139.79
71.71
NA
94.73
201.97

N

AbySS and MIRA assembly
homologue not found
T
Trinity assembly
RPM=reads per million
NA=not applicable
C

3.2.4 Polymerase Chain Reaction (PCR) and Cloning
After cloning CYP96T1, designated as narcissus-20101112|22907 in the ABySS and MIRA N. sp.
aff. pseudonarcissus assembly, a close homologue of CYP96T1 with the designation narcissus20101112|13079 was identified with a complete ORF. Primers based on the 5’ sequence of
narcissus-20101112|13079 and the 3’ sequence of CYP96T1. Design of inner primers was
validated by sequencing (GENEWIZ Inc.) of the outer PCR product using the following primers
CYP96T forward outer (5’-ACATCCCCCCCAAAAAAATCATAAC-3’), CYP96T reverse outer
(5’-AGACCATCAATGTGATCACCA-3’),

and

CYP96T

reverse

sequencing

(5’-

TGGTGAAATCGTTGAATTGGTTGT-3’). N. sp. aff. pseudonarcissus bulb cDNA was prepared
as described in Chapter 2 (Kilgore et al., 2014). The outer PCR reaction contained 0.2 µM each of
CYP96T forward outer and CYP96T reverse outer primers, 1 µl of bulb cDNA, 1X Phusion HF
reaction buffer, 0.3 mM dNTPs, and 1 U NEB Phusion High-Fidelity DNA Polymerase in a 50 µl
reaction. The PCR program parameters were as follows: 30 s 98 ºC 1 cycle, 15 s 98 ºC, 30 s 52 ºC,
2 min 72 ºC 35 cycles, and 5 min 72 ºC 1 cycle. Inner PCR parameters were identical except
primers

used

were

CYP96T

aattGCGGCCGCATGGCCACTTCTTCTTCAGCA-3’)
76

forward
and

CYP96T

inner
reverse

(5’inner

(5’-

aattTCTAGATCACATGACTGATCTCTTTCT-3’) adding NotI and XbaI restriction sites,
respectively (underlined), the outer PCR reaction was added as template as opposed to cDNA, and
the PCR cycles were reduced to 25.

Figure 3.3. Work-flow for identification of candidate cytochrome P450 enzymes. Following the generation of
transcriptome assemblies, cytochrome P450 enzymes were identified with BLASTP (Navy blue) and genes correlating
with N4OMT were identified with HAYSTACK (Red). The genes present in both lists makeup the initial candidate
gene list (Green). Homologues of these genes were identified in the N4OMT correlating lists of the other
transcriptomes using BLASTN (Gray). Candidates with homologues in all five N4OMT correlating lists were cloned
from N. sp. aff. pseudonarcissus, Narcissus sp. (light blue). The analysis for the N. sp. aff. pseudonarcissus ABySS
and MIRA assembly is completely diagrammed to illustrate the process followed in every assembly. The number of
transcripts selected in each step is in parentheses. The N. sp. aff. pseudonarcissus Trinity assembly is excluded from
this work-flow due to its poor quality.

The inner PCR product and pVL1392 vector were digested with NEB NotI and XbaI
followed by PCR purification with the QIAquick PCR Purification Kit and ligation with NEB T4
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DNA ligase according to manufacturer’s instructions. The resulting construct was transformed into
DH5α E. coli chemically competent cells. Recombinant bacteria were selected on Luria-Bertani
1.5 % agar plates with 50 µg/ml ampicillin.
Transformants were screened by colony PCR with the following components: 0.67 µM
polyhedrin forward (5’-AAAATGATAACCATCTCGC-3’) and polyhedrin reverse (5’GTCCAAGTTTCCCTGTAGA-3’) primers, ThermoPol Reaction buffer 1X, 0.2 mM dNTPs, and
1 U of NEB Taq DNA polymerase in a volume of 20 µl. The PCR parameters were as described
in Chapter 2 (Kilgore et al., 2014). Plasmid minipreps of 5 ml cultures in LB supplemented with
50 µg/ml ampicillin were prepared using the QIAGEN QIAprep Spin Miniprep Kit according to
manufacturer’s instructions and sequenced with polyhedrin forward and reverse primers by
Eurofins genomics. All reproducible sequences were named by Dr. David Nelson, University of
Tennessee. The closest biochemically characterized homologue to the resulting CYP96T1 clone,
CYP96A15, was identified in the UniProt database with BLASTP. CYP97T1 (KT693311),
CYP96T2 (KT693312), CYP96T3 (KT693313), the original CYP96T1 sequence, and CYP96A15
were aligned with MUSCLE in the CLC main workbench version 6.9.1 (Edgar, 2004).

3.2.5 Protein Expression
Co-transfection of CYP96T1 in pVL1392 and Baculogold baculoviurus (BD Biosciences), viral
amplification, protein expression, and microsome preparation in Spodoptera frugiperda Sf9 cells
was performed as previously described (Gesell et al., 2009). Microsomes of Sf9 cells expressing
CYP96T1 were solubilized with 0.17 % emulgen 913 at 4 ⁰C for 15 min followed by centrifugation
(15,000 X g for 15 min) before obtaining the CO difference spectra. The resulting CYP96T1
concentration was used to calculate concentration of CYP96T1 in all subsequent Sf9 cell cultures.
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CYP96T1 was always co-expressed with Eschscholzia californica cytochrome P450 reductase
(CPR) (Gesell et al., 2009). For a negative control CPR was expressed without CYP96T1.

3.2.6 3’-O-Methylnorbelladine and 3’,4’-O-Dimethylnorbelladine Synthesis
For the synthesis of 3’-O-methylnorbelladine sodium cyanoborohydride (48.5 mM), vanillin (5.66
mM), and tyramine (5.15 mM) were mixed in 2.5 ml anhydrous methanol for 2 days at room
temperature. For synthesis of 3’,4’-O-dimethylnorbelladine, sodium cyanoborohydride (65.18
mM), veratraldehyde (9.40 mM), and tyramine (7.29 mM) were mixed in 2.5 ml anhydrous
methanol for 2 days at room temperature. The reaction mix was then taken to dryness under N2.
The resulting material was suspended in 200 µl of 1 M NaCO3 pH 9.5 and extracted twice with
400 µl of ethyl acetate by vortexing for 1 min, followed by centrifugation at 16.1 x g for 2 min at
room temperature. Ethyl acetate extractions were pooled and dried under vacuum. Extractions
were re-suspended in 10 % acetonitrile and 0.1 % formic acid and purified by fractionation using
a Waters fraction collector III and Waters 1525 binary HPLC pump as described in Chapter 2
(Kilgore et al., 2014). 3’-O-methylnorbelladine was collected at 9 min for ~1 min and 3’,4’-Odimethylnorbelladine at 11.5 min for ~1 min. Purified compound was dried under vacuum, resuspended in H2O and quantified with a 4’-O-methylnorbelladine standard curve using peak area
by HPLC with the method stated above.

3.2.7 Enzyme Assays
Screening assays contained 30 mM KPO4 pH 8.0, 1.25 mM NADPH, 10 µM substrate, and 70 µl
of virus infected Sf9 cell suspension in 200 µl total volume. The assays were incubated for 2-4 hr
at 30 ºC. 4’-O-metylnorbelladine was tested for all CYP96T variants. CYP96T1 was used for
substrate

specificity

tests

on

norbelladine,

N-methylnorbelladine,

4’-O-methyl-N-

methylnorbelladine, 3’-O-methylnorbelladine, 3’,4’-O-dimethylnorbelladine, haemanthamine,
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(S)-coclaurine, (R)-coclaurine, and mixed (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (see
Figure 3.1 and Figure 3.2 for chemical structures). Assays derivatized with sodium borohydride
were incubated 2 hr at 30 ºC followed by addition of 0.5 volumes 0.5 M sodium borohydride in
0.5 M sodium hydroxide and incubated 30 min at RT. The CYP96T1 assay resolved on a ChiralCBH column and assays measured with HPLC used fresh CYP96T1 and CPR expressing Sf9 cell
protein prepared using re-amplified virus. Kinetic assays were run in the linear time range for each
substrate in 200 mM KPO4 pH 6.5 buffer with 40 µl assays. Product for overnight enzyme assays
of (R)-coclaurine, (S)-coclaurine, and 4’-O-methyl-N-methylnorbelladine were quantified at 277
nm against a noroxomaritidine standard curve with the same HPLC method and setup used for 3’O-methylnorbelladine and 3’,4’-O-dimethylnorbelladine isolation. These products were
subsequently used as standards for quantifying kinetic assays. Km and kcat values were estimated
using R version 3.2.0 with nonlinear fitting.

3.2.8 LC-MS/MS
Enzyme assays on all substrates were extracted as previously described and run on a QTRAP 4000
coupled to a IL-20AC XR prominence liquid auto sampler, 20AD XR prominence liquid
chromatograph and Phenomenex Luna 5 µm C8(2) 250 x 4.60 mm column. HPLC gradient and
MS settings were as described in Chapter 2 (Kilgore et al., 2014). Assay specific MS/MS
parameters are presented in Table 3.2. Multiple Reaction Monitoring (MRM) parameters for
relative quantification of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine, N-demethylnarwedine,
narwedine, and the two unknown compounds are presented in Table 3.3. For analysis of product
chirality, a Chrom Tech, Inc. Chiral-CBH 100 x 4.0 mm, 5 µM column was used with a 30 min
isocratic flow of 2.5 % HPLC grade ethanol and 10 mM ammonium acetate with pH adjusted to
7.0 with ammonium hydroxide. Kinetic assays were quantified with an isocratic flow 20 %
80

acetonitrile and 0.08 % formic acid with the Phenomenex Luna 5 µm C8(2) 250 x 4.60 mm column
connected to the same QTRAP 4000 setup. MRM transitions used in kinetics were 284.1/223.0
m/z for the (S)-coclaurine and (R)-coclaurine products, 286.1/271.0 m/z for the 4’-O-methyl-Nmethylnorbelladine para-para’ product, and 272.3/229.0 m/z for noroxomaritidine.
Table 3.2. MS/MS parameters for substrate tests

Substrate

Product specific Substrate specific
parameters
parameters
(CE)(DP)(Q1
(CE)(DP)(Q1 m/z)
m/z)

4’-O-Methylnorbelladine
4’-O-Methyl-Nmethylnorbelladine
3’-O-Methylnorbelladine
3’,4’-O-Dimethylnorbelladine

(35)(70)(272.30)
(35)(70)(286.20)

(20)(60)(274.30)
(20)(60)(288.30)

(35)(70)(272.30)
(35)(70)(286.20)

(35)(60)(274.30)
(20)(60)(288.30)

Norbelladine
N-Methylnorbelladine
Haemanthamine

(35)(60)(258.00)
(35)(70)(272.30)
(35)(70)(300.12)/
(35)(70)(318.13)HO
(35)(70)(270.30)/
(35)(70)(288.30)HO
(20)(40)(290.30)a/
(20)(60)(272.20)b/
(35)(70)(270.20)c
(35)(70)(284.30)/
(30)(60)(570.60)dim
(35)(70)(284.30)/
(30)(60)(570.60)dim
(20)(60)(274.30)

(15)(50)(260.00)
(20)(60)(274.30)
(35)(70)(302.14)

(10bS,4aR)- and (10bR,4aS)Noroxomaritidine
Isovanillin and tyramine

(S)-Coclaurine
(R)-Coclaurine
4’-O-Methylnorbelladine assays
followed by sodium borohydride
derivatization
HO

(35)(70)(272.30)
(20)(60)(138.20)/
(20)(50)(153.20)
(20)(70)(286.30)
(20)(70)(286.30)
(20)(60)(274.30)

hydroxylation monitored
dimer formation monitored
a
C-C phenol coupling with no amine aldehyde condensation
b
amine aldehyde condensation/amine aldehyde condensation with C-C phenol coupling and a
reduction.
c
amine aldehyde condensation with C-C phenol coupling
dim
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Table 3.3. MS/MS parameters used in MRM studies

Compound(C-C phenol coupling type)

MRM

parameters(CE)(DP)(Q1

m/z)(Q2

m/z)(RT min)
Noroxomaritidine(para’-para)

(35)(70)(272.3)(229.0)(5.3)

N-Demethylnarwedine(para’-ortho)

(35)(70)(272.3)(201.0)(7.9)

4’-O-Methyl-N-methylnorbelladine

assay

unknown

(35)(70)(286.1)(271.0)(4.7)

4’-O-Methyl-N-methylnorbelladine assay unknown 2

(30)(70)(286.1)(243.0)(7.5)

1(potential para’-para product)

(potential ortho’-para product)
Narwedine(para’-ortho)

(30)(70)(286.1)(229.1)(8.1)

3.3 Results
3.3.1 Transcriptome Assembly and Transcript Abundance Estimation
Key statistics for each transcriptome including total number of transcripts, maximum transcript length, and
average transcript length are summarized in Table 3.4. ABySS and MIRA assemblies were found to have
a high number of incomplete ORFs. This was problematic for cloning and highlighted the potential problem
of unannotated transcripts and inaccurate expression estimates in transcripts with short assemblies. Quality
processed reads were reassembled with Trinity to provide alternate information on the same transcripts.
These assemblies provided additional sequence information with comparable expression estimates. The N.
sp. aff. pseudonarcissus Trinity assembly resulted in a large number of contigs but lacked wellcharacterized genes, such as ribulose bisphosphate carboxylase small chain 1A and NpN4OMT1. In
addition, the maximum contig length was 73,933, well above the expected size range. For these reasons,
further analysis of the N. sp. aff. pseudonarcissus Trinity assembly was abandoned. The other assemblies
have comparable statistics regardless of assembly method. Because these assemblies are complementary to
each other, both sets of Galanthus assembles were used for subsequent analysis (Table 3.4).
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Table 3.4. Transcriptome statistics

Sequence
s (bp)
Longest
(bp)
N50 (bp)
Mean
(bp)
Median
(bp)

N.
sp.
aff.
pseudonarcissu
s AbySS and
MIRA*!

Galanthu
s
sp.
AbySS
and
MIRA*

Galanthu N.
sp.
aff. Galanthu Galanthu
s elwesii pseudonarcissu s
sp. s elwesii
#
#
AbySS
s Trinity
Trinity
Trinity#
and
MIRA*

106,450

143,394

224,205

608,439

103,471

97,789

13,381

15,365

19,356

40,450

13,629

13,055

1,130
551

1,418
664

1,330
602

931
671

1,044
723

1,139
777

248

271

245

430

481

528

*assemblies were set to have a minimum cut off of 100 bp.
#
assemblies were set to have a minimum cut off of 201 bp.
!

assembly reported in Chapter 2 (Kilgore et al., 2014)

3.3.2 Candidate Gene Identification and Cloning
The pattern-matching algorithm HAYSTACK was used to identify transcripts that co-express with
N4OMT. N4OMT is the only validated gene involved in Amaryllidaceae alkaloid biosynthesis to
date. Its position in the pathway is just prior to the C-C phenol-coupling step therefore, N4OMT
gene expression is a suitable choice to serve as a model for analysis of co-expressing transcripts
encoding additional Amaryllidaceae alkaloid biosynthetic genes. Since the C-C phenol-coupling
enzyme is targeted herein, BLASTP was used to find transcripts that encode putative cytochrome
P450 enzymes. The resulting 544 N. sp. aff. pseudonarcissus cytochrome P450 protein sequences
were compared to the list of 3,704 N4OMT co-expressing transcripts identified by HAYSTACK.
This resulted in the identification of 18 N4OMT co-expressing cytochrome P450 transcripts in the
N. sp. aff. pseudonarcissus assembly. The Galanthus assemblies were interrogated using these 18
sequences to identify close homologues. This allowed for selection of the cytochrome P450
transcripts that consistently co-expressed with N4OMT across species in all assemblies. One
candidate (CYP96T1) co-expressed with N4OMT in all assemblies and was investigated further in
N. sp. aff. pseudonarcissus where its correlation was 0.9995. A close homologue to CYP96T1 with
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99 % identity in shared ORF sequence and the first 67 bases of the 3’ UTR was identified. In
contrast to CYP96T1, this transcript was complete at the 5’ end of the ORF and contained 5’ UTR
sequence information. This allowed the incomplete 5’ region of CYP96T1 to be predicted by
comparison. The PCR product generated with outer primers was sequenced and the inner primer
sequences were found not to deviate from the assembly prediction. A clone was acquired with no
conflicts to the previously known CYP96T1 sequence and was used for functional characterization.
Two additional variants were cloned reproducibly. The closest biochemically characterized
homologue to CYP96T1 was CYP96A15 from A. thaliana (Q9FVS9) (Figure 3.4).
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Figure 3.4. MUSCLE alignment of protein sequences for CYP96T1, CYP96T2, CYP96T3, the CYP96T1 sequence
from the N. sp. aff. pseudonarcissus ABySS and MIRA assembly and CYP96A15 from A. thaliana (Q9FVS9).
Simplified consensus motifs for cytochrome P450 enzymes are placed above the corresponding color inverted
CYP96T1 sequence. Dots are exact matches to CYP96T1 and dashes are gaps.

3.3.3 Enzyme Assays and Analysis by LC-MS/MS
The concentration of CYP96T1 in Sf9 cell culture was determined to be 2.5 nM by CO-difference
spectra. The temperature and pH optima for 4’-O-methylnorbelladine substrate were determined
to be 30⁰C (half height ±5-10⁰C) and 6.5 (half height ±1), respectively. Testing of the CYP96T1
enzyme demonstrated that several structurally related alkaloids were C-C phenol coupled as
detected by LC-MS/MS. These reactions were accompanied by a background reaction catalyzed
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by the Sf9 cells. 4’-O-Methylnorbelladine was C-C phenol coupled into N-demethylnarwedine,
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine in CYP96T1 assays. (10bS,4aR)- and (10bR,4aS)noroxomaritidine were identified by their identical liquid chromatographic retention times (Figure
3.5A) and mass spectrometric fragmentation pattern with (10bS,4aR)- and (10bR,4aS)noroxomaritidine mixed standard (Figure 3.5C and D). To determine the chirality of the
noroxomaritidine product, 4’-O-methylnorbelladine assays with CYP96T1 were analyzed with a
chiral-CBH column by LC-MS/MS. Chromatographic separation of (10bS,4aR)- and (10bR,4aS)noroxomaritidine standards was achieved preceding MS/MS analysis. Equal amounts of each
enantiomer were observed (Figure 3.6A). A mass spectrometric comparison of standards (Figure
3.6B and C) and enzymatically formed (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (Figure
3.6D and E) yielded identical MS/MS fragmentation patterns. The enzyme is, therefore, producing
both (10bS,4aR)- and (10bR,4aS)-noroxomaritidine. A minor N-demethylnarwedine product was
also detected in assays analyzed by HPLC on the Luna C8 column. The relative quantity of
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine and N-demethylnarwedine formed in assays with
CYP96T1 are quantified in Figure 3.7A and B. HPLC was used to measure the relative
contribution of these compounds to total product. (10bS,4aR)- and (10bR,4aS)-noroxomaritidine
account for ~99 % of the total product in CYP96T1 assays. (10bS,4aR)- and/or (10bR,4aS)noroxomaritidine and N-demethylnarwedine are also produced in assays containing only Sf9 cells
and 4’-O-methylnorbelladine, but not in an enzyme-free control, indicating Sf9 cells have the
ability to catalyze the C-C phenol couple with 4’-O-methylnorbelladine (Figure 3.5 A). In addition,
the N-methylated form of 4’-O-methylnorbelladine, 4’-O-methyl-N-methylnorbelladine, was
shown to produce several C-C phenol-coupled products when assayed with Sf9 cells alone, as
indicated by the detection of products with a mass reduction of 2 m/z, including narwedine and
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two unknown products (Figure 3.5B and 3.7D). Unknown 1 is enzymatically produced from 4’O-methyl-N-methylnorbelladine by CYP96T1, as indicated by the increase of product in assays
containing CYP96T1 as compared to the CPR-only control (Figure 3.5B). Unknown 2 production
can be explained by the endogenous activity of Sf9 cells only expressing CPR on 4’-Omethylnorbelladine (Figure 3.7E). These observations were confirmed by an MRM-based relative
quantification of selected transitions of these three products (Figure 3.7C, D, and E). The LCMS/MS fragmentation pattern of unknown 1 is a mixture of masses found in the para’-para
products (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (165.1 m/z, 184.2 m/z, 195.0 m/z, 212.2
m/z, 229.0 m/z) and masses +14 m/z (120.1 m/z, 149.1 m/z, 243.2 m/z, 258.1 m/z, 271.0 m/z),
representing the addition of a methyl moiety (Figure 3.5E). For this reason, it appears the enzyme
is capable of catalyzing formation of the para-para’ C-C phenol-couple regardless of Nmethylation state (Figure 3.7A and C). To examine the ability of CYP96T1 to C-C phenol couple
substrates with an altered carbon linker between the phenol groups, (S)-coclaurine and (R)coclaurine were also tested. Assays on ether (S)-coclaurine or (R)-coclaurine yield products with
a mass -2 m/z, which is consistent with a C-C phenol coupling. Product formation is not observed
when norbelladine or N-methylnorbelladine is used as substrate. These results indicate the 4’-Omethylation state of norbelladine may be important for substrate-enzyme binding. The substrates
3’-O-methylnorbelladine and 3’,4’-O-dimethylnorbelladine were tested to determine the relevance
of 3’-O-methylation; products were not detected (Table 3.5).
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Figure 3.5. LC-MS/MS enhanced product ion scan (EPI) monitoring the C-C phenol coupling of 4’-Omethylnorbelladine and 4’-O-methyl-N-methylnorbelladine in CYP96T1 assays. Arrows indicate peaks unique to Sf9
cell containing assays with substrate present. (A) Standards and assays with 4’-O-methylnorbelladine as the substrate.
Sample runs top to bottom (10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard (1 µM), CYP96T1 assay, CPR
assay, CYP96T1 assay without 4’-O-methylnorbelladine, and assay without Sf9 cells. (B) Standards and assays with
4’-O-methyl-N-methylnorbelladine as the substrate. Top to bottom narwedine standard, CYP96T1 assay, CPR assay,
assay without 4’-O-methylnorbelladine, and assay without Sf9 cells. (C) EPI of the (10bR,4aS)- and (10bS,4aR)noroxomaritidine standard. (D) EPI of the CYP96T1 (10bR,4aS)- and (10bS,4aR)-noroxomaritidine product with 4’O-methylnorbelladine as substrate. E. EPI of the CYP96T1 para-para’ product (Unknown 1) with 4’-O-methyl-Nmethylnorbelladine as substrate. Red fragments indicate the addition of one methyl group, 14 m/z, relative to
(10bR,4aS)- and (10bS,4aR)-noroxomaritidine and blue fragments indicate the same m/z as (10bR,4aS)- and
(10bS,4aR)-noroxomaritidine fragments. Intensity is presented in counts per second (CPS).
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Figure 3.6. Chromatographic separation and MS/MS analysis of the primary 4’-O-methylnorbelladine products
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine. The enantiomers (10bS,4aR)- and (10bR,4aS)-noroxomaritidine were
chromatographically separated with a chiral-CBH column and analyzed by MS/MS using an enhanced product ion
(EPI) scan. (A) Samples, top to bottom: (10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard, CYP96T1 assay,
CPR assay, CYP96T1 assay without 4’-O-methylnorbelladine substrate and no Sf9 cells assay. (B) EPI fragmentation
pattern for enantiomer 1 of (10bR,4aS)- and (10bS,4aR)-noroxomaritidine. (C) EPI fragmentation pattern for
enantiomer 2 of (10bR,4aS)- and (10bS,4aR)-noroxomaritidine. (D) EPI fragmentation pattern for enantiomer 1 in the
CYP96T1 assay with 4’-O-methylnorbelladine as substrate. (E) EPI fragmentation pattern for enantiomer 2 in the
CYP96T1 assay with 4’-O-methylnorbelladine as substrate. Intensity is presented in counts per second (CPS).
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Figure 3.7. Relative product formed in assays with 4’-O-methylnorbelladine (A and B) or 4’-O-methyl-Nmethylnorbelladine (C, D, and E) as substrate. Assays are performed in triplicate only expressing CPR or with CPR
in combination with CYP96T1. (A) para-para’ ((10bR,4aS)- and (10bS,4aR)-noroxomaritidine) product. (B) paraortho’ (N-demethylnarwedine) product. (C) Potentially para-para’ C-C phenol coupling (unknown 1) product. (D)
para-ortho’ (Narwedine) product. (E) Potentially ortho-para’ C-C phenol coupling (unknown 2) product.

The Km of (S)-coclaurine, 636.7 µM, and (R)-coclaurine, 658.8 µM, are several orders of
magnitude higher than the Km values for 4’-O-methylnorbelladine, 1.13, and 4’-O-methyl-Nmethylnorbelladine, 3.28 (Table

3.5).

Substrate inhibition

was

observed in

4’-O-

methylnorbelladine and 4’-O-methyl-N-methylnorbelladine with Ki values of 64.34±26.36 µM and
173.7±140.0 µM respectively. No substrate inhibition was observed in (R)-coclaurine or (S)coclaurine with concentrations up to 1000 µM. The kcat of 4’-O-methylnorbelladine was higher
than observed for 4’-O-methyl-N-methylnorbelladine, (R)-coclaurine, or (S)-coclaurine. The
kcat/Km value 4’-O-methylnorbelladine is at least one order of magnitude larger than the 4’-Omethyl-N-methylnorbelladine, (R)-coclaurine, or (S)-coclaurine values consistent with the role of
4’-O-methylnorbelladine as the native substrate.
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Table 3.5. Substrate specificity tests for CYP96T1

Substrate

Km (µM)

kcat (1/min)

kcat/Km
Ki
(1/µM*m
in)

Modifications
monitored

4’-OMethylnorbelladine
4’-O-Methyl-Nmethylnorbelladine
(S)-Coclaurine

1.13±0.54

15.0±2.03

13

64.3±26.4

C-C phenol coupling

3.28±2.27

2.44±0.54

0.742

174±140

C-C phenol coupling

637±156

1.34±0.15

2.11x10-3

NA

(R)-Coclaurine

659±104

2.07±0.14

3.15x10-3

NA

3’-OMethylnorbelladine
3’,4’-ODimethylnorbelladin
e
Norbelladine
NMethylnorbelladine
Haemanthamine

NA

ND

NA

NA

Intramolecular
phenol
coupling and Intermolecular
coupling
Intramolecular
phenol
coupling and Intermolecular
coupling
C-C phenol coupling

NA

ND

NA

NA

C-C phenol coupling

NA
NA

ND
ND

NA
NA

NA
NA

C-C phenol coupling
C-C phenol coupling

NA

ND

NA

NA

(10bS,4aR)and
(10bR,4aS)Noroxomaritidine
Isovanillin
and
tyramine

NA

ND

NA

NA

Methoxy bridge formation
and hydroxylation
Methoxy bridge formation
and hydroxylation

NA

ND

NA

NA

C-C
phenol
coupling,
amine-aldehyde
condensation,
aminealdehyde condensation, and
C-C phenol coupling

ND=not detected
NA=not applicable

3.3.4 Sodium Borohydride Assays and Analysis by LC-MS/MS
Enzymatically formed N-demethylnarwedine from enzyme assays with CYP96T1 was converted
to N-demethylgalanthamine by sodium borohydride reduction and detected by LC-MS/MS (Figure
3.8A). Sodium borohydride selectively reduced the ketone group on (10bS,4aR)- and (10bR,4aS)noroxomaritidine and N-demethylnarwedine to yield a stereoisomeric mixture of the
corresponding alcohols 8-O-demethylmaritidine and N-demethylgalanthamine. Confirmation of
N-demethylgalanthamine in these assays is demonstrated by the identical retention time (Figure
3.8A,) and fragmentation pattern (Figure 3.8B and C) with N-demethylgalanthamine standard.
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Another peak is also present with a different retention time (Figure 3.8A) and very similar
fragmentation pattern (Figure 3.8D) and is likely the diastereomer epi-N-demethylgalanthamine
formed by non-stereospecific ketone reduction. Stereoisomeric 8-O-demethylmaritidine is present
in sodium borohydride reduced CYP96T1 4’-O-methylnorbelladine assays as the largest product
peak (Figure 3.8A). This is validated by a comparison of the LC-MS/MS fragmentation pattern of
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine reduced by sodium borohydride to the
corresponding peak in the CYP96T1 assay (Figure 3.8E and F).

Figure 3.8. LC-MS/MS Enhanced Product Ion (EPI) scan of sodium borohydride (NaBH 4) treated CYP96T1 assays
with 4’-O-methylnorbelladine substrate. (A) Chromatograph with the following sample runs top to bottom: Ndemethylgalanthamine standard, CYP96T1 assay, CPR assay, assay with no Sf9 cells and CYP96T1 assay without
4’-O-methylnorbelladine. (B) EPI fragmentation pattern of the N-demethylgalanthamine standard peak eluting at 4
min. (C) EPI fragmentation pattern of the N-demethylgalanthamine product in the CYP96T1 assay. (D) EPI
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fragmentation pattern of epi-N-demethylgalanthamine from the CYP96T1 assay. E. EPI fragmentation pattern of
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine standard reduced to stereoisomeric 8-O-demethylmaritidine. F. EPI
fragmentation pattern of reduced (10bS,4aR)- and (10bR,4aS)-noroxomaritidine product from CYP96T1 assays.

3.4 Discussion
CYP96T1 converts 4’-O-methylnorbelladine to the products (10bS,4aR)- and (10bR,4aS)noroxomaritidine indicating that this enzyme is involved in the biosynthesis of (10bR,4aS)noroxomaritidine-derived

alkaloids

such

as

haemanthamine.

Because

(10bS,4aR)-

noroxomaritidine derivatives have not been previously reported from Narcissus spp., the
enantiomeric mixture of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine made by CYP96T1 is
interesting. It is possible the CYP96T1 enzyme is only making the achiral intermediate that later
spontaneously forms the different enantiomeric forms of noroxomaritidine. If this is the case the
absence of the (10bS,4aR)-noroxomaritidine derivatives in Narcissus spp. may result from another
enzyme perhaps associated with CYP96T1 directing the chirality of the ring closure.
The production of N-demethylnarwedine by CYP96T1 is of interest to galanthamine
biosynthesis. The low amount produced relative to (10bS,4aR)- and (10bR,4aS)-noroxomaritidine
indicates that under the assay conditions used N-demethylnarwedine is not the enzyme’s primary
product. Kinetic analysis shows a clear preference for 4’-O-methylnorbelladine over all other
tested substrates (Table 3.5).
A diradical mechanism has been proposed for formation of the C-C phenol coupled product
of (R)-reticuline and 4’-O-methylnorbelladine (Eichhorn et al., 1998; Grobe et al., 2009) (Figure
3.9A and B). A radical is formed on a hydroxyl group ortho or para to the position for formation
of a carbon bond. To determine if the 3’(para’) hydroxyl group is important to C-C phenol
coupling, 3’-O-methylnorbelladine and 3’,4’-O-dimethylnorbelladine were tested for enzymatic
activity; product formation was not observed. The lack of activity with a methoxy group at the
93

para’ position indicates that a free hydroxyl moiety is important at this position to enable
extraction of a hydroxyl radical by the enzyme (Figure 3.9A). These results support the proposed
mechanism for C-C phenol coupling of 4’-O-methylnorbelladine.

Figure 3.9. Proposed C-C phenol coupling mechanisms. (A) 4’-O-Methylnorbelladine para-para’ C-C phenol
coupling mechanism followed by spontaneous nitrogen ring closure to form noroxomaritidine. (B) (R)-Reticuline
para-ortho’ C-C phenol coupling mechanism to form salutaridine panel adapted from (Grobe et al., 2009).

The oxygen binding and activation motif (A/G)GX(D/E)TT is substantially different
between CYP96T1 (and its variants) when compared to cytochrome P450 enzymes that catalyze
hydroxylation reactions. The substitutions G322Q, D324N and T326Q replace key hydrophobic,
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acidic and alcoholic groups with neutral hydrophilic amide groups. This is consistent with the
proposal of Mizutani and Sato that cytochrome P450 enzymes not performing hydroxylation
reactions can have a significantly altered oxygen binding and activation site (Mizutani and Sato,
2011). The highly conserved (387-389) EXXR, PERF (430-433) PXRX, and heme binding (464473) FXXGXRXCXG motifs are present (Syed and Mashele, 2014). These motifs are thought to
have more universal functions than substrate hydroxylation including maintenance of proper
structural integrity and heme placement in cytochrome P450 enzymes (Hasemann et al., 1995;
Hatae et al., 1996).
Presented herein is the first documented C-C phenol coupling cytochrome P450 enzyme in
monocots. It is in the CYP96 family of cytochrome P450 enzymes, which falls into the CYP86
clan. The CYP96A15 from A. thaliana has been previously documented to be a midchain alkane
hydroxylase involved in wax synthesis (Greer et al., 2007). Previously documented members of
the CYP86 clan have shown activity towards fatty alcohols, fatty acids, alkanes, and derivatives
thereof (Nelson and Werck-Reichhart, 2011). This makes this phenolic alkaloid a novel substrate
class for this clan of cytochrome P450 enzymes. All other documented C-C phenol coupling plant
cytochrome P450 enzymes are in the CYP71 clan (Nelson and Werck-Reichhart, 2011). This
indicates the C-C phenol coupling activity of CYP96T1 was acquired independently from other
known C-C phenol coupling cytochrome P450 enzymes. This independent origin of C-C phenol
coupling could help direct the search for new C-C phenol coupling cytochrome P450 enzymes.
The independent evolution of CYP96T1 shows that future searches for novel C-C phenol coupling
enzymes should look broadly across the cytochrome P450 families because lineages of cytochrome
P450 enzymes responsible for these reaction activities have likely not all been identified. Other
phenol-phenol coupling reactions potentially performed by cytochromes P450 include the
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intramolecular coupling of 4’-O-methylnorbelladine to oxonorpluvine in lycorine biosynthesis,
(S)-autumnaline to isoandrocymbine in colchicine biosynthesis, and the intermolecular C-C phenol
coupling of dioncophylline A biosynthesis (Bringmann et al., 2000; Herbert, 2003).
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Chapter 4: The Identification of a
Noroxomaritidine/Norcraugsodine
Reductase in the Core Amaryllidaceae
Alkaloid Biosynthetic Pathway
Amaryllidaceae alkaloids are a large group of plant natural products with over 300 documented
structures and diverse biological activities. An approved medication from this group is the
Alzheimer’s treatment drug galanthamine. The first committed steps in the core Amaryllidaceae
alkaloid biosynthetic pathway are the condensation of 3,4-dihydroxybenzaldehyde and tyramine
to form the Schiff-base norcraugsodine and subsequent reduction of the imine to norbelladine. In
this study, oxidoreductase genes that co-express with the previously discovered norbelladine 4’O-methyltransferase gene in Narcissus sp. and Galanthus spp. were cloned and expressed in E.
coli. One of these genes named noroxomaritidine/norcraugsodine reductase encodes an enzyme
that forms norbelladine from a mixture of 3,4-dihydroxybenzaldehyde and tyramine. Considering
the ability of norcraugsodine to form spontaneously in solution, the protein was crystallized and
shown to bind tyramine and an analogue of 3,4-dihydroxybenzaldehyde, piperonal, individually.
This binding indicates the enzyme may be able to facilitate norcraugsodine formation by binding
the substrates, thereby providing a scaffold for the Schiff-base condensation prior to imine bond
reduction.

4.1 Introduction
Norbelladine is an intermediate in the biosynthesis of all Amaryllidaceae alkaloids (Battersby et
al., 1961b; Battersby et al., 1961a; Wildman et al., 1962c). norbelladine can act as a reactive
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oxygen species scavenger and suppress enzymes associated with inflammation including CAS1,
CAS2, and NF-ҡB making it a potential drug for mitigating the effects of obesity (Park, 2014). It
is synthesized from the condensation and reduction of 3,4-dihydroxybenzaldehyde and tyramine
(Figure 4.1). Tyrosine decarboxylase catalyzes the formation of tyramine from tyrosine (Lehmann
and Pollmann, 2009). 3,4-Dihydroxybenzaldehyde is hypothesized to originate from a branch of
the phenylpropanoid pathway with demonstrated intermediates trans-cinnamic acid, 4hydroxycinnamic acid, and either 3,4-dihydroxycinnamic acid or 4-hydoryxbenzaldehyde
(Suhadolnik et al., 1963a). 3,4-Dihydroxycinnamic acid could be directly converted to 3,4dihydroxybenzaldehyde by a paralogue of vanillin synthase. Vanillin synthase converts ferulic
acid to vanillin (Gallage et al., 2014). This reaction is similar to that proposed for the reduction of
3,4-dihydroxycinnamic acid to 3,4-dihydroxybenzaldehyde by a hydratase/lyase type mechanism.
An analogous, non-oxidative pathway is proposed for benzaldehyde biosynthesis. Reactions
similar to the beta-oxidative and non-oxidative CoA-dependent pathways of benzaldehyde
biosynthesis are also a possibility (Widhalm and Dudareva, 2015). The condensation to the Schiffbase norcraugsodine is analogous to known amine-aldehyde condensing enzymes including
norcoclaurine synthase and strictosidine synthase (Kutchan et al., 1994; Samanani and Facchini,
2002). Considering the simple chemistry required for the formation of norcraugsodine, it is
possible that the condensation occurs either nonenzymatically or in the active site of the same
enzyme that reduces norcraugsodine to norbelladine. Enzyme superfamilies capable of catalyzing
reductions similar to the reduction of norcraugsodine to norbelladine include aldo-keto reductases
(AKRs) and short-chain dehydrogenase/reductases (SDRs) (Jörnvall et al., 1995; Penning, 2015).
An example of an imine reductase from the alcohol dehydrogenase (ADH) branch of the SDR
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superfamily is tetrahydroalstonine synthase from Catharanthus roseus, which reduces strictosidine
aglycone to tetrahydroalstonine (Stavrinides et al., 2015).

Figure 4.1. Amaryllidaceae alkaloid biosynthesis. Enzymes involved in the pathway are indicated in blue.
Abbreviations phenylalanine ammonia lyase (PAL), norbelladine 4’-O-methyltransferase (N4OMT), and
noroxomaritidine/norcraugsodine reductase (NNR).
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Norbelladine is methylated and phenol-coupled to produce the vast diversity of
Amaryllidaceae alkaloids, including the representative alkaloids for the primary skeletons
haemanthamine, crinine, galanthamine, and lycorine. Several downstream Amaryllidaceae
alkaloid biosynthetic enzymes have been characterized on a molecular level including norbelladine
4’-O-methyltransferase (N4OMT) and CYP96T1. N4OMT is responsible for the 4’-O-methylation
of norbelladine to 4’-O-methylnorbelladine (Kilgore et al., 2014). CYP96T1 is a para-para’
phenol-phenol coupling cytochrome P450 that generates an enantiomeric mixture of
noroxomaritidine with a small quantity of N-demethylnarwedine from 4’-O-methylnorbelladine
(Chapter 3). The two enantiomers of noroxomaritidine are further modified into haemanthamineand crinine-type alkaloids. N-demethylnarwedine from CYP96T1 may contribute a small amount
to the galanthamine type alkaloids (Figure 4.1). Several of these compounds are interesting to
medicine including the anticancer compound haemanthamine and the Alzheimer’s disease
treatment galanthamine (Wilcock et al., 2003; Havelek et al., 2014). These gene discoveries
facilitate co-expression analysis to identify additional Amaryllidaceae alkaloid biosynthetic genes.
In this study, previously described in Chapters 2 and 3 Narcissus sp. aff. pseudonarcissus,
Galanthus sp., and Galanthus elwesii transcriptomes are interrogated for reductase genes that
consistently co-express with the previously discovered N4OMT in 4 or more of these
transcriptomes (Kilgore et al., 2014). These reductase cDNAs were cloned, expressed in E. coli,
and the proteins affinity purified. Assays monitoring the formation of norbelladine from a solution
containing 3,4-dihydroxybenzaldehyde and tyramine show formation of norbelladine with the
SDR, which we designated noroxomaritidine/norcraugsodine reductase (NNR). Competition
experiments and crystal structures indicate this enzyme acts directly on the 3,4dihydroxybenzaldhyde and tyramine and acts as a norcraugsodine synthase. In addition, the
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enzyme reduces a carbon-carbon double bond of the Amaryllidaceae alkaloid noroxomaritidine to
form one of the enantiomeric forms of oxomaritinamine. This enzyme is responsible for the first
committed biosynthetic step in the Amaryllidaceae alkaloids and will be key to future biological
production of these compounds.

4.2 Materials and Methods
4.2.1 Plant Tissue and Chemicals
Plant tissue and chemicals are as described for isolation and characterization of N4OMT and
CYP96T1 in Chapters 2 and 3 (Kilgore et al., 2014). In addition, the following chemicals were
used: piperonal from Sigma; 8,9-O-didemethyloxomaritidine and noroxomaritidine were from our
natural product collection; DMSO from New England BioLabs; nicotinamide adenine dinucleotide
phosphate disodium salt (NADP+) from MP Biomedicals, Inc; citric acid anhydrous reagent ACS
99.5% from ACROS; sodium borohydride 99% from Acros Organics; and sodium
cyanoborohydride reagent grade 95 % from Aldrich.

4.2.2 Candidate Gene Identification
Candidates were selected as in the discovery of CYP96T1 (Chapter 3), but instead of a list of
cytochromes P450, a list of oxidoreductases were used as a BLASTP query (Table D.1 and Table
D.2). Contigs found to co-express with N4OMT in 4 or more of the 5 available Amaryllidaceae
transcriptomes were cloned and tested for enzymatic activity (Chapter 3).

4.2.3 cDNA Cloning and Recombinant Enzyme Purification
cDNA was prepared as previously described in Chapter 3. The outer PCR reaction contained the
following components: 25 ng Narcissus sp. aff. pseudonarcissus bulb cDNA, 1X Phusion HF
reaction buffer, 1 U NEB Phusion High-Fidelity DNA polymerase, 3% DMSO, 0.4 mM dNTPs,
0.4 µM NNR forward outer, and 0.4 µM NNR reverse outer primers (Table D.3). The parameters
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for the PCR were 98 ⁰C 30 sec for 1 cycle, 98 ⁰C 10 sec, 50 ⁰C 30 sec, 72 ⁰C 60 sec for 35 cycles,
72 ⁰C 5 min 1 cycle, 4 ⁰C until removed. The inner PCR solution was the same except 0.2 µM
NNR forward inner and 0.2 µM NNR reverse inner primers were used and the outer PCR was used
as template instead of cDNA (Table D.3). The inner PCR program had a Tm of 52 ⁰C instead of
50 ⁰C and 25 cycles instead of 35 cycles. Primers for inner PCR have BamHI and NotI restriction
sites appended to the start and stop sites of the open reading frame. These were used for ligation
into pET28a and subsequent transformation into E. coli. Expression and subsequent affinity
purification of hexahistidine-tagged protein was as for N4OMT (Chapter 2).

4.2.4 Enzyme Assays
Initial screening assays contained 100 mM sodium phosphate buffer pH 7.0, 1 mM NADPH, 1
mM tyramine, 1 mM 3,4-dihydroxybenzaldehyde, and 10 µg pure protein in 100 µl. Reactions
were incubated at 30 ⁰C for 2 hr. Assays were extracted with ethyl acetate at pH 9.5 as previously
described (Kilgore et al., 2014). The extracts were re-suspended in mobile phase matching the
solvent composition at the beginning of the HPLC program. Samples were run on the same LCMS/MS instrument and with the same program as for CYP96T1 (Chapter 3). MS/MS parameters
used to specifically monitor norbelladine are collision energy (CE) 15, declustering potential (DP)
50, and m/z 260.0. Other compounds screened were tested with the parameters listed in Table D.4.
IC50 and specific activity assays were performed with 100 mM citrate buffer pH 6.0 at 35 ⁰C in 40
µl reactions. Substrates used in specific activity assays were all 500 µM with 1 mM NADPH. For
temperature optima and pH optima determination, the MRM parameters used to monitor
norbelladine were m/z 260.0/138.0 and m/z 260.0/121.0 with the same CE and DP as for screening.
For IC50 assays, oxomaritinamine was monitored with the following MRMs m/z 274.3/136.1 and
m/z 274.3/219.1 with CE (35) and DP (70). For specific activity measurements, a QTRAP 6500
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was used for MRM analysis with the same isocratic LC set up as previously described (Chapter
3). The MRM parameters for specific activity measurements were norbelladine m/z 260.1/238.0
and m/z 260.1/121.0 CE (60) and DP (10), 4’-O-methylnorbelladine m/z 274.1/137.0 and m/z
274.1/122.0 CE (20) and DP (60), and oxomaritinamine m/z 274.1/136.1 and m/z 274.1/219.1 CE
(30) and DP (70). Oxomaritinamine was quantified by incubating noroxomaritidine and NNR
overnight and equating the quantity of noroxomaritidine consumed to the quantity of
oxomaritinamine produced using the same HPLC program used to analyze enzyme assays during
N4OMT characterization at 288 nm (Kilgore et al., 2014). This standardized oxomaritinamine was
then used in specific activity experiments on the LC-MS/MS to determine product quantity.

4.2.5 Substrate Synthesis
4-(2-((1,3-Benzodioxol-5-ylmethyl)amino)ethyl)phenol, 3’-O-methylnorbelladine, and 4’-Omethylnorbelladine were made by mixing ~100 mM sodium cyanoborohydride and ~10 mM
tyramine with ~10 mM piperonal, vanillin, or isovanillin respectively in 2.5 ml anhydrous
methanol. After incubation overnight at room temperature the reactions were dried to 0.5 ml with
subsequent addition of 2 ml 1 M sodium carbonate pH 9.5 and extracted with 2 ml ethyl acetate
two times. After drying, all extracts were dissolved in 1 ml water, diluted 1/20 and purified by
fraction collection with the same HPLC program used to analyze enzyme assays during N4OMT
characterization (Kilgore et al., 2014).

4.2.6 Protein Expression and Purification for Crystallography
NNR in pET28a was transformed into E. coli Rosetta II (DE3) cells (EMD Millipore). Cells were
cultured in Terrific broth up to A600nm∼0.6-0.8. Induction of protein production used a final
concentration of 1 mM IPTG overnight at 16⁰C. Cells were pelleted by centrifugation and
resuspended in lysis buffer (50mM Tris, pH 8.0, 500 mM NaCl, 20 mM imidazole, 10% glycerol,
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and 1% Tween). Following sonication, cell debris were removed by centrifugation, and the
resulting lysate was passed over a Ni2+-nitriloacetic acid (Qiagen) column equilibrated in lysis
buffer. The column was then washed with 50 mM Tris, pH 8.0, 500 mM NaCl, 20 mM imidazole,
and 10% glycerol. Bound His-tagged protein was eluted with 50 mM Tris pH 8.0, 500 mM NaCl,
250 mM imidazole, and 10% glycerol. Prior to crystallization the His-tag was removed by
overnight dialysis at 4 ⁰C using thrombin (1:2000 total protein). Dialyzed protein was loaded onto
a mixed Benzamidine-Sepharose/Ni2+-nitrilotriacetic acid column. The flow-through was loaded
onto a Superdex-75 26/60 HiLoad FPLC size-exclusion column (GE Healthcare) equilibrated with
25 mM Hepes, pH 7.5, and 100 mM NaCl. Protein concentration was determined by the Bradford
method (Protein Assay, Bio-Rad) with bovine serum albumin as a standard.

4.2.7 Protein Crystallography
Purified NNR was concentrated to 8 mg ml−1 and crystallized using the hanging-drop vapordiffusion method with a 2 μl drop (1:1 concentrated protein and crystallization buffer). Diffraction
quality crystals of the NNR·NADP+ complex were obtained at 4 ⁰C with a crystallization buffer
of 20% PEG-8000 and 100 mM Hepes, pH 7.5. Crystals of the NNR·tyramine complex formed at
4 ⁰C with a crystallization buffer of 2 M ammonium sulfate, 100 mM CAPS, pH 10.5, 200 mM
lithium sulfate, 1.5 mM NADP+, and 6 mM tyramine. For the NNR·piperonal complex, 35% MPD,
100 mM sodium acetate, pH 4.5 and 3 mM piperonal was the crystallization buffer. Crystals were
flash-frozen in liquid nitrogen the mother liquor supplemented with 25% glycerol as a
cryoprotectant. Diffraction data (100 K) was collected at the Argonne National Laboratory
Advanced Photon Source 19-ID beamline. The data were indexed, scaled, and integrated with
HKL3000 (Minor et al., 2006). Molecular replacement implemented in PHASER (de La Fortelle
and Bricogne, 1997) using Datura stramonium tropioine reductase-II (PDB: 2AE2; (Yamashita et
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al., 1999) as a search model to determine the structure of the NNR·tyramine complex. Iterative
rounds of manual model building and refinement, which included translation-libration-screen
(TLS) models, used COOT (Emsley and Cowtan, 2004) and PHENIX (Adams et al., 2010). The
crystal structures of NNR·NADP+ and NNR·piperonal were determined by molecular replacement
using PHASER (de La Fortelle and Bricogne, 1997) and the NNR·tyramine structure with ligands
removed as the search model. Data collection and refinement data are summarized in Table D.5.
The final model of the NNR·NADP+ complex included residues Ser-16- Gly-271, the NADP+
ligand, and 136 waters. The final model of the NNR·tyramine complex included residues Ser-16–
Gly-271 for chain A, residues Met15–Gly-271 for chain B, residues Leu-17–Asn-270 for chain C,
and residues Leu-17–Gly-271 for chain D, the NADP+ ligand in chains A-C, the tyrosine ligand in
chains B and D, and 443 waters. The final model of the NNR·piperonal complex included Met15–Gly-271, the NADP+ ligand, the piperonal ligand in chain A, and 644 waters.

4.3 Results
4.3.1 Identification and Initial Characterization of NNR
When interrogating for N4OMT co-expressing oxidoreductase homologues, 36 transcripts were
identified in the Narcissus sp. aff. Pseudonarcissus transcriptome. Of these 36 transcripts,
medp_9narc_20101112|58880 was found to co-express with N4OMT in the previously described
ABySS and MIRA based assemblies for Narcissus sp. aff. pseudonarcissus, Galanthus elwesii and
Galanthus sp. (Kilgore et al., 2014). It also co-expressed with N4OMT in the previously described
Trinity based assembly for Galanthus sp. (Chapter 3). The medp_9narc_20101112|58880 was
incomplete in the 3’ and 5’ regions. The medp_9narc_20101112|12438 sequence, a close
homologue of apparent full-length, was used to design primers for PCR amplification. A clone
with the genbank accession number KU295569 was obtained that differed from the
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medp_9narc_20101112|58880 at four nucleic acids with one nonsynonymous change (see Figure
D.1 for details).
Expression in E. coli followed by affinity purification on a cobalt column resulted in a
prominent ~31 kDa band on SDS-PAGE. When this enzyme was tested for norcraugsodine
reductase activity, it was found to produce norbelladine (Figure 4.2A). The identity of norbelladine
was ascertained by comparison of the MS fragmentation pattern to that of authentic standard
(Figure 4.2B and C). The gene was therefore named noroxomaritidine/norcraugsodine reductase
(NNR). A norbelladine background is present in all assays with 3,4-dihydroxybenzaldehyde and
tyramine due to spontaneous formation of norcraugsodine. The enzyme was found to be NADPH
dependent. This is consistent with the prediction that this will be a NADPH-dependent SDR based
on the residues Lys-21, Ser-42, and Arg-43 (Kallberg et al., 2002). NADH did not serve as
reductant for NNR. To simplify analysis quantity of enzymatic product relative to chemical
background was maximized for pH and temperature. This maximum was found to be at pH 6.0
and 35 ⁰C (Figure D.2 A-D).
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Figure 4.2. LC-MS/MS enhanced product ion scan (EPI) of the enzyme assays testing
noroxomaritidine/norcraugsodine reductase (NNR) m/z 260.0. (A) Top to bottom Norbelladine standard, functioning
NNR assay, assay without tyramine and 3,4-dihydroxybenzaldehyde, assay without NADPH, and assay with His-tag
purified E. coli vector control protein extract but no NNR protein. (B) EPI of norbelladine standard. (C) EPI of NNR
product.

4.3.2 Substrate Specificity
Substrate specificity tests identified vanillin, isovanillin, and piperonal as substrates. These
substrates, paired with tyramine, generated the products 3’-O-methylnorbelladine, 4’-Omethylnorbelladine, and 4-(2-((1,3-benzodioxol-5-ylmethyl)amino)ethyl)phenol, respectively
(Table 4.1). The structures of the enzymatic products were confirmed by comparing to the products
produced by chemical condensation and reduction of vanillin, isovanillin, or piperonal with
tyramine in methanol containing sodium cyanoborohydride and subsequent examination with LCMS/MS. The resulting LC-MS/MS spectra were identical whether the products were chemically
or enzymatically generated. To examine the ability of NNR to operate in other points of
Amaryllidaceae alkaloid pathways noroxomaritidine was tested for reductase activity. This
substrate in planta is thought to be reduced at a ketone group to yield the alcohol normaritidine
that is further modified into haemanthamine or potentially at a 1-2 carbon-carbon double bond to
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give oxomaritinamine. Noroxomaritidine was reduced by NNR (Figure 4.3A). When
noroxomaritidine reduced by NNR was compared to noroxomaritidine reduced with sodium
borohydride, the fragmentation patterns were not the same (Figure 4.3B and C). Aldehyde and
ketone double bonds are the typical substrates of sodium borohydride (Banfi et al., 2001). Carboncarbon double bonds can be reduced, but the ketone will be reduced as well. For this reason, the
product generated by the sodium borohydride reduction is likely normaritidine. The 1-2 carboncarbon double bond is, therefore, likely reduced by NNR into oxomaritinamine. The
noroxomaritidine substrate is an enantiomeric mixture. The enantiomers were therefore resolved
by chiral chromatography as previously described (Chapter 3). In overnight assays only one of the
noroxomaritidine enantiomers was notably consumed. More than half of the enantiomeric mixture
was never consumed, indicating that the enzyme acts preferentially on one of the two enantiomers.
Optically pure standards of known configuration are lacking, so the absolute configuration of the
preferred substrate remains unknown. To examine the ability of NNR to take different substrates
like noroxomaritidine the demethylated form 8,9-O-didemethyloxomaritidine was tested for
enzymatic activity. 8,9-O-Didemethyloxomaritidine was reduced by NNR yielding a product
highly similar to oxomaritinamine in its mass spectrum indicating that the product is also reduced
at the carbon-carbon double bond and therefore is 9-O-demethyloxomaritinamine. Fragments that
are identical from these two molecules include m/z 91.1, m/z 94.1, m/z 108.1, and m/z 136.1.
Fragments that represent the presence of an additional methyl group in oxomaritinamine compared
to 9-O-demethyloxomaritinamine are m/z 246.1 and m/z 232.1, m/z 219.1 and m/z 205.1, m/z 204.1
and m/z 190.1, m/z 190.1 and m/z 176.1, and m/z 165.0 and m/z 151.0.
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Table 4.1. Substrate specificity of NNR

+

Substrate

Product monitored

Specific
activity
(standard
deviation) (pmol min-1 mg-1)

3,4-Dihydroxybenzaldehyde
and tyramine

Norbelladine

21.2 (1.2)

Isovanillin and tyramine

4’-O-Methylnorbelladine

5.33 (0.21)

Noroxomaritidine

Oxomaritinamine

8600 (1250)

Vanillin and tyramine

3’-O-Methylnorbelladine

+

Piperonal and tyramine

4-(2-((1,3-Benzodioxol-5ylmethyl)amino)ethyl)phenol

+

8-O-,9-ODidemethyloxomaritidine

9-O-Demethyloxomaritinamine

+

product made but not quantified

Figure 4.3. LC-MS/MS enhanced product ion scan (EPI) for NNR enzyme assays m/z 274.3 monitoring reduction of
noroxomaritidine. (A) Top to bottom substrates noroxomaritidine standard, NNR assay, assay without
noroxomaritidine, assay without NADPH, and assay with E. coli empty vector protein extract substituted for NNR
protein. (B) EPI of NNR product. (C) EPI of noroxomaritidine reduced with NaBH4.

An analysis of the relative reaction rates for substrates potentially involved in
Amaryllidaceae alkaloid biosynthesis indicated several NNR preferences. Assays on 3,4dihydroxybenzaldehyde-tyramine or noroxomaritidine show preference for the noroxomaritidine
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reduction by several orders of magnitude, 21.2(1.2) µmol min-1 mg-1 verses 8600(1250) µmol min1

mg-1 (Table 4.1). This is not surprising considering the condensation reaction that is prerequisite

to the reduction of norcraugsodine. The specific activity for the isovanillin-tyramine reaction,
5.33(0.21) µmol min-1 mg-1, was determined to be about 4-fold less than 3,4dihydroxybenzaldehyde-tyramine. This difference supports the proposed pathway with 3,4dihydroxybenzaldehyde as the substrate for condensation and reduction with subsequent
methylation by N4OMT to 4’-O-methylnorbelladine.

4.3.3 Inhibition of Noroxomaritidine Reduction
The reduction of noroxomaritidine provided the opportunity to test the occupancy of the active site
of NNR by 3,4-dihydroxybenzaldehyde and tyramine. If the enzyme active site binds these
substrates, it could facilitate the formation of norcraugsodine prior to reduction to norbelladine.
Also, if the enzyme binds these substrates then the individual components could act as competitive
inhibitors for the reduction of noroxomaritidine. If previously formed norcraugsodine is the
substrate NNR acts on than this inhibition would not be expected. The IC50 values of tyramine,
3,4-dihydroxybenzaldehyde, and piperonal are greater than 300 µM (Table 4.2). Piperonal has a
lower IC50 value (330 µM) than 3,4-dihydroxybenzaldehyde (1,050 µM). This could result from
the increased stability of piperonal relative to 3,4-dihydroxybenzaldehyde or a stronger binding to
the active site. These values are high, however, strictosidine synthase has been shown to have a
Km of even greater magnitude Km ~4 mM for tryptamine and secologanin (Hampp and Zenk, 1988).
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Table 4.2. NNR noroxomaritidine reduction inhibition

Inhibitor

IC50 (µM)

Tyramine

1,050

3,4-Dihydroxybenzaldehyde

3,870

Piperonal

330

4.3.4 Structure of NNR
The crystal structures of Narcissus sp. aff. pseudonarcissus NNR complexed with NADP+, NADP+
and tyramine, and NADP+ and piperonal were determined to 1.7 Å, 1.8 Å and 1.5 Å, respectively.
NNR can be classified as a classical short-chain dehydrogenase reductase (SDR), containing the
conserved dinucleotide binding motif TGxxxGxG at the N-terminus (Persson and Kallberg, 2013).
NNR is a tetramer with each chain being 271 amino acids in length and contains the classic
Rossmann fold typical of the SDR enzyme family (Rossmann et al., 1975). An alternating α/β
structure formed by seven parallel β-sheets sandwiched between two layers of three α-helices
shapes the NADPH binding domain (Figure 4.4A). NNR uses NADPH as an electron donor to
catalyze the reduction of norcraugsodine to norbelladine. NADPH binds the active site pocket of
NNR through polar interactions and nonpolar interactions (Figure 4.4B). The adenine ring, which
is in the anti conformation, interacts with the side chain carboxylate of Val-83 through its exocyclic
N6 and a terminal hydroxyl group of Asp-82 through hydrogen bonding with N1. The 2′-phosphate
of the adenine ribose interacts with Arg-57 through hydrogen bonds to 1N and N of the side
chain and to the backbone amide-nitrogen. Additionally, the adenine ribose phosphate interacts
with the hydroxyl side chain of Ser-56. These interactions are key structural features that
distinguish the NADPH SDRs from the NADH-specific enzymes (Deacon et al., 2000; Filling et
al., 2002). The adenine binding pockets of all SDRs are stabilized by a highly conserved DxxD
motif (Filling et al., 2002). The nicotinamide ribose has the C3′-endo conformation, and its C3
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hydroxyl group hydrogen bonds to the Thr-34 hydroxyl. The 2′-hydroxyl of the nicotinamide
ribose interacts with Tyr-175, a key residue for substrate recognition, and the 3′-hydroxyl of the
nicotinamide ribose interacts with another key substrate-recognition residue, Lys-199, and the
carboxylate of Asn-110. A water molecule is responsible for hydrogen bonding to two of the
nicotinamide ribose phosphate oxygens, while a third hydrogen bond forms between an oxygen on
the first nicotinamide ribose phosphate and Thr-210. The syn conformation of the nicotinamide
ring is stabilized by a hydrogen bond involving the nicotinamide carboxamide group to the
backbone amide-nitrogen Ile-208. The A-face of the nicotinamide ring packs against several
aliphatic side chains (Ile-208, Pro-225, Gly-226, and Ala-227) and directs the B-face toward the
binding pocket for the imine substrate. The NNR·NADP+ complex was intended to be an apo
enzyme but the binding affinity of NADP+ to the NNR active site prevented its removal during
purification from E. coli.

Figure 4.4. Crystal structure of NNR. (A) Ribbon diagram of the NNR tetramer complexed with NADP+ and tyramine.
(B) Polar contacts between NADP+ and NNR. (C) Tyramine co-crystallized with NNR. (D) Piperonal co-crystallized
with NNR.
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Tyramine and piperonal were co-crystallized with NNR with NADP+ (Figure 4.4C and D).
These crystals demonstrate that these two compounds can bind to the NNR active site prior to
condensation into a Schiff-base. In the context of the noroxomaritidine reduction both these
compounds were demonstrated to inhibit the reduction and this is consistent with their position in
the active site (Table 4.2). Both compounds interact with residues Tyr-175 and Lys-179, blocking
the transfer of the hydride from C4 of the nicotinamide ring, and would prevent the reduction
reaction of noroxomaritidine. The amine group of tyramine hydrogen bonds to Tyr-175 at a
distance of 3.2 Å, while the distance between tyramine and C4 of the nicotinamide is 3.36 Å.

4.4 Discussion
NNR belongs to the SDR superfamily. It is closely related to the tropinone reductase-like
reductases that are frequently involved in the metabolism of secondary metabolites (Brock et al.,
2008; Reinhardt et al., 2014). This is the second example of a member of the SDR superfamily in
plants reducing an imine functional group (Stavrinides et al., 2015). This makes SDRs promising
candidates to target for identifying additional imine reductase activities.
NNR shows two separate enzymatic activities. One is the formation of norbelladine from
a mixture of tyramine and 3,4-dihydroxybenzaldehyde. The norbelladine forming reaction is one
of the first committed steps in Amaryllidaceae alkaloid biosynthesis. The reaction consists of two
steps: condensation of tyramine and 3,4-dihydroxybenzaldehyde to an imine, and subsequent
reduction of the imine. NNR was shown to have norcraugsodine reductase activity, and potentially
facilitates the condensation of tyramine and 3,4-dihydroxybenzaldehyde to form norcraugsodine.
The competition experiments designed to determine the enzyme’s ability to bind 3,4dihydroxybenzaldehyde and tyramine alone resulted in high IC50 values. However, actual
concentrations of tyramine can be 3 mM in bulb tissue of Narcissus sp. aff. pseudonarciss. In
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addition, enzymes for secondary metabolism can have high Km values, such as that for strictosidine
synthase (Hampp and Zenk, 1988). Crystal structures also showed binding of the individual
components tyramine and piperonal to the NNR active site. This confirms the binding of these
uncondensed molecules to the active site.
A second activity of the enzyme is the reduction of one of the enantiomeric forms of
noroxomaritidine to oxomaritinamine. Depending on the enantiomer being reduced, this second
activity could contribute to the biosynthesis of maritinamine or elwesine (Boit and Döpke, 1961;
Pabuççuoglu et al., 1989). The double bond is reduced in both maritinamine or elwesine, but are
derived from (10bR,4aS)-noroxomaritidine and (10bS,4aR)-noroxomaritidine, respectively.
When using co-expression analysis to search for additional Amaryllidaceae alkaloid
biosynthetic genes individual genes will vary in their expression pattern over diverse
environmental, developmental, tissue, and time points. Because of these differences the addition
of NNR to a co-expression analysis with N4OMT and CYP96T1 in systems other than what was
initially used to identify them will enrich efforts to identify additional biosynthetic genes and
provide a deeper understanding of the relationships between Amaryllidaceae alkaloid biosynthesis
and accumulation of participating enzymes.
The discovery of NNR now makes it possible to produce Amaryllidaceae alkaloids through
bioengineering. Tyrosine decarboxylase, a well-known enzyme in other systems, has been
identified in Narcissus sp. aff. pseudonarcissus and the recombinant enzyme has been
biochemically validated to have tyrosine decarboxylase activity (Appendix A). While some
aspects of 3,4-dihydroxybenzaldehyde synthesis remain unknown, a synthetic biology system for
the production of vanillin produces 3,4-dihydroxybenzaldehyde as an intermediate (Hansen et al.,
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2009). It is possible that the addition of tyrosine decarboxylase, the enzymes required for 3,4dihydroxybenzaldehyde production, and NNR to a heterologous system would be sufficient for the
production of norbelladine. Even if the synthase activity is not sufficient in NNR to drive the
condensation reaction, a heterologous system may make sufficient quantities of the two substrates
that the spontaneous condensation proceeds and NNR can mediate reduction. The previously
discovered N4OMT and CYP96T1 could also be added to the system to potentially obtain
haemanthamine, crinine, and some galanthamine skeleton derivatives (Kilgore et al., 2014). This
could provide a more efficient production system for these anticancer compounds and Alzheimer’s
disease treatments (Wilcock et al., 2003; Havelek et al., 2014).
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Chapter 5: Conclusions and Perspectives
5.1 Thesis Conclusions
This thesis examines how Amaryllidaceae alkaloids are biosynthesized using an effective workflow
for identifying pathway genes in non-model systems. The hypothesis from which this workflow
evolved is that genes involved in the biosynthesis of particular Amaryllidaceae alkaloids are coregulated and this leads to correlations between biosynthetic gene expression and corresponding
end-product accumulation. The discovery of the Amaryllidaceae alkaloid biosynthetic genes
norbelladine 4’-O-methyltransferase (N4OMT), CYP96T1, and noroxomaritidine/norcraugsodine
reductase (NNR) in Chapters 2, 3, and 4 through correlations with galanthamine accumulation
(N4OMT) and co-expression with N4OMT (CYP96T1 and NNR) confirms this underlying
hypothesis. The confirmation of this hypothesis is in keeping with previous work demonstrating
co-expression of other pathways with end metabolites and their biosynthetic genes (Augustin et al.,
2015). These core pathway enzyme discoveries also provide biosynthetic information relevant to
many biologically active Amaryllidaceae alkaloids, including the Alzheimer’s treatment
galanthamine and the anti-cancer compound haemanthamine (Wilcock et al., 2003; Havelek et al.,
2014).
The three newly discovered enzymes were found to have the following activities: NNR
reduces

norcraugsodine

methylnorbelladine,

and

to

norbelladine,

CYP96T1

N4OMT

phenol-phenol

methylates
couples

norbelladine

to

4’-O-

4’-O-methylnorbelladine

to

noroxomaritidine. When characterizing N4OMT, CYP96T1, and NNR, previously unknown
aspects of Amaryllidaceae alkaloid biosynthesis were discovered. N4OMT and CYP96T1 were
both shown to accept N-methylated versions of norbelladine and 4’-O-methylnorbelladine as
substrate. Detailed radiolabeling experiments by Eichhorn et al. have placed the N-methylation of
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galanthamine-type alkaloids after phenol-phenol coupling (Eichhorn et al., 1998). Prior to these
experiments, it was thought that N-methylation occurred prior to phenol-phenol coupling due to
radiolabeling experiments of Barton and Kirby (Barton and Kirby, 1962). The ability of N4OMT
and CYP96T1 to accept substrates with and without N-methylation may explain incorporation of
4’-O-methyl-N-methylnorbelladine in earlier work.
CYP96T1 generated the enantiomeric mixture (+)-noroxomaritidine when using 4’-Omethylnorbelladine as substrate. This could indicate a role of this cytochrome P450 in formation of
both the haemanthamine series of compounds and the crinine series. The presence or absence of
derivatives from one or the other enantiomer in different Amaryllidaceae species could be a result
of degradation pathways, a stereospecific version of this enzyme, or chiral directing of the achiral
intermediate by another enzyme in planta.
NNR was shown to have norcraugsodine reductase activity, and potentially facilitates the
condensation of tyramine and 3,4-dihydroxybenzaldehyde to form norcraugsodine. It was also
shown to be multifunctional with the ability to reduce the carbon-carbon double bond on one of the
enantiomers of noroxomaritidine. The potential involvement of NNR in all these reactions will be
informative to future work on these reactions.

5.2 Application of Minimalist and Extensive Workflows
This thesis demonstrates that a simple workflow consisting of RNA-seq on only a few welldetermined tissues and quantification of a limited number of metabolites can be used to discover
biosynthetic genes in species and pathways for which previous genetic knowledge is lacking. This
is a practical alternative workflow to methods that take a metabolomics approach with substantial
expression data (Saito et al., 2008). The extensive approach has better statistical power, but can be
cost and labor prohibitive in non-model species without available omic data. The extensive
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approach is particularly problematic if the plant tissue being analyzed comes from a rare plant,
which is sometimes the case in secondary metabolism research (Augustin et al., 2015). However,
the minimalist approach is limited statistically, due to the low sample number, causing small
correlations to be undetectable. Also, experimental conditions with strong correlations between
genes may be lacking from the dataset. Because of the resulting danger of false negatives when
using a minimalist approach, the ability to test for multiple enzymes in a pathway can be vital. If
one enzyme in the pathway is not observed to co-express with another under tested conditions a
third enzyme in the pathway may be co-expressing and discoveries can be made without 100 %
success for every enzymatic activity tested.
The CYP96T1 work demonstrates the ability to identify biosynthetic genes by comparing
co-expression across species in the Amaryllidaceae. In a rare species, this could be applied to
identify shared biosynthetic genes using data from closely related common species with similar
alkaloids, forming the basis for the identification of the unique biosynthetic genes in the rare
species. Interspecies comparisons are useful when applied to species with extensive information in
relation to a species with limited information. Homology, along with a few expression data points,
can be used to link one of these well-studied species with an orphan species of interest. Using
known genes along with the unique properties of non-model species, new insights can be obtained
by just adding a few more data points to the well-characterized system. The co-expression of
transcripts in Amaryllidaceae alkaloid biosynthesis and co-accumulation of alkaloids with these
transcripts opens the door for future co-expression studies in Amaryllidaceae alkaloids. It also
validates the use of co-expression analysis as a starting point when studying secondary metabolism
in non-model species.
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5.3 Future
Biosynthesis

Directions

for

Amaryllidaceae

Alkaloid

The discovery of more biosynthetic genes in the pathways for Amaryllidaceae alkaloids is an area
of future interest because of their medicinal potential and importance to Amaryllidaceae biology.
Many of the biosynthetic steps leading to compounds like haemanthamine and galanthamine remain
undiscovered. These uncharacterized genes likely belong to established biosynthetic gene
superfamilies. Given the co-expression observed between the discovered biosynthetic genes, it is
likely several of these uncharacterized genes will also co-express. For this reason, the application
of co-expression coupled with homology to superfamilies with the same underlying chemistry will
likely result in the discovery of additional biosynthetic genes. Steps of particular interest include
the reduction of N-demethylnarwedine to N-demethylgalanthamine, which is likely catalyzed by an
AKR or an SDR superfamily member. While this gene was not found to co-express with N4OMT
in ≥ 4 of the transcriptomes in Chapter 4, it is likely present in the ≥ 3 or the ≥ 2 lists. These genes
were observed during the discovery of the NNR, but were assigned a lower priority than the genes
co-expressing in 4 transcriptomes. The same applies to the reductase responsible for the reduction
of noroxomaritidine to normaritidine. These reductases would be of particular biotechnological
interest because they are directly downstream of the enzymatically characterized core biosynthetic
genes and could prove useful for the production of these compounds in heterologous systems. Also
of interest are the N-methyltransferase that converts N-demethylgalanthamine to galanthamine, the
oxidase (probably a cytochrome P450) responsible for the oxide bridge formation in the
normaritidine to vittatine conversion, the hydroxylase (possibly a cytochrome P450 or a 2oxoglutarate-dependent dioxygenase) that converts vittatine to 11-hydroxyvittatine, and the
methyltransferase that converts 11-hydroxyvittatine to haemanthamine. A cytochrome P450 that
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yields more N-demethylnarwedine than CYP96T1 may yet be discovered, given the high content
of galanthamine type alkaloids in some Amaryllidaceae.
In addition to biosynthetic genes transcription factors regulating their biosynthesis could be
discovered through co-expression analysis, examination of transcription factor binding motifs on
the promoters of known genes, or proximity on gene clusters. The discovery of these transcription
factors could enable an understanding of the biosynthetic regulation of these compounds and help
identify other plant pathways that may share these transcription factors and therefore experience
similar regulation. The resulting understanding of this regulation could assist efforts to boost the
content of specific Amaryllidaceae alkaloids in members of the Amaryllidaceae and provide insight
into other co-regulated pathways that may work with Amaryllidaceae alkaloid biosynthesis to
achieve goals such as deterring herbivores.
A potential expansion of the work would be to sequence more members of the
Amaryllidaceae. Sequencing projects have already been performed on the closely related bulbs
Allium cepa (onion), Allium sativum (garlic), Allium fistulosum (bunching onion), and Allium
tuberosum (chinese chive) (Kamenetsky et al., 2015; Rajkumar et al., 2015; Tsukazaki et al., 2015).
A cross comparison of additional species could make phylogenetic sense of the distribution of
Amaryllidaceae alkaloids across the Amaryllidaceae. Searching for the characterized genes in
additional species and in the neighboring alliums could yield information regarding their origin. In
addition, the sequencing of species with unique metabolites such as Crinum spp. would facilitate
the discovery of the enzymes that lead to these unique products. These studies on the diversity of
Amaryllidaceae alkaloids would provide key information for attempts to tailor Amaryllidaceae
alkaloid pathways, in heterologous systems and members of the Amaryllidaceae, for optimal
alkaloid production or the absence of these frequently poisonous alkaloids.
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The discovery of additional biosynthetic genes may require a more extensive collection of
conditions and tissues to use for co-expression analysis. Because some biosynthetic genes differ in
regulation (modulated for example through differing transcription factors) depending on tissue,
time in development, and stress some genes may require data sets with diverse tissues, time points,
and environmental conditions to identify co-expression. To determine how consistently these
discovered biosynthetic genes co-express, a finer organ or cell type level than leaf, bulb, and
inflorescence could be monitored with qRT-PCR. Effects of environmental conditions and variation
over the course of a year could also be monitored. This data could help identify the level of
variability between known biosynthetic genes providing a baseline for unknown biosynthetic genes.
Problematic tissues, time points, and conditions with little correlation between the known
biosynthetic genes could be observed and perhaps excluded in co-expression experiments, or
examined more thoroughly to determine the cause of the discrepancy between the expression
patterns.
A cell type by cell type analysis of known-gene expression and the alkaloid end products
could help determine if the Amaryllidaceae alkaloid biosynthesis is cell type specific or if transport
occurs as in the biosynthesis of vindoline in Catharanthus roseus. In vindoline biosynthesis
different cell types are required for early and late biosynthetic steps (St-Pierre et al., 1999). When
transport of intermediates between cell types is required for the biosynthesis of secondary
metabolites this other cell type could be next to the original cell or in a completely different organ
of the plant. Potential reasons for the transport of intermediates include regulation of the
biosynthetic process through prevention of undesired side reactions or a simpler evolutionary route
where transport rather than alteration of ancestral biosynthetic gene promoters allow for cell type
co-expression. An example of specialized cells for secondary metabolite production is the secretory
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cells on the glandular trichomes of Mentha piperita. These cells secrete monoterpenoids into a
central subcuticular cavity that stores the toxic terpenoids for protection of the leaf from herbivore
attack (McCaskill et al., 1992). The need for a specialized cavity to store the toxic monoterpenoids
is what drives cell type specific production in Mentha piperita. In addition to minimizing toxicity
through specialized structures these cells may produce these metabolites to spare other cells from
the associated metabolic load.
In addition to measuring transcript level, measuring changes in alkaloid content during the
above experiments could provide information on the expression of unknown biosynthetic genes
responsible for the elaboration of these alkaloids. For example, if 11-hydroxyvittatine is present but
not haemanthamine in one tissue, while haemanthamine and not 11-hydroxvittatine is present in
another tissue this would be an indication that the methyltransferase that methylates 11hydroxyvittatine to haemanthamine is present in the latter tissue but not the former. Such
discoveries would help with the detection of the corresponding enzyme by incorporating new
information into the co-expression analysis.
The examination of the proteome during any of these experiments could provide the actual
levels of the enzymes of interest in different tissues. The correlation of the transcriptome to the
proteome can be moderate (Ghazalpour et al., 2011). Discrepancies between transcript levels and
active protein levels can be due to protein degradation, protein inactivation by redox signaling, a
phosphorylation requirement, or other regulatory modification. These changes can be detected
through proteomic analysis (Zhang and Ge, 2011). The ability of proteomic analysis to detect these
changes could enable the identification of changes in active protein content and identify candidates
correlating with the biosynthesis of Amaryllidaceae alkaloids on the protein level but not on the
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transcript level. The proteome would also serve as an independent validation of sequences in the
transcriptome that frequently align to peptides.
Another route to discover more biosynthetic genes is to place candidate genes under more
biologically relevant conditions for enzyme assays. The temperature and pH used in screening
assays are slightly higher than biological 30 ⁰C verses 20-25 ⁰C and the pH is approximately 7.58.0 which may not mimic biological conditions if enzymes are compartmentalized in locations such
as the vacuole with a reported pH of 5.5 (Mathieu et al., 1989). If the Amaryllidaceae alkaloids are
biosynthesized in a complex of enzymes that facilitates biosynthesis through shuttling of the
intermediates or a localized increase in intermediates, then some enzymes in the pathway may only
function effectively in the context of this complex. It has been observed that when chorismate
mutase and 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase, two biosynthetic enzymes in
aromatic amino acid biosynthesis, in Mycobacterium tuberculosis interact their allosteric properties
are extended and enzymatic activity is enhanced (Blackmore et al., 2015). If some Amaryllidaceae
alkaloid biosynthetic enzymes require this physical interaction to function, then some enzyme
activates may not be identifiable through an enzyme assay approach until a better understanding of
this potential complex and its components is achieved.

5.4 Potential Applications
Amaryllidaceae Basic Science

to

Biotechnology

and

In addition to interrogating metabolomics, transcriptomic, and genomic datasets for other
biosynthetic genes, several experiments could be done using the three genes characterized in this
thesis. These genes can be used for the production of noroxomaritidine and some Ndemethylnarwedine in a heterologous expression system such as yeast or Camelina. The
biosynthesis of 3,4-dihydroxybenzaldehyde in the Amaryllidaceae has at least one uncharacterized
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enzyme, but a synthetic system for the creation of this compound has already been described using
3-dehydroshikimate dehydratase from Podospora pauciseta and an aromatic carboxylic acid
reductase from Nocardia sp. that could be used in these heterologous systems (Hansen et al., 2009).
To create a system for the production of galanthamine in yeast or in planta will require 2-3 enzymes
in addition to the 3 discovered (if you count CYP96T1) and the 3 required for 3,4dihydroxybenzaldehdye

and

tyramine

production.

CYP96T1

will

make

some

N-

demethylnarwedine but an enzyme with a higher specificity for this product would be desirable.
The reductase for the N-demethylnarwedine to N-demethylgalanthamine conversion and the Nmethyltransferase for the N-demethylgalanthamine to galanthamine conversion would also be
required. A system producing haemanthamine will require the discovery of a reductase, an oxide
bridge forming enzyme, and a methyltransferase. A hydroxylase is also required for the conversion
of vittatine to 11-hydorxyvittatine in haemanthamine biosynthesis but the 2-oxoglutarate-dependent
dioxygenase described in Appendix B would provide this activity if the chirality of the product is
appropriate for haemanthamine biosynthesis.
Although many Amaryllidaceae alkaloids can be made chemically, this process can require
toxic catalysts and many of the chemical synthesis protocols are not efficient or scalable for
commercial production. The ability to produce these compounds with low cost inputs and low
toxicity outputs using biological systems including members of the Amaryllidaceae, yeast, or a fast
growing plant such as Camelina is appealing. The discovery of the missing enzymes for
galanthamine or haemanthamine biosynthesis would enable experiments aimed at improving their
production in biological systems. The need to discover biosynthetic genes in valuable secondary
metabolite pathways from non-model systems for improved production of these compounds is a
general need to achieve the goal of more affordable healthcare. The development of generally
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applicable workflows, such as the ones utilized in this thesis featuring technologies such as next
generation sequencing, will enable the future discovery of these valuable biosynthetic genes.
Amaryllidaceae alkaloid biosynthetic gene knock-out cultivars with resulting altered
alkaloid profiles could prove ideal systems for ecological tests of the effects of Amaryllidaceae
alkaloids on plant fitness and species interactions. An Amaryllidaceae plant with a knockout
mutation for N4OMT or NNR could be devoid of Amaryllidaceae alkaloids and a comparison of
this plant to wild type under stresses including herbivore challenge would enable a direct testing of
the proposed roles of these alkaloids in planta as described in section 1.1.2. The knockout of
CYP96T1 would potentially result in a deficiency of haemanthamine type alkaloids but not others
like galanthamine. The importance of the small quantity of galanthamine type alkaloid phenolphenol coupling made by CYP96T1 could be determined by the presence or absence of
galanthamine derivatives in the CYP96T1 mutant. If galanthamine type alkaloids are not
significantly reduced in this mutant, then another enzyme may be primarily responsible for this
reaction and the resulting plant may provide a cleaner alkaloid extract when preparing galanthamine
commercially. CRISPR/Cas technology enables the creation of these knockout mutants in these
genes and their close paralogues in various Amaryllidaceae plants through precise gene editing
(Sander and Joung, 2014).
The transcriptomic resources are also useful for CRISPR/Cas guided mutagenesis of other
genes not necessarily related to Amaryllidaceae alkaloid biosynthesis, including genes for plant
development, floral morphology, and floral color. These traits are of particular interest to the floral
industry and using CRISPR/Cas with the transcriptomes in this way could lead to more desirable
cultivars. It could also be used for answering basic biology questions regarding bulb development.
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Due to the slow turnaround of the tissue culture and transformation protocol previously reported in
Narcissus tazzeta var. chinensis, these projects would be long-term (Lu et al., 2007).

5.5 Summary
In summary, this thesis confirmed the hypothesis that genes involved in the biosynthesis of selected
Amaryllidaceae alkaloids are co-regulated and that this leads to correlations between biosynthetic
gene expression and corresponding end-product accumulation. Biosynthetic genes that were either
co-accumulating with the Amaryllidaceae alkaloid galanthamine or were co-expressing with the
biosynthetic gene N4OMT were thereby discovered. During the subsequent characterization of
these enzymes, hypotheses on how Amaryllidaceae alkaloids are made were tested. The discovery
of these enzymes validates a simple workflow for biosynthetic gene discovery in Amaryllidaceae
and provides tools in the form of transcriptomes and validated enzymes. These tools can be used
for further study of Amaryllidaceae alkaloid biosynthesis and regulation, general molecular biology
questions relating to members of the Amaryllidaceae including bulb development, and
biotechnology applications. This could lead to better production systems for medicinal compounds
such as the Alzheimer’s treatment galanthamine and anticancer compound haemanthamine and to
a better understanding of this plant family.
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Appendix A: The Identification and
Confirmation of the Narcissus sp. aff.
pseudonarcissus Tyrosine Decarboxylase
A.1 Introduction, Results, and Discussion
Tyrosine decarboxylase (TyrDC) is the enzyme responsible for the conversion of tyrosine to
tyramine in an early stage of the Amaryllidaceae alkaloid biosynthetic pathway. This enzyme was
previously discovered in other plants (Lehmann and Pollmann, 2009). To confirm the presence of
a similar enzyme in Narcissus, homologues to a previously characterized TyrDC from Arabidopsis
thaliana were identified and tested for enzymatic activity. A TyrDC homologue was found to
encode an enzyme with tyrosine decarboxylase as shown in Figure A.1 and is deposited in
GenBank under the Accession Number KT378599.

A.2 Methods
A.2.1 PCR and Cloning
Nested PCR reactions were used to amplify the TyrDC as in as for N4OMT in Chapter 2 except
TyrDC specific primers were used for outer and inner PCR, the outer PCR consisted of 30 cycles
with a Tm of 52 ⁰C, and the inner PCR consisted of 30 cycles with a Tm of 54 ⁰C. Digestion with
NotI and BamHI with subsequent ligation into pET28a and transformation into DH5a for plasmid
amplification are also as in Chapter 2. The resulting plasmid was purified, sequenced, and
transformed into BL21 Rosetta cells as in Chapter 2.

A.2.2 Protein Purification, Enzyme Assays, and HPLC
The protein was purified by inducing the transformed E. coli overnight at 16 ⁰C with 1 mM IPTG
and subsequent His-tag purification as in Chapter 2. The protein concentration was determined by
the Bradford assay and the purity evaluated with SDS-PAGE as in Chapter 2. The enzyme assays
are based on the work of Lehmann and Pollmann with 100 mM potassium phosphate pH 7.5, 5 µg
pure TyrDC, 2 mM pyridoxal 5’-phosphate, and 200 µM tyrosine at 30 ⁰C for 2 hr (Lehmann and
Pollmann, 2009). The assays were extracted by adjusting the pH to 10 with the addition of two
volumes 1 M NaCO2 and extracting with two volumes ethyl acetate two times as in Chapter 2.
Samples were analyzed using the same HPLC system and program as described in Chapter 2.
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Figure A.1. Production of tyramine by tyrosine decarboxylase monitored at 288 nm on HPLC. Top to bottom; blank,
tyramine, tyrosine, functioning assay with TyrDC, no substrate control, and no enzyme control.

A.3 References
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Appendix B: The Identification of a 2Oxoglutarate Dependent Dioxygenase
Capable of Hydroxylating Vittatine into
One of the Two Diastereomeric Forms of
11-Hydroxvittatine.
B.1 Introduction, Results, and Discussion
The biosynthesis of the haemanthamine-type alkaloids involves the hydroxylation of vittatine to
11-hydroxyvittatien as discussed in detail in Chapter 1.1.5. During the research described in this
thesis, a 2-oxoglutarate dioxygenase was found to co-express with N4OMT in all the Galanthus
spp. assemblies described in Chapter 3. This cDNA was expressed in Sf9 cells and the recombinant
enzyme tested for the ability to hydroxylate vittatine. It was found to hydroxylate vittatine with a
fragmentation pattern and retention time identical to one of the two peaks produced by the
diastereomeric mixture present in the reference compound (Figure B.1A-C), however, the absolute
configuration of the product is unknown. The enzyme clearly only makes one diastereomer (Figure
B.1A). The cDNA sequence of vittatine 11-hydroxylase has been deposited in GenBank under the
accession number KT985905.

B.2 Methods
B.2.1 Reagents
Reagents were as described in Chapters 2, 3, and 4. Vittatine and 11-hydroxyvittatine were
synthesized previously. Reagents unique to this study were sodium ascorbate and α-ketoglutaric
acid potassium salt (2-oxoglutarate) from Sigma-Aldrich and ferrous sulfate from Fisher
Scientific.

B.2.2 Candidate Gene Selection
As a part of the search for oxidoreductases in Chapter 4, Galanthus-20120814-25202 (vittatine 11hydroxylase), a homologue of the Pisum sativum 2-oxoglutarate-dependent dioxygenase
(O24648), was found to co-express with N4OMT in both the ABySS and MIRA and the Trinity
based assemblies for Galanthus sp. and Galanthus elwesii (Lester et al., 1997). Its co-expression
with four of the five available transcriptomes prompted further study.

B.2.3 PCR
Vittatine 11-hydroxylase had a complete open reading frame in the Galanthus sp. ABySS and
MIRA assembly. Nested PCR was used to generate this ORF, followed by cloning and expression
in insect cells as in Chapter 3 (see Table B.1 for primers). When sequenced, several assembly
errors were identified with several substitutions and an insertion of nucleotides at both the 3’- and
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5’ end. These changes corrected several frame shifts predicted by the assembly that would have
resulted in a truncated protein.

B.2.4 Enzyme assays
Enzyme assays were incubated at 30 ⁰C for 4 hr and consisted of 100 µM Tris pH 7.5, 500 µM
ferrous sulfate, 500 µM sodium ascorbate, 500 µM 2-oxoglutarate, 35 % Sf9 cell suspension, and
10 µM vittatine. Assays were extracted with EtOAc, resuspended, and run on the same LC-MS/MS
hardware set-up as in Chapter 3. Specific parameters for vittatine monitoring were m/z 272.1,
declustering potential (70), and collision energy (35). The product 11-hydroxyvittatine was
monitored at m/z 288.1, declustering potential (70), and collision energy (35).

Figure B.1. Assays for the vittatine 11-hydroxylase. (A) Top to bottom 11-hydroxyvittatine, assay with vittatine 11hydroxylase expressing Sf9 cells, assay with no Sf9 cells, assay with no vittatine substrate, and Sf9 cells expressing
CPR instead of vittatine 11-hydroxylase. (B) Fragmentation pattern of 11-hydroxyvittatine. (C) Fragmentation pattern
of vittatine 11-hydroxylase product.

Table B.1. Primers used

Primer name

Primer sequence

Ga25202_FW_o
Ga25202_FW_i
Ga25202_RV_o
Ga25202_RV_i

TCAAGCAAAGACACCCATTCT
aattGGATCCATGGGTTCCGATGTCAAATCA
CTTGTTCCAAACACATTACAACA
aattGCGGCCGCTTACACGATTCGTTTCTGCCA
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Table C.1. Methyltransferases used in BLAST search

Accession
number

Substrate specificity

AAQ01669.1

(R,S)-Norcoclaurine, (R)-norprotosinomenine,
norprotosinomenine, (R,S)-isoorientaline,

AAQ01670.1
AAQ01668.1

BAI79244.1

BAI79245.1

BAI79243.1

BAA06192.1
AAD29843.1
AAD29841.1
AAD29845.1
AAD29842.1
AAD29844.1
BAC22084.1

ACV50428.1
AAN61072.1

AAR02420.1

Reference
(S)-

Guaiacol, isovanillic acid, (R)-reticuline, (S)-reticuline,
(R,S)-orientaline,
(R)-protosinomenine,
(R,S)laudanidine
(1S)-N-Deacetylisoipecoside, (1R)-N-deacetylipecoside,
(13aR)-demethylalangiside,
(11bS)-7′-Odemethylcephaeline, (13aS)-redipecamine, (1R,S)isococlaurine,
(1R,S)-norcoclaurine,
(1R,S)isoorientaline, oripavine
(13aS)-3-O-Methylredipecamine,
(1S)-coclaurine,
(1R,S)-N-methylcoclaurine,
(1R,S)-4′-Omethylcoclaurine,
(1R,S)-6-O-methyllaudanosoline,
(1R,S)-nororientaline, (1S)-norreticuline, (1S)-reticuline,
(13aS)-coreximine
(1S)-N-Deacetylisoipecoside,
(1S)-7-O-methyl-Ndeacetylisoipecoside,
(11bS)-cephaeline,
(1R,S)isococlaurine,
(1R,S)-norcoclaurine,
(1S)-4′-Omethyllaudanosoline, (1R,S)-nororientaline, (1R,S)isoorientaline,
(1S)-norprotosinomenine,
(1R)norprotosinomenine, (1R,S)-protosinomenine
(R,S)-Scoulerine
See reference
See reference
See reference
See reference
See reference
Columbamine,
tetrahydrocolumbamine,
(S)-scoulerine,
2,3,9,10tetrahydroxyprotoberberine
Homology with caffeoyl-CoA O-methyltransferase
described in (Day et al., 2009)
Quercetin,
7-O-methylquercetin,
quercetin-3-Oglucoside, quercetagetin, 3-O-methylquercetagetin 6-Omethylquercetagetin, 6-hydroxykaempferol, myricetin,
luteolin, caffeoyl-CoA
Eriodictyol, homoeriodictyol, kaempferol, quercetin,
isorhamnetin, chrysoeriol
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(Ounaroon et al., 2003)
unpublished
(Ounaroon et al., 2003)

(Nomura
2010)

and

Kutchan,

(Nomura
2010)

and

Kutchan,

(Nomura
2010)

and

Kutchan,

(Takeshita et al., 1995)
(Frick and Kutchan, 1999)
(Frick and Kutchan, 1999)
(Frick and Kutchan, 1999)
(Frick and Kutchan, 1999)
(Frick and Kutchan, 1999)

(Eswaran et al., 2010)
(Ibdah et al., 2003)

(Schröder et al., 2004)

Table C.2. Methyltransferases used in phylogeny

Accession
number

Short name

Species

Substrate specificity

Reference

AAQ01669.1

PsN6OMT

(R,S)-Norcoclaurine, (R)-norprotosinomenine,
(S)-norprotosinomenine, (R,S)-isoorientaline,

AAQ01670.1

PsCOMT

(Ounaroon et
al., 2003)
Unpublished

AAQ01668.1

PsR7OMT

Papaver
somniferum
Papaver
somniferum
Papaver
somniferum

(Ounaroon et
al., 2003)

BAI79244.1

PiOMT2

Psychotria
ipecacuanha

BAI79243.1

PiOMT1

Psychotria
ipecacuanha

BAA06192.1

CjS9OMT

AAD29843.1

TtCOMT3

Coptis
japonica
Thalictrum
tuberosum

Guaiacol, isovanillic acid, (R)-reticuline, (S)reticuline,
(R,S)-orientaline,
(R)protosinomenine, (R,S)-laudanidine
(1S)-N-Deacetylisoipecoside,
(1R)-Ndeacetylipecoside, (13aR)-demethylalangiside,
(11bS)-7′-O-demethylcephaeline,
(13aS)redipecamine, (1R,S)-isococlaurine, (1R,S)norcoclaurine, (1R,S)-isoorientaline, oripavine
(1S)-N-Deacetylisoipecoside, (1S)-7-O-methylN-deacetylisoipecoside,
(11bS)-cephaeline,
(1R,S)-Isococlaurine, (1R,S)-norcoclaurine, (1S)
4′O-methyllaudanosoline,
(1R,S)nororientaline, (1R,S)-isoorientaline, (1S)norprotosinomenine, (1R)-norprotosinomenine,
(1R,S)-protosinomenine
(R,S)-Scoulerine

AAD29841.1

TtCOMT1

Thalictrum
tuberosum

See reference

AAD29845.1

TtCOMT5

Thalictrum
tuberosum

See reference

AAD29842.1

TtCOMT2

Thalictrum
tuberosum

See reference

AAD29844.1

TtCOMT4

Thalictrum
tuberosum

See reference

BAC22084.1

CjCOMT

Coptis
japonica

ACV50428.1

JcCCoAOMT

AAR02420.1

CrF4OMT

Q9C5D7.1

AtCCoAOMT

C7AE94.1

VvAOMT

Jatropha
curcas
Catharanthus
roseus
Arabidopsis
thaliana
Vitis vinifera

Columbamine,
tetrahydrocolumbamine,
(S)-scoulerine,
2,3,9,10-tetrahydroxyprotoberberine
Homology
with
caffeoyl-CoA
Omethyltransferase described in (Day et al., 2009)
Eriodictyol, homoeriodictyol, kaempferol,
quercetin, isorhamnetin, chrysoeriol
Not determined

ADZ76153.1

VpOMT4

Vanilla
planifolia

See reference

Cyanidin 3-glucoside, delphinidin 3-glucoside,
quercetin 3-glucoside, cyanidin, quercetin,
myricetin, pelargonidin 3-glucoside, catechin,
epicatechin
Tricetin, 5-hydroxyferulic acid ethyl ester, 5hydroxyferulic
acid,
myricetin,
3,4-
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(Nomura and
Kutchan,
2010)

(Nomura and
Kutchan,
2010)

(Takeshita et
al., 1995)
(Frick and
Kutchan,
1999)
(Frick and
Kutchan,
1999)
(Frick and
Kutchan,
1999)
(Frick and
Kutchan,
1999)
(Frick and
Kutchan,
1999)
(Morishige
et al., 2002)
(Eswaran et
al., 2010)
(Schröder et
al., 2004)
(Ibrahim et
al., 1998)
(Hugueney
et al., 2009)

(Widiez et
al., 2011)

dihydroxybenzaldehyde,
quercetin,
5hydroxyconiferaldehyde, caffeoyl CoA, caffeic
acid ethyl ester, caffeoylaldehyde, caffeic acid
Tricetin, 5-hydroxyferulic acid ethyl ester, 5hydroxyferulic
acid,
myricetin,
3,4dihydroxybenzaldehyde,
quercetin,
5hydroxyconiferaldehyde, caffeoyl CoA, caffeic
acid ethyl ester, caffeoylaldehyde, caffeic acid
2,7,4'-Trihydroxyisoflavanone, medicarpin

ADZ76154.1

VpOMT5

Vanilla
planifolia

Q84KK6

GeI4OMT

C6TAY1

GmF4OMT

Glycyrrhiza
echinata
Glycine max

AAY89237.1
3C3Y|A

LuCCoA3O
MT
McPFOMT

Linum
usitatissimum
Mesembryant
hemum
crystallinum

62361_DF6

NpN4OMT1

BAB71802.1

CjCNMT

Narcissus sp.
aff.
pseudonarcis
sus
Coptis
japonica

BAB12278.1

CsCNMT

Camellia
sinensis

Q93WU3

ObCV4OMT

Ocimum
basilicum

Q8WZ04

HsCOMT

Homo sapiens

A catechol

3CBG|A

SynOMT

Cyanobacteri
um
Synechocystis
sp. strain PCC
6803

Hydroxyferulic acid, caffeic acid, caffeoylCoA,
caffeoylglucose,
3,4,5trihydorxycinnamic
acid,
tricetin,
3,4dihydroxybenzoic acid

(Widiez et
al., 2011)

Quercetin, quercetagetin, caffeic acid, CoA,
caffeoyl glucose

(Akashi et
al., 2003)
(Kim et al.,
2005)
(Apuya
et
al., 2008)
(Kopycki et
al., 2008a)

Norbelladine, N-methylnorbelladine, dopamine

this study

(R)-Coclaurine,
(S)-coclaurine,
(R,S)norreticuline, (R,S)-norlaudanosoline, (R,S)-6O-methylnorlaudanosoline,
6,7-dimethoxyl1,2,3,4-tetrahydroisoquinoline, 1-methyl-6,7dihydroxy-1,2,3,4-tetrahydroisoquinolinne
7-Methylxanthine,
3-methylxanthine,
1methylxanthine, theobromine, theophylline,
paraxanthine
Chavicol, phenol, eugenol, t-isoeugenol, t-anol

(Choi et al.,
2002)

Apigenin, daidzein,
naringenin
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genistein,

quercetin,

(Kato et al.,
2000)
(Gang et al.,
2002)

(Kopycki et
al., 2008b)

Table C.3. Primers used in RACE, cloning, and colony PCR

Primer name

Primer sequence

62361_5’_RACE_outer

TCCACCTCATCTTCCGGACGAA

62361_5’_RACE_inner

ACTTCCGTTCCAGAGCGTGTT

62361_3’_RACE_outer

AGAAGACCTGTACGACCATGCAT

62361_3’_RACE_inner

ACGAGCGATTAGTGAAGCTCGTCA

62361_forward_outer

CTTCACTTGTGTCAAGTTCAAT

62361_reverse_outer

CCRATAGATAGCATGCAGAATCT

62361_forward_inner

a,b

aattCATATGGGTGCTAGCATAGATGATT

62361_reverse_inner

a,b

aattGCGGCCGCTCAATAAAGACGTCGGCAAATAGT

qRT-PCR_forward_62361

ATTGGTGTGTACACCGGCTATT

qRT-PCR_reverse_62361

TTCCATCTTCCGGTAAAGCCAAA

qRT-PCR_probe_62361

CTCTGCTCACAACTGC

T7 sequencing

TAATACGACTCACTATA

T7 terminator

GCTAGTTATTGCTCAGCGG

Table C.4. Parameters used for LC/MS/MS analysis

Compound

Predicted
CE value DP value Injection
molecular ion m/z (V)
(V)
volume (µl)
[M+H]

Galanthamine

288.1

35

70

10

Norbelladine*

260.1

15

60

10

4’-O-Methylnorbelladine*
N-Methylnorbelladine
4’-O-Methyl-N-methylnorbelladine*

274.1
274.1
288.2

35
20
20

60
60
60

10
10
10

Dopamine*
3’-O-Methyldopamine

154.1
168.1

20
20

70
70

20
20

Methylated dopamine product
Papaverine

168.1
340.2

20
52

70
70

20
10
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.

Figure C.1. NpN4OMT1 product 4’-O-methylnorbelladine proton NMR spectra with peak assignments.
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Figure C.2. NpN4OMT1 product 4’-O-methylnorbelladine COSY spectra.

[158]

Figure C.3. NpN4OMT1 product 4’-O-methylnorbelladine HMBC spectra.

[159]

Figure C.4. NpN4OMT1 product 4’-O-methylnorbelladine ROESY spectra.

[160]

Figure C.5. NpN4OMT1 product 4’-O-methylnorbelladine HSQC spectra.

[161]

Figure C.6. Effect of divalent cations, temperature, and pH on NpN4OMT1 enzyme activity. (A) Divalent cations
tested with 5 min assays with 5 µM of cation Ca2+, Co2+, Zn2+, Mg2+ or Mn2+. (B) pH optimum 15 min assays with 5
µM Mg2+. (C) Temperature optimum 15 min assays with 5 µM Mg2+. Divalent cation and pH testing reactions are 100
µl reactions at 37⁰C. The divalent cation test contained 4 µM norbelladine, while pH and temperature optimum tests
contained 100 µM norbelladine in the assay mix.

[162]
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Table D. 1. Oxidoreductases used in BLASTP search

Accession
number

Short name

Q9SE94
AAW60421.1
Q9SQ70

Species

Reference

Maize
Gluconobacter
oxydans
621H
Papaver somniferum

(Roje et al., 1999)
(Chen et al., 2010;
Schweiger et al., 2010)
(Unterlinner et al., 1999)

P. somniferum,
bracteatum

(Ziegler et al., 2006;
Geissler et al., 2007)

ABO93462.1

NADPH-dependent codeinone
reductase
SalR

P51102
Q40316
3H7U

Dihydroflavonol-4-reductase
Vestitone reductase
Akr4c9

Arabidopsis thaliana
Medicago sativa
Arabidopsis thaliana

(Saito et al., 2013)
(Guo and Paiva, 1995)
(Simpson et al., 2009)

AAD37373.1
B5WWZ8
O23240

Quinone oxidoreductase
FAO1
D-2-Hydroxyglutarate
dehydrogenase
Probable cinnamyl alcohol
dehydrogenase
2-Oxoglutarate-dependent
dioxygenase
Protochlorophyllide reductase
C, chloroplastic
GDP-L-fucose synthase 1

Arabidopsis thaliana
Lotus japonicus
Arabidopsis thaliana

(Sparla et al., 1999)
(Zhao et al., 2008)
(Engqvist et al., 2009)

Zea mays

(Halpin et al., 1998)

Pisum sativum

(Lester et al., 1997)

Arabidopsis thaliana

(Oosawa et al., 2000)

Arabidopsis thaliana

(Bonin and Reiter, 2000)

Cinnamyl
alcohol
dehydrogenase 5
Aldo-keto reductase family 4
member C8
Bifunctional
aspartokinase/homoserine
dehydrogenase 2
Alcohol dehydrogenase classP
Ferredoxin-2, chloroplastic
Ascorbate
peroxidase
1,
cytosolic
Aldo-keto reductase family 4
member C9
Ubiquinol
oxidase
1a,
mitochondrial

Arabidopsis thaliana

(Sibout et al., 2005)

Arabidopsis thaliana

(Simpson et al., 2009)

Arabidopsis thaliana

(Paris et al., 2002)

Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana

(Chang and Meyerowitz,
1986)
(Somers et al., 1990)
(Davletova et al., 2005)

Arabidopsis thaliana

(Simpson et al., 2009)

Arabidopsis thaliana

(Berthold, 1998)

O24562
O24648
O48741
O49213
O49482
O80944
O81852

P06525
P16972
Q05431
Q0PGJ6
Q39219
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Papaver

Q39659

Q43727
Q56Y42
Q56YU0
Q5C9I9
Q5N800
Q6ZHS4
Q8GWA1

Q8GXR9

Q8L799
Q8L9C4
Q8LEU3
Q949Q0

Q94AX4
Q9C9W5
Q9CA90
Q9FJ95
Q9LKA3
Q9LW56
Q9SA18

Q9SJ10
Q9SQT8

Q9ST62

Q9ST63

Glyoxysomal fatty acid betaoxidation
multifunctional
protein MFP-a
Glucose-6-phosphate
1dehydrogenase 1, chloroplastic
Pyridoxal
reductase,
chloroplastic
Aldehyde
dehydrogenase
family 2 member C4
(-)-Isopiperitenol/(-)-carveol
dehydrogenase, mitochondrial
Probable chlorophyll(ide) b
reductase NYC1 chloroplastic
Cinnamyl
alcohol
dehydrogenase 2
Internal alternative NAD(P)Hubiquinone oxidoreductase A1,
mitochondrial
Alternative
NAD(P)Hubiquinone oxidoreductase C1,
chloroplastic/mitochondrial
Inositol oxygenase 1
Very-long-chain 3-oxoacylCoA reductase 1
Chlorophyll(ide) b reductase
NOL, chloroplastic
Glycerol-3-phosphate
dehydrogenase [NAD(+)] 2,
chloroplastic
lactate
dehydrogenase
[cytochrome], mitochondrial
Glycerate
dehydrogenase
HPR, peroxisomal
Glyoxylate/hydroxypyruvate
reductase A HPR2
Sorbitol dehydrogenase
Malate dehydrogenase 2,
mitochondrial
Long-chain-alcohol oxidase
Bifunctional
aspartokinase/homoserine
dehydrogenase 1, chloroplastic
Cinnamyl
alcohol
dehydrogenase 3
Bifunctional 3-dehydroquinate
dehydratase/shikimate
dehydrogenase, chloroplastic
External alternative NADPHubiquinone oxidoreductase B1,
mitochondrial
Internal alternative NADPHubiquinone oxidoreductase A1,
mitochondrial

Cucumis sativus

(Preisig-Müller et al., 1994)

Arabidopsis thaliana
Arabidopsis thaliana

(Herrero et al., 2011)

Arabidopsis thaliana
Mentha piperita

(Ringer et al., 2005)

Oryza sativa subsp. Japonica

(Sato et al., 2009)

Oryza sativa subsp. japonica
Arabidopsis thaliana

(Michalecka et al., 2003)

Arabidopsis thaliana

Arabidopsis thaliana
Arabidopsis thaliana

(Beaudoin et al., 2009)

Arabidopsis thaliana

(Horie et al., 2009)

Arabidopsis thaliana

(Nandi et al., 2004)

Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana

Arabidopsis thaliana
Arabidopsis thaliana

Solanum tuberosum

Solanum tuberosum
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Q9SU56
Q9SZB3
Q9ZP06
Q9ZPI5

Galactono-1,4-lactone
dehydrogenase, mitochondrial
Putative
uncharacterized
protein
Malate dehydrogenase 1,
mitochondrial
Peroxisomal fatty acid betaoxidation
multifunctional
protein MFP2

Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana

*the end list contains all sequences in this table plus all plant AKRs listed on the
http://www.med.upenn.edu/akr/members.shtml web page and all sequences minus
GRMZM2G086773 from (Moummou et al., 2012) Table #3 were included.
Table D.2. Imine oxidoreductases used in BLASTP search

Accession
number

Short name

Species

Reference

AED92078.1
Q05762

Arabidopsis thaliana
Arabidopsis thaliana

(Funck et al., 2012)
(Lazar et al., 1993)

Arabidopsis thaliana

(Stepansky et al., 2005)

O22213

Pyrroline-5-carboxylate reductase
Bifunctional
dihydrofolate
reductase-thymidylate synthase 1
Lysine-ketoglutarate
reductase/saccharopine
dehydrogenase
bifunctional
enzyme
Cytokinin dehydrogenase 1

Arabidopsis thaliana

(Bilyeu et al., 2001)

Q4ADV8

Cytokinin dehydrogenase 2

Q6NKX1

Proline
dehydrogenase
2,
mitochondrial
Probable polyamine oxidase 4
Polyamine oxidase 1
Cytokinin dehydrogenase 2
Polyamine oxidase 3
Probable sarcosine oxidase
Probable polyamine oxidase 2

Oryza
sativa
subsp.
japonica
Arabidopsis thaliana

(Funck et al., 2010)

F4JVY8

Q8H191
Q9FNA2
Q9FUJ3
Q9LYT1
Q9SJA7
Q9SKX5

Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
Arabidopsis thaliana
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(Tavladoraki et al., 2006)

(Tavladoraki et al., 2006)

Table D.3. Primers used

Primer name

Primer sequence

NNR forward outer
NNR forward inner
NNR reverse outer
NNR reverse inner

GGAAAGCCTTCAGAGGAGATT
aattGGATCCATGTCGTTGGAGAAGAGATGGT
AGATAGCACCGTGGAGAT
aattGCGGCCGCTCAACCATTTATGGTCCGTCCT

Table D.4. Product MS/MS parameters

Substrate

Product

Parameters (parent ion
m/z)(CE)(DP)

3,4-Dihydroxybenzaldehyde
and tyramine

Norbelladine

(260.0)(15)(50)

Noroxomaritidine

Oxomaritinamine

(274.3)(35)(70)

Vanillin and tyramine

3’-O-Methylnorbelladine

(274.3)(20)(60)

Isovanillin and tyramine

4’-O-Methylnorbelladine

(274.3)(20)(60)

Piperonal and tyramine

4-(2-((1,3-Benzodioxol-5ylmethyl)amino)ethyl)phenol

(272.1)(20)(60)

8-O-,9-ODidemethyloxomaritidine

9-O-Demethyloxomaritinamine

(260.1)(35)(70)

Collision energy=CE
Declustering potential=DP
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Table D.5. NNR crystal structure parameters

Crystal

NNR•NADP+

NNR•NADP+•Piperonal NNR•NADP+•Tyramine

Space group

P 42 2 2

P 31 2 1

P 21 21 21

Cell dimensions

a = b = 60.377, c =
136.142Å

a = b = 73.386, c = 167.892Å

a = 61.8, b = 86.964, c =
186.115 Å

Wavelength (Å)

0.98

0.98

0.98

Resolution range (Å)
(highest shell resolution)

45.17 - 1.73 (1.792 1.73)

35.85-1.501 (1.554-1.501)

39.39 - 1.814 (1.879 - 1.814)

Reflections
(total/unique)
Completeness
shell)

27,098/2,606

84,467/8,243

90,854/8,266

99.73% (98.60%)

99.86% (98.67%)

99.17% (91.62%)

21.96 (2.39)

17.55 (2.30)

23.73 (2.30)

Rcryst/Rfree

18.1/21.5%

14.9/16.0%

18.3/21.3%

No. of protein atoms

1870

3971

7,650

No. of water molecules

136

644

443

No. of ligand atoms

48

107

174

Root
mean
square
deviation, bond lengths
(Å)
Root
mean
square
deviation, bond angles
(°)
Average B-factor (Å2),
protein, solvent

0.013

0.007

0.008

1.21

1.18

1.13

37.9, 37.7, 41.8

20.2,18.2,33.1

41.2, 41.2, 42.4

Data collection

(highest

〈I/σ〉 (highest shell)
Model and refinement

Stereochemistry, most favored,
allowed, outliers
Figure 0.1Figure A. 2Figure B. 2Figure C. 7
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Figure D.1. Alignment, generated with CLC main workbench version 6.9.1, of the original sequence
(medp_9narc_20101112|58880), the full length homologue (medp_9narc_20101112|12438), and the cloned sequence
(NNR). Dots indicate identical base pairs, identical amino acids are not shown, altered amino acids are shown in red
below the corresponding sequence, black arrows are over outer primer sequences, and red arrows are over inner primer
sequences.

[170]

Figure D.2. pH and temperature optima for NNR using MRM based quantification of norbelladine. (A) pH optimum
for NNR. (B) Temperature optimum for NNR. (C) NNR product:vector control background ratio with pH on the xaxis. (D) NNR product:vector control background ratio with temperature on the x-axis. Abbreviations counts per
second (CPS) and noroxomaritidine/norcraugsodine reductase (NNR).
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